# Den Europæiske Unions L 11/2009

| | ISSN 1725-2520 |
| --- | --- |
| Den Europæiske Unions
  Tidende | L 11 |
| | |
| Dansk udgave | Retsforskrifter | 52. årgang16. januar 2009 |

ISSN 1725-2520

Den Europæiske Unions

Tidende

L 11

Dansk udgave

Retsforskrifter

52. årgang16. januar 2009

---

| Indhold | | I   Retsakter vedtaget i henhold til traktaterne om oprettelse af Det Europæiske Fællesskab/Euratom, hvis offentliggørelse er obligatorisk | Side |
| --- | --- | --- | --- |
| | | FORORDNINGER |
| | | Kommissionens forordning (EF) nr. 26/2009 af 15. januar 2009 om faste importværdier med henblik på fastsættelse af indgangsprisen for visse frugter og grøntsager | 1 |
| | | Kommissionens forordning (EF) nr. 27/2009 af 15. januar 2009 om fastsættelse af importtolden for korn gældende fra den 16. januar 2009 | 3 |
| | | DIREKTIVER |
| | * | Kommissionens direktiv 2009/2/EF af 15. januar 2009 om 31. tilpasning til den tekniske udvikling af Rådets direktiv 67/548/EØF om tilnærmelse af lovgivning om klassificering, emballering og etikettering af farlige stoffer (
  1
  ) | 6 |

Indhold

I   Retsakter vedtaget i henhold til traktaterne om oprettelse af Det Europæiske Fællesskab/Euratom, hvis offentliggørelse er obligatorisk

Side

FORORDNINGER

Kommissionens forordning (EF) nr. 26/2009 af 15. januar 2009 om faste importværdier med henblik på fastsættelse af indgangsprisen for visse frugter og grøntsager

1

Kommissionens forordning (EF) nr. 27/2009 af 15. januar 2009 om fastsættelse af importtolden for korn gældende fra den 16. januar 2009

3

DIREKTIVER

*

Kommissionens direktiv 2009/2/EF af 15. januar 2009 om 31. tilpasning til den tekniske udvikling af Rådets direktiv 67/548/EØF om tilnærmelse af lovgivning om klassificering, emballering og etikettering af farlige stoffer (
  1
  )

1

6

| | | II   Retsakter vedtaget i henhold til traktaterne om oprettelse af Det Europæiske Fællesskab/Euratom, hvis offentliggørelse ikke er obligatorisk |
| --- | --- | --- |
| | | AFGØRELSER OG BESLUTNINGER |
| | | Europa-Parlamentet og Rådet |
| | | 2009/30/EF |
| | * | Europa-Parlamentets og Rådets afgørelse af 14. januar 2009 om udnævnelse af den europæiske tilsynsførende for databeskyttelse og den assisterende tilsynsførende | 83 |
| | | Kommissionen |
| | | 2009/31/EF |
| | * | Kommissionens beslutning af 12. januar 2009 om ændring af beslutning 2007/716/EF for så vidt angår visse virksomheder i sektorerne for kød og mælk i Bulgarien
  (meddelt under nummer K(2008) 8988)

   (
  1
  ) | 84 |

II   Retsakter vedtaget i henhold til traktaterne om oprettelse af Det Europæiske Fællesskab/Euratom, hvis offentliggørelse ikke er obligatorisk

AFGØRELSER OG BESLUTNINGER

Europa-Parlamentet og Rådet

2009/30/EF

*

Europa-Parlamentets og Rådets afgørelse af 14. januar 2009 om udnævnelse af den europæiske tilsynsførende for databeskyttelse og den assisterende tilsynsførende

83

Kommissionen

2009/31/EF

*

Kommissionens beslutning af 12. januar 2009 om ændring af beslutning 2007/716/EF for så vidt angår visse virksomheder i sektorerne for kød og mælk i Bulgarien
  (meddelt under nummer K(2008) 8988)

   (
  1
  )

(meddelt under nummer K(2008) 8988)

1

84

| | | |
| --- | --- | --- |
| | * | Meddelelse til læserne (se omslagets tredje side) | s3 |

*

Meddelelse til læserne (se omslagets tredje side)

Meddelelse til læserne

s3

| | |
| --- | --- |
| | (1)   EØS-relevant tekst |

---

(1)   EØS-relevant tekst

1

| DA | De akter, hvis titel er trykt med magre typer, er løbende retsakter inden for rammerne af landbrugspolitikken og har normalt en begrænset gyldighedsperiode.
  Titlen på alle øvrige akter er trykt med fede typer efter en asterisk. |
| --- | --- |

DA

De akter, hvis titel er trykt med magre typer, er løbende retsakter inden for rammerne af landbrugspolitikken og har normalt en begrænset gyldighedsperiode.

Titlen på alle øvrige akter er trykt med fede typer efter en asterisk.

---

I Retsakter vedtaget i henhold til traktaterne om oprettelse af Det Europæiske Fællesskab/Euratom, hvis offentliggørelse er obligatorisk

FORORDNINGER

| 16.1.2009 | DA | Den Europæiske Unions Tidende | L 11/1 |
| --- | --- | --- | --- |

16.1.2009

DA

Den Europæiske Unions Tidende

L 11/1

---

KOMMISSIONENS FORORDNING (EF) Nr. 26/2009

af 15. januar 2009

om faste importværdier med henblik på fastsættelse af indgangsprisen for visse frugter og grøntsager

KOMMISSIONEN FOR DE EUROPÆISKE FÆLLESSKABER HAR —

under henvisning til traktaten om oprettelse af Det Europæiske Fællesskab,

under henvisning til Rådets forordning (EF) nr. 1234/2007 af 22. oktober 2007 om en fælles markedsordning for landbrugsprodukter og om særlige bestemmelser for visse landbrugsprodukter (fusionsmarkedsordningen) (1),

under henvisning til Kommissionens forordning (EF) nr. 1580/2007 af 21. december 2007 om gennemførelsesbestemmelser til Rådets forordning (EF) nr. 2200/96, (EF) nr. 2201/96 og (EF) nr. 1182/2007 vedrørende frugt og grøntsager (2), og

ud fra følgende betragtninger:

Ved forordning (EF) nr. 1580/2007 fastsættes der, på basis af resultatet af de multilaterale handelsforhandlinger under Uruguay-runden, kriterier for Kommissionens fastsættelse af faste importværdier for tredjelande for de produkter og perioder, der er anført i del A i bilag XV til nævnte forordning —

UDSTEDT FØLGENDE FORORDNING:

Artikel 1

De faste importværdier som omhandlet i artikel 138 i forordning (EF) nr. 1580/2007 fastsættes i bilaget til nærværende forordning.

Artikel 2

Denne forordning træder i kraft den 16. januar 2009.

Denne forordning er bindende i alle enkeltheder og gælder umiddelbart i hver medlemsstat.

Udfærdiget i Bruxelles, den 15. januar 2009.

På Kommissionens vegne

Jean-Luc DEMARTY

Generaldirektør for landbrug og udvikling af landdistrikter

---

(1)  EUT L 299 af 16.11.2007, s. 1.

1

(2)  EUT L 350 af 31.12.2007, s. 1.

2

---

BILAG

Faste importværdier med henblik på fastsættelse af indgangsprisen for visse frugter og grøntsager

| (EUR/100 kg) |
| --- |
| KN-kode | Tredjelandskode (1) | Fast importværdi |
| 0702 00 00 | IL | 147,8 |
| JO | 75,8 |
| MA | 44,5 |
| TN | 134,4 |
| TR | 103,5 |
| ZZ | 101,2 |
| 0707 00 05 | JO | 155,5 |
| MA | 64,8 |
| TR | 138,1 |
| ZZ | 119,5 |
| 0709 90 70 | MA | 136,6 |
| TR | 116,4 |
| ZZ | 126,5 |
| 0805 10 20 | EG | 45,7 |
| IL | 56,2 |
| MA | 64,3 |
| TN | 47,4 |
| TR | 64,7 |
| ZZ | 55,7 |
| 0805 20 10 | MA | 77,5 |
| TR | 58,0 |
| ZZ | 67,8 |
| 0805 20 30, 0805 20 50, 0805 20 70, 0805 20 90 | CN | 61,5 |
| EG | 96,8 |
| IL | 59,1 |
| JM | 94,4 |
| TR | 69,2 |
| ZZ | 76,2 |
| 0805 50 10 | MA | 65,8 |
| TR | 64,1 |
| ZZ | 65,0 |
| 0808 10 80 | CA | 87,4 |
| CN | 64,4 |
| MK | 34,5 |
| US | 109,1 |
| ZZ | 73,9 |
| 0808 20 50 | CN | 66,0 |
| KR | 148,7 |
| US | 111,8 |
| ZZ | 108,8 |

(EUR/100 kg)

KN-kode

Tredjelandskode (1)

Fast importværdi

0702 00 00

IL

147,8

JO

75,8

MA

44,5

TN

134,4

TR

103,5

ZZ

101,2

0707 00 05

JO

155,5

MA

64,8

TR

138,1

ZZ

119,5

0709 90 70

MA

136,6

TR

116,4

ZZ

126,5

0805 10 20

EG

45,7

IL

56,2

MA

64,3

TN

47,4

TR

64,7

ZZ

55,7

0805 20 10

MA

77,5

TR

58,0

ZZ

67,8

0805 20 30, 0805 20 50, 0805 20 70, 0805 20 90

CN

61,5

EG

96,8

IL

59,1

JM

94,4

TR

69,2

ZZ

76,2

0805 50 10

MA

65,8

TR

64,1

ZZ

65,0

0808 10 80

CA

87,4

CN

64,4

MK

34,5

US

109,1

ZZ

73,9

0808 20 50

CN

66,0

KR

148,7

US

111,8

ZZ

108,8

---

(1)  Landefortegnelse fastsat ved Kommissionens forordning (EF) nr. 1833/2006 (EUT L 354 af 14.12.2006, s. 19). Koden »ZZ« = »anden oprindelse«.

---

| 16.1.2009 | DA | Den Europæiske Unions Tidende | L 11/3 |
| --- | --- | --- | --- |

16.1.2009

DA

Den Europæiske Unions Tidende

L 11/3

---

KOMMISSIONENS FORORDNING (EF) Nr. 27/2009

af 15. januar 2009

om fastsættelse af importtolden for korn gældende fra den 16. januar 2009

KOMMISSIONEN FOR DE EUROPÆISKE FÆLLESSKABER HAR —

under henvisning til traktaten om oprettelse af Det Europæiske Fællesskab,

under henvisning til Rådets forordning (EF) nr. 1234/2007 af 22. oktober 2007 om en fælles markedsordning for landbrugsprodukter og om særlige bestemmelser for visse landbrugsprodukter (fusionsmarkedsordningen) (1)

under henvisning til Kommissionens forordning (EF) nr. 1249/96 af 28. juni 1996 om gennemførelsesbestemmelser til Rådets forordning (EØF) nr. 1766/92 for så vidt angår importtold for korn (2), særlig artikel 2, stk. 1, og

ud fra følgende betragtninger:

| (1) | Ifølge artikel 136, stk. 1, i forordning (EF) nr. 1234/2007 er importtolden for produkter henhørende under KN-kode 1001 10 00, 1001 90 91, ex 1001 90 99 [blød hvede af høj kvalitet], 1002, ex 1005 undtagen hybridmajs til udsæd, og ex 1007 undtagen hybridsorghum til udsæd, lig med interventionsprisen for sådanne produkter ved import forhøjet med 55 % minus cif-importprisen for den pågældende sending. Denne told kan dog ikke overstige toldsatsen i den fælles toldtarif. |
| --- | --- |

(1)

Ifølge artikel 136, stk. 1, i forordning (EF) nr. 1234/2007 er importtolden for produkter henhørende under KN-kode 1001 10 00, 1001 90 91, ex 1001 90 99 [blød hvede af høj kvalitet], 1002, ex 1005 undtagen hybridmajs til udsæd, og ex 1007 undtagen hybridsorghum til udsæd, lig med interventionsprisen for sådanne produkter ved import forhøjet med 55 % minus cif-importprisen for den pågældende sending. Denne told kan dog ikke overstige toldsatsen i den fælles toldtarif.

| (2) | Ifølge artikel 136, stk. 2, i forordning (EF) nr. 1234/2007 skal der med henblik på beregning af importtolden som omhandlet i nævnte artikels stk. 1 regelmæssigt fastsættes repræsentative cif-importpriser for de pågældende produkter. |
| --- | --- |

(2)

Ifølge artikel 136, stk. 2, i forordning (EF) nr. 1234/2007 skal der med henblik på beregning af importtolden som omhandlet i nævnte artikels stk. 1 regelmæssigt fastsættes repræsentative cif-importpriser for de pågældende produkter.

| (3) | Ifølge artikel 2, stk. 2, i forordning (EF) nr. 1249/96 er den pris, der skal anvendes ved beregning af importtolden for produkter henhørende under KN-kode 1001 10 00, 1001 90 91, ex 1001 90 99 (blød hvede af høj kvalitet), 1002 00, 1005 10 90, 1005 90 00 og 1007 00 90 den daglige repræsentative cif-importpris fastlagt efter metoden i nævnte forordnings artikel 4. |
| --- | --- |

(3)

Ifølge artikel 2, stk. 2, i forordning (EF) nr. 1249/96 er den pris, der skal anvendes ved beregning af importtolden for produkter henhørende under KN-kode 1001 10 00, 1001 90 91, ex 1001 90 99 (blød hvede af høj kvalitet), 1002 00, 1005 10 90, 1005 90 00 og 1007 00 90 den daglige repræsentative cif-importpris fastlagt efter metoden i nævnte forordnings artikel 4.

| (4) | Importtolden bør fastsættes for perioden fra den 16. januar 2009 og gælde, indtil en ny importtold træder i kraft — |
| --- | --- |

(4)

Importtolden bør fastsættes for perioden fra den 16. januar 2009 og gælde, indtil en ny importtold træder i kraft —

UDSTEDT FØLGENDE FORORDNING:

Artikel 1

Fra den 16. januar 2009 gælder den importtold, der er fastsat i bilag I til nærværende forordning på grundlag af elementerne i bilag II, for korn som omhandlet i artikel 136, stk. 1, i forordning (EF) nr. 1234/2007.

Artikel 2

Denne forordning træder i kraft den 16. januar 2009.

Denne forordning er bindende i alle enkeltheder og gælder umiddelbart i hver medlemsstat.

Udfærdiget i Bruxelles, den 15. januar 2009.

På Kommissionens vegne

Jean-Luc DEMARTY

Generaldirektør for landbrug og udvikling af landdistrikter

---

(1)  EUT L 299 af 16.11.2007, s. 1.

1

(2)  EFT L 161 af 29.6.1996, s. 125.

2

---

BILAG I

Importtold for produkter som omhandlet i artikel 136, stk. 1, i forordning (EF) nr. 1234/2007 gældende fra den 16. januar 2009

| KN-kode | Varebeskrivelse | Importtold (1)

  (EUR/t) |
| --- | --- | --- |
| 1001 10 00 | Hård HVEDE af høj kvalitet | 0,00 |
| af middel kvalitet | 0,00 |
| af lav kvalitet | 0,00 |
| 1001 90 91 | Blød HVEDE, til udsæd | 0,00 |
| ex 1001 90 99 | Blød HVEDE af høj kvalitet, undtagen blød hvede til udsæd | 0,00 |
| 1002 00 00 | RUG | 21,27 |
| 1005 10 90 | MAJS til udsæd, undtagen hybridmajs | 19,25 |
| 1005 90 00 | MAJS, undtagen til udsæd (2) | 19,25 |
| 1007 00 90 | SORGHUM i hele kerner, undtagen hybridsorghum til udsæd | 21,27 |

KN-kode

Varebeskrivelse

Importtold (1)

(EUR/t)

1001 10 00

Hård HVEDE af høj kvalitet

0,00

af middel kvalitet

0,00

af lav kvalitet

0,00

1001 90 91

Blød HVEDE, til udsæd

0,00

ex 1001 90 99

Blød HVEDE af høj kvalitet, undtagen blød hvede til udsæd

0,00

1002 00 00

RUG

21,27

1005 10 90

MAJS til udsæd, undtagen hybridmajs

19,25

1005 90 00

MAJS, undtagen til udsæd (2)

19,25

1007 00 90

SORGHUM i hele kerner, undtagen hybridsorghum til udsæd

21,27

---

(1)  For varer, der ankommer til Fællesskabet via Atlanterhavet eller Suezkanalen, kan importøren i henhold til artikel 2, stk. 4, i forordning (EF) nr. 1249/96 opnå en nedsættelse af tolden på:

| — | 3 EUR/t, hvis lossehavnen befinder sig ved Middelhavet, eller |
| --- | --- |

—

3 EUR/t, hvis lossehavnen befinder sig ved Middelhavet, eller

| — | 2 EUR/t, hvis lossehavnen befinder sig i Irland, Danmark, Estland, Letland, Litauen, Polen, Finland, Sverige, Det Forenede Kongerige eller på Den Iberiske Halvøs Atlanterhavskyst. |
| --- | --- |

—

2 EUR/t, hvis lossehavnen befinder sig i Irland, Danmark, Estland, Letland, Litauen, Polen, Finland, Sverige, Det Forenede Kongerige eller på Den Iberiske Halvøs Atlanterhavskyst.

(2)  Importøren kan opnå en fast nedsættelse på 24 EUR/t, når betingelserne i artikel 2, stk. 5, i forordning (EF) nr. 1249/96 opfyldes.

---

BILAG II

Elementer til beregning af tolden, jf. bilag I

2.1.2009-14.1.2009

| 1) | Gennemsnit for den referenceperiode, der er nævnt i artikel 2, stk. 2, i forordning (EF) nr. 1249/96:











  (EUR/t) |
| --- | --- |
| | Blød hvede (1) | Majs | Hård hvede, høj kvalitet | Hård hvede, middel kvalitet (2) | Hård hvede, lav kvalitet (3) | Byg |
| Børs | Minnéapolis | Chicago | — | — | — | — |
| Notering | 192,81 | 116,44 | — | — | — | — |
| Pris fob USA | — | — | 230,68 | 220,68 | 200,68 | 128,35 |
| Præmie for Golfen | 57,28 | 13,93 | — | — | — | — |
| Præmie for The Great Lakes | — | — | — | — | — | — |

1)

Gennemsnit for den referenceperiode, der er nævnt i artikel 2, stk. 2, i forordning (EF) nr. 1249/96:

(EUR/t)

Blød hvede (1)

Majs

Hård hvede, høj kvalitet

Hård hvede, middel kvalitet (2)

Hård hvede, lav kvalitet (3)

Byg

Børs

Minnéapolis

Chicago

—

—

—

—

Notering

192,81

116,44

—

—

—

—

Pris fob USA

—

—

230,68

220,68

200,68

128,35

Præmie for Golfen

57,28

13,93

—

—

—

—

Præmie for The Great Lakes

—

—

—

—

—

—

| 2) | Gennemsnit for den referenceperiode, der er nævnt i artikel 2, stk. 2, i forordning (EF) nr. 1249/96:






  Fragt/omkostninger: Mexicanske Golf–Rotterdam | 9,55 EUR/t |
| --- | --- | --- |
| Fragt/omkostninger: The Great Lakes–Rotterdam | 6,91 EUR/t |

2)

Gennemsnit for den referenceperiode, der er nævnt i artikel 2, stk. 2, i forordning (EF) nr. 1249/96:

Fragt/omkostninger: Mexicanske Golf–Rotterdam

9,55 EUR/t

Fragt/omkostninger: The Great Lakes–Rotterdam

6,91 EUR/t

---

(1)  Positiv præmie på 14 EUR/t indbefattet (artikel 4, stk. 3, i forordning (EF) nr. 1249/96).

(2)  Negativ præmie på 10 EUR/t (artikel 4, stk. 3, i forordning (EF) nr. 1249/96).

(3)  Negativ præmie på 30 EUR/t (artikel 4, stk. 3, i forordning (EF) nr. 1249/96).

---

DIREKTIVER

| 16.1.2009 | DA | Den Europæiske Unions Tidende | L 11/6 |
| --- | --- | --- | --- |

16.1.2009

DA

Den Europæiske Unions Tidende

L 11/6

---

KOMMISSIONENS DIREKTIV 2009/2/EF

af 15. januar 2009

om 31. tilpasning til den tekniske udvikling af Rådets direktiv 67/548/EØF om tilnærmelse af lovgivning om klassificering, emballering og etikettering af farlige stoffer

(EØS-relevant tekst)

KOMMISSIONEN FOR DE EUROPÆISKE FÆLLESSKABER HAR —

under henvisning til traktaten om oprettelse af Det Europæiske Fællesskab,

under henvisning til Rådets direktiv 67/548/EØF af 27. juni 1967 om tilnærmelse af lovgivning om klassificering, emballering og etikettering af farlige stoffer (1), særlig artikel 28, og

ud fra følgende betragtninger:

| (1) | Artikel 4, stk. 3, i direktiv 67/548/EØF fastsætter kriterier og procedurer for harmonisering af klassificering og etikettering af stoffer. Punkt 4.1.3, 4.1.4 og 4.1.5 i bilag VI til direktiv 67/548/EØF pålægger virksomhederne så hurtigt som muligt at indlevere oplysninger til medlemsstaterne med forslag til harmoniseret klassificering og etikettering, når der fremkommer oplysninger, som taler for, at stoffet opfylder kriterierne for klassificering som mutagent, kræftfremkaldende eller reproduktionstoksisk. |
| --- | --- |

(1)

Artikel 4, stk. 3, i direktiv 67/548/EØF fastsætter kriterier og procedurer for harmonisering af klassificering og etikettering af stoffer. Punkt 4.1.3, 4.1.4 og 4.1.5 i bilag VI til direktiv 67/548/EØF pålægger virksomhederne så hurtigt som muligt at indlevere oplysninger til medlemsstaterne med forslag til harmoniseret klassificering og etikettering, når der fremkommer oplysninger, som taler for, at stoffet opfylder kriterierne for klassificering som mutagent, kræftfremkaldende eller reproduktionstoksisk.

| (2) | Bilag I til direktiv 67/548/EØF indeholder en liste over farlige stoffer med angivelse af de enkelte stoffers klassificering og etikettering. Der er behov for ajourføring af denne liste ved, at der indsættes anmeldte nye stoffer og yderligere eksisterende stoffer, og at de allerede opførte stoffer tilpasses til den tekniske udvikling. Det er desuden nødvendigt, at visse stoffer udgår af listen. |
| --- | --- |

(2)

Bilag I til direktiv 67/548/EØF indeholder en liste over farlige stoffer med angivelse af de enkelte stoffers klassificering og etikettering. Der er behov for ajourføring af denne liste ved, at der indsættes anmeldte nye stoffer og yderligere eksisterende stoffer, og at de allerede opførte stoffer tilpasses til den tekniske udvikling. Det er desuden nødvendigt, at visse stoffer udgår af listen.

| (3) | I bilag I til direktiv 67/548/EØF er der allerede opført grupper af stoffer, især metalforbindelser, der er vurderet gruppevis og ved analogisering mellem stoffer. |
| --- | --- |

(3)

I bilag I til direktiv 67/548/EØF er der allerede opført grupper af stoffer, især metalforbindelser, der er vurderet gruppevis og ved analogisering mellem stoffer.

| (4) | I bilag I til direktiv 67/548/EØF er der ligeledes en række grupper, hvor de enkelte stoffer i gruppen er beskrevet, og hvor der til klassificeringen er benyttet grupperings- og analogiseringsprincipper, f.eks. mineraloliestrømme og gasser. |
| --- | --- |

(4)

I bilag I til direktiv 67/548/EØF er der ligeledes en række grupper, hvor de enkelte stoffer i gruppen er beskrevet, og hvor der til klassificeringen er benyttet grupperings- og analogiseringsprincipper, f.eks. mineraloliestrømme og gasser.

| (5) | Det anføres i bilag VI til direktiv 67/548/EØF, at data, som er nødvendige for klassificering og etikettering, kan fremskaffes fra en række forskellige kilder, herunder resultaterne af validerede struktur/aktivitet-relationer og ekspertvurderinger. |
| --- | --- |

(5)

Det anføres i bilag VI til direktiv 67/548/EØF, at data, som er nødvendige for klassificering og etikettering, kan fremskaffes fra en række forskellige kilder, herunder resultaterne af validerede struktur/aktivitet-relationer og ekspertvurderinger.

| (6) | Klassificeringen af nikkelforbindelserne i dette direktiv bygger på virkninger, der skyldes Ni2+-ionen, og foreliggende data for nikkelforbindelser. Klassificeringen bygger på en indplacering af nikkelforbindelser i grupper alt efter deres opløselighed i vand (f.eks. de uopløselige, de svagt opløselige og de opløselige nikkelforbindelser i hver sin gruppe). Vandopløseligheden er valgt som det første kriterium for afgrænsning af grupperne ud fra den begrundelse, at nikkelforbindelser med omtrent samme vandopløselighed vil føre til omtrent samme biotilgængelighed for Ni2+-ionerne og omtrent samme systemiske toksicitet. Det begrunder analogiseringen inden for grupperne fra stoffer, som foreliggende fyldestgørende testdata viser har en specifik virkning, til stoffer, der ikke findes sådanne testdata om. For nogle virkningers vedkommende er analogisering mellem grupperne velbegrundet, da omtrent samme virkninger er iagttaget for alle niveauer af vandopløselighed. Eksempelvis har epidemiologiske undersøgelser vist, at både opløselige og uopløselige nikkelforbindelser (i hver sin ende af opløselighedsskalaen) har lokale kræftfremkaldende virkninger i luftvejene. Der er derfor god grund til at konkludere, at svagt opløselige forbindelser (midt på skalaen) har lignende kræftfremkaldende egenskaber. |
| --- | --- |

(6)

Klassificeringen af nikkelforbindelserne i dette direktiv bygger på virkninger, der skyldes Ni2+-ionen, og foreliggende data for nikkelforbindelser. Klassificeringen bygger på en indplacering af nikkelforbindelser i grupper alt efter deres opløselighed i vand (f.eks. de uopløselige, de svagt opløselige og de opløselige nikkelforbindelser i hver sin gruppe). Vandopløseligheden er valgt som det første kriterium for afgrænsning af grupperne ud fra den begrundelse, at nikkelforbindelser med omtrent samme vandopløselighed vil føre til omtrent samme biotilgængelighed for Ni2+-ionerne og omtrent samme systemiske toksicitet. Det begrunder analogiseringen inden for grupperne fra stoffer, som foreliggende fyldestgørende testdata viser har en specifik virkning, til stoffer, der ikke findes sådanne testdata om. For nogle virkningers vedkommende er analogisering mellem grupperne velbegrundet, da omtrent samme virkninger er iagttaget for alle niveauer af vandopløselighed. Eksempelvis har epidemiologiske undersøgelser vist, at både opløselige og uopløselige nikkelforbindelser (i hver sin ende af opløselighedsskalaen) har lokale kræftfremkaldende virkninger i luftvejene. Der er derfor god grund til at konkludere, at svagt opløselige forbindelser (midt på skalaen) har lignende kræftfremkaldende egenskaber.

| (7) | Ved den samlede vurdering af alle foreliggende oplysninger om nikkelforbindelser kan vandopløseligheden benyttes som tilnærmelse for Ni2+-ionens systemiske biotilgængelighed for mange virkningers og stoffers vedkommende. |
| --- | --- |

(7)

Ved den samlede vurdering af alle foreliggende oplysninger om nikkelforbindelser kan vandopløseligheden benyttes som tilnærmelse for Ni2+-ionens systemiske biotilgængelighed for mange virkningers og stoffers vedkommende.

| (8) | Klassificeringen og etiketteringen af stoffer, som er opført i dette direktiv, bør tages op til fornyet overvejelse, hvis der fremkommer ny videnskabelig viden. Således bør især nikkelbranchens nylige fremlæggelse af foreløbige, ufuldstændige og ikke-fagfællebedømte oplysninger betyde, at resultaterne af de kommende drøftelser i WHO's Internationale Kræftforskningscenter af nikkelforbindelsers carcinogenicitet og alle nye relevante videnskabelige resultater eller fortolkninger af de data, der ligger til grund for klassificeringen af nikkelforbindelserne i dette direktiv, tillægges særlig betydning. |
| --- | --- |

(8)

Klassificeringen og etiketteringen af stoffer, som er opført i dette direktiv, bør tages op til fornyet overvejelse, hvis der fremkommer ny videnskabelig viden. Således bør især nikkelbranchens nylige fremlæggelse af foreløbige, ufuldstændige og ikke-fagfællebedømte oplysninger betyde, at resultaterne af de kommende drøftelser i WHO's Internationale Kræftforskningscenter af nikkelforbindelsers carcinogenicitet og alle nye relevante videnskabelige resultater eller fortolkninger af de data, der ligger til grund for klassificeringen af nikkelforbindelserne i dette direktiv, tillægges særlig betydning.

| (9) | De i dette direktiv fastsatte foranstaltninger er i overensstemmelse med udtalelse fra Udvalget for Tilpasning til den Tekniske Udvikling af Direktiverne om Fjernelse af Tekniske Hindringer for Handelen med Farlige Stoffer og Præparater — |
| --- | --- |

(9)

De i dette direktiv fastsatte foranstaltninger er i overensstemmelse med udtalelse fra Udvalget for Tilpasning til den Tekniske Udvikling af Direktiverne om Fjernelse af Tekniske Hindringer for Handelen med Farlige Stoffer og Præparater —

UDSTEDT FØLGENDE DIREKTIV:

Artikel 1

I direktiv 67/548/EØF foretages følgende ændringer. I bilag I foretages følgende ændringer:

| a) | Stofferne, der svarer til stofferne i bilag 1A til dette direktiv, erstattes af stofferne i bilag 1A til dette direktiv. |
| --- | --- |

a)

Stofferne, der svarer til stofferne i bilag 1A til dette direktiv, erstattes af stofferne i bilag 1A til dette direktiv.

| b) | Stofferne i bilag 1B til dette direktiv indføjes i overensstemmelse med den rækkefølge, hvori stofferne er opført i bilag I til direktiv 67/548/EØF. |
| --- | --- |

b)

Stofferne i bilag 1B til dette direktiv indføjes i overensstemmelse med den rækkefølge, hvori stofferne er opført i bilag I til direktiv 67/548/EØF.

| c) | Stofferne på listen i bilag 1C til dette direktiv udgår. |
| --- | --- |

c)

Stofferne på listen i bilag 1C til dette direktiv udgår.

Artikel 2

Medlemsstaterne sætter de nødvendige love og administrative bestemmelser i kraft for at efterkomme dette direktiv senest den 1. juni 2009. De tilsender straks Kommissionen disse bestemmelser med en sammenligningstabel, som viser sammenhængen mellem de pågældende bestemmelser og dette direktiv.

Disse bestemmelser skal ved vedtagelsen indeholde en henvisning til dette direktiv eller skal ved offentliggørelsen ledsages af en sådan henvisning. De nærmere regler for henvisningen fastsættes af medlemsstaterne.

Medlemsstaterne tilsender Kommissionen de vigtigste nationale bestemmelser, som de udsteder på det område, der er omfattet af dette direktiv.

Artikel 3

Dette direktiv træder i kraft på tyvendedagen efter offentliggørelsen i Den Europæiske Unions Tidende.

Artikel 4

Dette direktiv er rettet til medlemsstaterne.

Udfærdiget i Bruxelles, den 15. januar 2009.

På Kommissionens vegne

Stavros DIMAS

Medlem af Kommissionen

---

(1)  EFT 196 af 16.8.1967, s. 1.

1

---

BILAG 1A

| Indeksnr. | Kemisk navn | Noter vedrørende stoffer | EF-nr. | CAS-nr. | Klassificering | Etikettering | Koncentrationsgrænser | Noter vedrørende tilberedninger |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 001-002-00-4 | aluminiumlithiumhydrid | | 240-877-9 | 16853-85-3 | F; R15
  C; R35 | F; C
  R: 15-35
  S: (1/2-)7/8-26-36/37/39-43-45 | | |
| 005-006-00-7 | dibutyltinhydrogenborat | E | 401-040-5 | 75113-37-0 | Muta. Cat. 3; R68
  Repr. Cat. 2; R60-61
  T; R48/25
  Xn; R21/22
  Xi; R41
  R43
  N; R50-53 | T; N
  R: 60-61-21/22-41-43-48/25-68-50/53
  S: 53-45-60-61 | | |
| 006-007-00-5 | salte af hydrogencyanid med undtagelse af komplekse salte som cyanoferrat (II) og-(III) og kviksølv(II)oxidcyanid | A | — | — | T+; R26/27/28
  R32
  N; R50-53 | T+; N
  R: 26/27/28-32-50/53
  S: (1/2-)7-28-29-45-60-61 | | |
| 006-015-00-9 | diuron (ISO);
  3-(3,4-dichlorphenyl)-1,1-dimethylurinstof | | 206-354-4 | 330-54-1 | Carc. Cat. 3; R40
  Xn; R22-48/22
  N; R50-53 | Xn; N
  R: 22-40-48/22-50/53
  S: (2-)13-36/37-46-60-61 | C ≥ 25 %: Xn, N; R22-40-48/22-50/53
  10 % ≤ C < 25 %: Xn, N; R40-48/22-50/53
  2,5 % ≤ C < 10 %: Xn, N; R40-50/53
  1 % ≤ C < 2,5 %: Xn, N; R40-51/53
  0,25 % ≤ C < 1 %: N; R51/53
  0,025 % ≤ C < 0,25 %: R52/53 | |
| 006-076-00-1 | mancozeb (ISO);
  manganethylenbis(dithiocarbamat) (polymer), kompleks med zinksalt | | — | 8018-01-7 | Repr. Cat. 3; R63
  R43
  N; R50 | Xn; N
  R: 43-63-50
  S: (2-)36/37-46-61 | C ≥ 5 %: Xn, N; R43-63-50
  2,5 ≤ C < 5 %: Xi, N; R43-50
  1 % ≤ C < 2,5 %: Xi; R43 | |
| 006-077-00-7 | maneb (ISO);
  manganethylenbis(dithiocarbamat) (polymer) | | 235-654-8 | 12427-38-2 | Repr. Cat. 3; R63
  Xn; R20
  Xi; R36
  R43
  N; R50-53 | Xn; N
  R: 20-36-43-63-50/53
  S: (2-)36/37-46-60-61 | C ≥ 25 %: Xn, N; R20-36-43-63-50/53
  20 % ≤ C < 25 %: Xn, N; R36-43-63-50/53
  5 % ≤ C < 20 %: Xn, N; R43-63-50/53
  2,5 % ≤ C < 5 %: Xi, N; R43-50/53
  1 % ≤ C < 2,5 %: Xi, N; R43-51/53
  0,25 % ≤ C < 1 %: N; R51/53
  0,025 % ≤ C < 0,25 %: R52/53 | |
| 006-084-00-5 | carbosulfan (ISO);
  2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamat | | 259-565-9 | 55285-14-8 | T+; R26
  T; R25
  R43
  N; R50-53 | T+; N
  R: 25-26-43-50/53
  S: (1/2-)28-36/37-38-45-63-60-61 | | |
| 006-088-00-7 | benfuracarb (ISO);
  ethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl-β-alaninat | | — | 82560-54-1 | Repr. Cat. 3; R62
  T; R23
  Xn; R22
  N; R50-53 | T; N
  R: 22-23-62-50/53
  S: (1/2-)36/37-45-60-61 | | |
| 007-002-00-0 | nitrogendioxid; [1]
  dinitrogentetraoxid [2] | | 233-272-6 [1]
  234-126-4 [2] | 10102-44-0 [1]
  10544-72-6 [2] | O; R8
  T+; R26
  C; R34 | O; T+
  R: 8-26-34
  S: (1/2-)9-26-28-36/37/39-45 | C ≥ 10 %: T+; R26-34
  5 % ≤ C < 10 %: T; R23-34
  1 % ≤ C < 5 %: T; R23-36/37/38
  0,5 % ≤ C < 1 %: Xn; R20-36/37/38
  0,1 % ≤ C < 0,5 %: Xn; R20 | 5 |
| 015-041-00-X | malathion (ISO);
  1,2-bis(ethoxycarbonyl)ethyl-O,O-dimethylphosphordithioat;
  [indeholdende ≤ 0,03 % isomalathion] | | 204-497-7 | 121-75-5 | Xn; R22
  R43
  N; R50-53 | Xn; N
  R: 22-43-50/53
  S: (2-)24-37-46-60-61 | C ≥ 25 %: Xn, N; R22-43-50/53
  1 % ≤ C < 25 %: Xi, N; R43-50/53
  0,025 % ≤ C < 1 %: N; R50/53
  0,0025 % ≤ C < 0,025 %: N; R51/53
  0,00025 % ≤ C < 0,0025 %: R52/53 | |
| 015-100-00-X | phoxim (ISO);
  α-(diethoxyphosphinothioylimino)phenylacetonitril | | 238-887-3 | 14816-18-3 | Repr. Cat. 3; R62
  Xn; R22
  R43
  N; R50-53 | Xn; N
  R: 22-43-62-50/53
  S: (2-)36/37-46-60-61 | C ≥ 25 %: Xn, N; R22-43-62-50/53
  5 % ≤ C < 25 %: Xn, N; R43-62-50/53
  1 % ≤ C < 5 %: Xi, N; R43-50/53
  0,025 % ≤ C < 1 %: N; R50/53
  0,0025 % ≤ C < 0,025 %: N; R51/53
  0,00025 % ≤ C < 0,0025 %: R52/53 | |
| 015-102-00-0 | tris(2-chlorethyl)phosphat | E | 204-118-5 | 115-96-8 | Carc. Cat. 3; R40
  Repr. Cat. 2; R60
  Xn; R22
  N; R51-53 | T; N
  R: 60-22-40-51/53
  S: 53-45-61 | | |
| 015-155-00-X | glufosinat ammonium (ISO);
  ammonium-2-amino-4-(hydroxymethylphosphinyl)butyrat | E | 278-636-5 | 77182-82-2 | Repr. Cat. 2; R60
  Repr. Cat. 3; R63
  Xn; R20/21/22-48/20/22 | T
  R: 60-20/21/22-48/20/22-63
  S: 53-45 | | |
| 016-009-00-8 | dinatriumsulfid;
  natriumsulfid | | 215-211-5 | 1313-82-2 | T; R24
  Xn; R22
  C; R34
  R31
  N; R50 | T; C; N
  R: 22-24-31-34-50
  S: (1/2-)26-36/37/39-45-61 | | |
| 017-009-00-0 | ammoniumperchlorat;
  [indeholdende ≥ 80 % partikler på 0-30 μm] | T | 232-235-1 | 7790-98-9 | E; R3
  O; R9 | E
  R: 3-9
  S: (2-)14-16-36/37 | | |
| 024-004-00-7 | natriumdichromat | E | 234-190-3 | 10588-01-9 | O; R8
  Carc. Cat. 2; R45
  Muta. Cat. 2; R46
  Repr. Cat. 2; R60-61
  T+; R26
  T; R25-48/23
  Xn; R21
  C; R34
  R42/43
  N; R50-53 | O; T+; N
  R: 45-46-60-61-8-21-25-26-34-42/43-48/23-50/53
  S: 53-45-60-61 | C ≥ 25 %: T+, N; R45-46-60-61-21-25-26-34-42/43-48/23-50/53
  10 % ≤ C < 25 %: T+, N; R45-46-60-61-22-26-34-42/43-48/23-51/53
  7 % ≤ C < 10 %: T+, N; R45-46-60-61-22-26-36/37/38-42/43-48/20-51/53
  5 % ≤ C < 7 %: T, N; R45-46-60-61-22-23-36/37/38-42/43-48/20-51/53
  3 % ≤ C < 5 %: T, N; R45-46-60-61-22-23-42/43-48/20-51/53
  2,5 % ≤ C < 3 %: T, N; R45-46-60-61-23-42/43-48/20-51/53
  1 % ≤ C < 2,5 %: T; R45-46-60-61-23-42/43-48/20-52/53
  0,5 % ≤ C < 1 %: T; R45-46-60-61-20-42/43-52/53
  0,25 % ≤ C < 0,5 %: T; R45-46-20-42/43-52/53
  0,2 % ≤ C < 0,25 %: T; R45-46-20-42/43
  0,1 % ≤ C < 0,2 %: T; R45-46-20 | 3 |
| 027-002-00-4 | cobaltoxid | | 215-154-6 | 1307-96-6 | Xn; R22
  R43
  N; R50-53 | Xn; N
  R: 22-43-50/53
  S: (2-)24-37-60-61 | C ≥ 25 %: Xn, N; R22-43-50/53
  2,5 % ≤ C < 25 %: Xi, N; R43-50/53
  1 % ≤ C < 2,5 %: Xi, N; R43-51/53
  0,25 % ≤ C < 1 %: N; R51/53
  0,025 % ≤ C < 0,25 %: R52/53 | |
| 027-003-00-X | cobaltsulfid | | 215-273-3 | 1317-42-6 | R43
  N; R50-53 | Xi; N
  R: 43-50/53
  S: (2-)24-37-60-61 | C ≥ 2,5 %: Xi, N; R43-50/53
  1 % ≤ C < 2,5 %: Xi, N; R43-51/53
  0,25 % ≤ C < 1 %: N; R51/53
  0,025 % ≤ C < 0,25 %: R52/53 | |
| 028-003-00-2 | nikkelmonoxid; [1]
  nikkeloxid; [2]
  bunsenit [3] | E | 215-215-7 [1]
  234-323-5 [2]
  - [3] | 1313-99-1 [1]
  11099-02-8 [2]
  34492-97-2 [3] | Carc. Cat. 1; R49
  T; R48/23
  R43
  R53 | T
  R: 49-43-48/23-53
  S: 53-45-61 | | |
| 028-004-00-8 | nikkeldioxid | E | 234-823-3 | 12035-36-8 | Carc. Cat. 1; R49
  T; R48/23
  R43
  R53 | T
  R: 49-43-48/23-53
  S: 53-45-61 | | |
| 028-005-00-3 | dinikkeltrioxid | E | 215-217-8 | 1314-06-3 | Carc. Cat. 1; R49
  T; R48/23
  R43
  R53 | T
  R: 49-43-48/23-53
  S: 53-45-61 | | |
| 028-006-00-9 | nikkel(II)sulfid; [1]
  nikkelsulfid; [2]
  millerit [3] | E | 240-841-2 [1]
  234-349-7 [2]
  - [3] | 16812-54-7 [1]
  11113-75-0 [2]
  1314-04-1 [3] | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  T; R48/23
  R43
  N; R50-53 | T; N
  R: 49-43-48/23-68-50/53
  S: 53-45-60-61 | | |
| 028-007-00-4 | trinikkeldisulfid;
  nikkelsubsulfid; [1]
  heazlewoodit [2] | E | 234-829-6 [1]
  - [2] | 12035-72-2 [1]
  12035-71-1 [2] | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  T; R48/23
  R43
  N; R50-53 | T; N
  R: 49-43-48/23-68-50/53
  S: 53-45-60-61 | | |
| 028-008-00-X | nikkeldihydroxid; [1]
  nikkelhydroxid [2] | E | 235-008-5 [1]
  234-348-1 [2] | 12054-48-7 [1]
  11113-74-9 [2] | Carc. Cat. 1; R49
  Repr. Cat. 2; R61
  Muta. Cat. 3; R68
  T; R48/23
  Xn; R20/22
  Xi; R38
  R42/43
  N; R50-53 | T; N
  R: 49-61-20/22-38-42/43-48/23-68-50/53
  S: 53-45-60-61 | | |
| 029-013-00-X | trinatrium-(2-(α-(3-(4-chlor-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)benzylidenhydrazino)-4-sulfonatobenzoato)kobber(II) | | 407-580-8 | 130201-51-3 | Xi; R41 | Xi
  R: 41
  S: (2-)26-39 | | |
| 033-005-00-1 | arsensyre og dets salte undtagen sådanne nævnt andetsteds i dette bilag | AE | — | — | Carc. Cat. 1; R45
  T; R23/25
  N; R50-53 | T; N
  R: 45-23/25-50/53
  S: 53-45-60-61 | | |
| 034-002-00-8 | selenforbindelser med undtagelse af cadmiumsulfoselenid (xCdS.yCdSe) undtagen sådanne nævnt andetsteds i dette bilag | A | — | — | T; R23/25
  R33
  N; R50-53 | T; N
  R: 23/25-33-50/53
  S: (1/2-)20/21-28-45-60-61 | | |
| 047-001-00-2 | sølvnitrat | | 231-853-9 | 7761-88-8 | O; R8
  C; R34
  N; R50-53 | O; C; N
  R: 8-34-50/53
  S: (1/2-)26-36/37/39-45-60-61 | | |
| 050-002-00-0 | cyhexatin (ISO);
  hydroxytricyclohexylstannan;
  tri(cyclohexyl)tinhydroxid | | 236-049-1 | 13121-70-5 | Xn; R20/21/22
  N; R50-53 | Xn; N
  R: 20/21/22-50/53
  S: (2-)13-60-61 | C ≥ 25 %: Xn, N; R20/21/22-50/53
  0,025 % ≤ C < 25 %: N; R50/53
  0,0025 % ≤ C < 0,025 %: N; R51/53
  0,00025 % ≤ C < 0,0025 %: R52/53 | |
| 050-003-00-6 | fentinacetat (ISO);
  triphenyltinacetat | | 212-984-0 | 900-95-8 | Carc. Cat. 3; R40
  Repr. Cat. 3; R63
  T+; R26
  T; R24/25-48/23
  Xi; R37/38-41
  N; R50-53 | T+; N
  R: 24/25-26-37/38-40-41-48/23-63-50/53
  S: (1/2-)26-28-36/37/39-45-60-61 | C ≥ 25 %: T+, N; R24/25-26-37/38-40-41-48/23-63-50/53
  20 % ≤ C < 25 %: T+, N; R21/22-26-37/38-40-41-48/23-63-50/53
  10% ≤ C < 20 %: T+, N; R21/22-26-40-41-48/23-63-50/53
  7 % ≤ C < 10 %: T+, N; R21/22-26-36-40-48/20-63-50/53
  5 % ≤ C < 7 %: T, N; R21/22-23-36-40-48/20-63-50/53
  3 % ≤ C < 5 %: T, N; R21/22-23-40-48/20-50/53
  2,5 % ≤ C < 3 %: T, N; R23-40-48/20-50/53.
  1 % ≤ C < 2,5 %: T, N; R23-40-48/20-51/53
  0,25 % ≤ C < 1 %: Xn, N; R20-51/53
  0,1 % ≤ C < 0,25 %: Xn; R20-52/53
  0,025 % ≤ C < 0,1 %: R52/53 | |
| 050-004-00-1 | fentinhydroxid (ISO);
  triphenyltinhydroxid | | 200-990-6 | 76-87-9 | Carc. Cat. 3; R40
  Repr. Cat. 3; R63
  T+; R26
  T; R24/25-48/23
  Xi; R37/38-41
  N; R50-53 | T+; N
  R: 24/25-26-37/38-40-41-48/23-63-50/53
  S: (1/2-)26-28-36/37/39-45-60-61 | C ≥ 25 %: T+, N; R24/25-26-37/38-40-41-48/23-63-50/53
  20 % ≤ C < 25 %: T+, N; R21/22-26-37/38-40-41-48/23-63-50/53
  10 % ≤ C < 20 %: T+, N; R21/22-26-40-41-48/23-63-50/53
  7 % ≤ C < 10 %: T+, N; R21/22-26-36-40-48/20-63-50/53
  5 % ≤ C < 7 %: T, N; R21/22-23-36-40-48/20-63-50/53
  3 % ≤ C < 5 %: T, N; R21/22-23-40-48/20-50/53
  2,5 % ≤ C < 3 %: T, N; R23-40-48/20-50/53
  1 % ≤ C < 2,5 %: T, N; R23-40-48/20-51/53
  0,25 % ≤ C < 1 %: Xn, N; R20-51/53
  0,1 % ≤ C < 0,25 %: Xn; R20-52/53
  0,025 % ≤ C < 0,1 %: R52/53 | |
| 050-008-00-3 | tributyltinforbindelser, undtagen sådanne nævnt andetsteds i dette bilag | A | — | — | T; R25-48/23/25
  Xn; R21
  Xi; R36/38
  N; R50-53 | T; N
  R: 21-25-36/38-48/23/25-50/53
  S: (1/2-)36/37/39-45-60-61 | C ≥ 2,5 %: T, N; R21-25-36/38-48/23/25-50/53
  1 % ≤ C < 2,5 %: T, N; R21-25-36/38-48/23/25-51/53
  0,25 % ≤ C < 1 %: Xn, N; R22-48/20/22-51/53
  0,025 % C < 0,25 %: R52/53 | 1 |
| 050-011-00-X | triphenyltinforbindelser, undtagen sådanne nævnt andetsteds i dette bilag | A | — | — | T; R23/24/25
  N; R50-53 | T; N
  R: 23/24/25-50/53
  S: (1/2-)26-27-28-45-60-61 | C ≥ 1 %: T, N; R23/24/25-50/53
  0,25 % ≤ C < 1 %: Xn, N; R20/21/22-50/53
  0,025 % ≤ C < 0,25 %: N; R51/53
  0,0025 % ≤ C < 0,025 %: R52/53 | 1 |
| 050-018-00-8 | tin(II)methansulfonat | | 401-640-7 | 53408-94-9 | C; R34
  Xn; R22
  R43
  N; R51-53 | C; N
  R: 22-34-43-51/53
  S: (1/2-)22-26-36/37/39-45-61 | | |
| 053-003-00-4 | iodoxybenzen | | — | 696-33-3 | E; R2 | E
  R: 2
  S: (2-)35 | | |
| 053-004-00-X | calciumiodoxybenzoat | C | — | — | E; R2 | E
  R: 2
  S: (2-)35 | | |
| 080-001-00-0 | kviksølv | E | 231-106-7 | 7439-97-6 | Repr. Cat. 2; R61
  T+; R26
  T; R48/23
  N; R50-53 | T+; N
  R: 61-26-48/23-50/53
  S: 53-45-60-61 | | |
| 080-010-00-X | kviksølvdichlorid;
  kviksølvchlorid | | 231-299-8 | 7487-94-7 | Muta. Cat. 3; R68
  Repr. Cat. 3; R62
  T+; R28
  T; R48/24/25
  C; R34
  N; R50-53 | T+; N
  R: 28-34-48/24/25-62-68-50/53
  S: (1/2-)26-36/37/39-45-60-61 | | |
| 092-002-00-3 | uranforbindelser, undtagen sådanne nævnt andetsteds i dette bilag | A | — | — | T+; R26/28
  R33
  N; R51-53 | T+; N
  R: 26/28-33-51/53
  S: (1/2-)20/21-45-61 | | |
| 601-065-00-3 | Blanding af: (1′α,3′α,6′α)-2,2,3′,7′,7′-pentamethylspiro(1,3-dioxan-5,2′-norcaran);
  (1′α,3′β,6′α)-2,2,3′,7′,7′-pentamethylspiro(1,3-dioxan-5,2′-norcaran) | | 416-930-9 | — | Xi; R38
  N; R51-53 | Xi; N
  R: 38-51/53
  S: (2-)36/37-61 | | |
| 602-007-00-X | bromoform;
  tribrommethan | | 200-854-6 | 75-25-2 | T; R23
  Xn; R22
  Xi; R36/38
  N; R51-53 | T; N
  R: 22-23-36/38-51/53
  S: (1/2-)28-45-63-61 | | |
| 602-030-00-5 | 1,3-dichlorpropen; [1]
  (Z)-1,3-dichlorpropen [2] | C D | 208-826-5 [1]
  233-195-8 [2] | 542-75-6 [1]
  10061-01-5 [2] | R10
  T; R24/25
  Xn; R20-65
  Xi; R36/37/38
  R43
  N; R50-53 | T; N
  R: 10-20-24/25-36/37/38-43-65-50/53
  S: (1/2-)36/37-45-60-61 | | |
| 602-054-00-6 | 3-iodpropen;
  allyliodid | | 209-130-4 | 556-56-9 | F; R11
  C; R34 | F; C
  R: 11-34
  S: (1/2-)7-16-26-45 | | |
| 603-005-00-1 | 2-methylpropan-2-ol;

  tert-butylalkohol | | 200-889-7 | 75-65-0 | F; R11
  Xn; R20
  Xi; R36/37 | F; Xn
  R: 11-20-36/37
  S: (2-)9-16-46 | | |
| 603-018-00-2 | furfurylalkohol | | 202-626-1 | 98-00-0 | Carc. Cat. 3; R40
  T; R23
  Xn; R21/22-48/20
  Xi; R36/37 | T
  R: 21/22-23-36/37-40-48/20
  S: (1/2-)36/37-45-63 | | |
| 603-023-00-X | ethylenoxid;
  oxiran | E | 200-849-9 | 75-21-8 | F+; R12
  R6
  Carc. Cat. 2; R45
  Muta. Cat. 2; R46
  T; R23
  Xi; R36/37/38 | F+; T
  R: 45-46-6-12-23-36/37/38
  S: 53-45 | | |
| 603-029-00-2 | bis(2-chlorethyl)ether | | 203-870-1 | 111-44-4 | Carc. Cat. 3; R40
  T+; R26/27/28 | T+
  R: 26/27/28-40
  S: (1/2-)7/9-27-28-36/37-45 | C ≥ 7 %: T+; R26/27/28-40
  1 % ≤ C < 7 %: T; R23/24/25-40
  0,1 % ≤ C < 1 %: Xn; R20/21/22 | |
| 603-037-00-6 | cellulosenitrat;
  nitrocellulose | T | — | — | E; R3 | E
  R: 3
  S: (2-)35 | | |
| 603-046-00-5 | bis(chlormethyl)ether;
  oxybis(chlormethan) | E | 208-832-8 | 542-88-1 | F; R11
  Carc. Cat. 1; R45
  T+; R26
  T; R24
  Xn; R22 | F; T+
  R: 45-11-22-24-26
  S: 53-45 | C ≥ 25 %: T+; R45-22-24-26
  7 % ≤ C < 25 %: T+; R45-21-26
  3 % ≤ C < 7 %: T; R45-21-23
  1 % ≤ C < 3 %: T; R45-23
  0,1 % ≤ C < 1 %: T; R45-20
  0,001 % ≤ C < 0,1 %: T; R45 | |
| 603-064-00-3 | 1-methoxy-2-propanol;
  monopropylenglycolmethylether | | 203-539-1 | 107-98-2 | R10
  R67 | R: 10-67
  S: (2-) | | |
| 603-066-00-4 | 1,2-epoxy-4-epoxyethylcyclohexan;
  4-vinylcyclohexendiepoxid | | 203-437-7 | 106-87-6 | Carc. Cat. 3; R40
  T; R23/24/25 | T
  R: 23/24/25-40
  S: (1/2-)36/37-45-63 | C ≥ 1 %: T; R23/24/25-40
  0,1 % ≤ C < 1 %: Xn; R20/21/22 | |
| 605-004-00-1 | 2,4,6-trimethyl-1,3,5-trioxan;
  paraldehyd | | 204-639-8 | 123-63-7 | R10 | R: 10
  S: (2-)29 | | |
| 605-005-00-7 | 2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctan;
  metaldehyd | | 203-600-2 | 108-62-3 | F; R11
  Xn; R22 | F; Xn
  R: 11-22
  S: (2-)13-16-25-46 | | |
| 606-021-00-7 | N-methyl-2-pyrrolidon;
  1-methyl-2-pyrrolidon | | 212-828-1 | 872-50-4 | Repr. Cat. 2; R61
  Xi; R36/37/38 | T
  R: 61-36/37/38
  S: 53-45 | C ≥ 10 %: T; R61-36/37/38
  5 % ≤ C < 10 %: T; R61 | |
| 607-007-00-3 | oxalsyrens salte undtagen sådanne nævnt andetsteds i dette bilag | A | — | — | Xn; R21/22 | Xn
  R: 21/22
  S: (2-)24/25 | C ≥ 5 %: Xn; R21/22 | |
| 607-012-00-0 | benzoylchlorid | | 202-710-8 | 98-88-4 | Xn; R20/21/22
  C; R34
  R43 | C
  R: 20/21/22-34-43
  S: (1/2-)26-36/37/39-45 | | |
| 607-037-00-7 | 2-ethoxyethylacetat;
  ethylglycolacetat | E | 203-839-2 | 111-15-9 | R10
  Repr. Cat. 2; R60-61
  Xn; R20/21/22 | T
  R: 60-61-10-20/21/22
  S: 53-45 | | |
| 607-051-00-3 | MCPA (ISO);
  4-chloro-o-tolyloxyeddikesyre | | 202-360-6 | 94-74-6 | Xn; R22
  Xi; R38-41
  N; R50-53 | Xn; N
  R: 22-38-41-50/53
  S: (2-)26-37-39-60-61 | | |
| 607-052-00-9 | salte og estere af MCPA | A | — | — | Xn; R20/21/22
  N; R50-53 | Xn; N
  R: 20/21/22-50/53
  S: (2-)13-60-61 | | |
| 607-085-00-9 | benzylbenzoat | | 204-402-9 | 120-51-4 | Xn; R22
  N; R51-53 | Xn; N
  R: 22-51/53
  S: (2-)25-46-61 | | |
| 607-095-00-3 | maleinsyre | | 203-742-5 | 110-16-7 | Xn; R22
  Xi; R36/37/38
  R43 | Xn
  R: 22-36/37/38-43
  S: (2-)24-26-28-37-46 | C ≥ 25 %: Xn; R22-36/37/38-43
  20 % ≤ C <25 %: Xi; R36/37/38-43
  0,1 % ≤ C < 20 %: Xi; R43 | |
| 607-103-00-5 | ravsyreanhydrid | | 203-570-0 | 108-30-5 | Xn; R22
  Xi; R36/37 | Xn
  R: 22-36/37
  S: (2-)25-46 | C ≥ 5 %: Xn; R22-36/37
  1 % ≤ C < 5 %: Xi; R36/37 | |
| 607-142-00-8 | propylchlorformiat;
  chlormyresyrepropylester;

  n-propylchlorformiat | | 203-687-7 | 109-61-5 | F; R11
  T; R23
  C; R34 | F; T
  R: 11-23-34
  S: (1/2-)16-26-36-45 | | |
| 607-195-00-7 | 2-methoxy-1-methylethylacetat | | 203-603-9 | 108-65-6 | R10 | R: 10
  S: (2-) | | |
| 607-216-00-X | glutaminsyre, reaktionsprodukter med N-(C12-14-alkyl)propylendiamin | | 403-950-8 | — | T+; R26
  Xn; R22
  C; R34
  N; R50 | T+; N
  R: 22-26-34-50
  S: (1/2-)26-36/37/39-38-45-61 | | |
| 607-231-00-1 | clopyralid (ISO);
  3,6-dichlorpyridin-2-carboxylsyre | | 216-935-4 | 1702-17-6 | Xi; R41 | Xi
  R: 41
  S: (2-)26-39 | | |
| 607-245-00-8 | tert-butylacrylat | D | 216-768-7 | 1663-39-4 | F; R11
  Xn; R20/21/22
  Xi; R37/38
  R43
  N; R51-53 | F; Xn; N
  R: 11-20/21/22-37/38-43-51/53
  S: (2-)16-25-37-61 | C ≥ 25 %: Xn; R20/21/22-37/38-43-51/53
  20 % ≤ C < 25 %: Xi; R37/38-43-52/53
  2,5 % ≤ C < 20 %: Xi; R43-52/53
  1 % ≤ C < 2,5 %: Xi; R43 | |
| 607-397-00-5 | blanding af: Ca-salicylater (forgrenet C10-14- og C18-30-alkyleret);
  Ca-phenater (forgrenet C10-14- og C18-30-alkyleret);
  Ca-phenater, svovlbehandlede (forgrenet C10-14- og C18-30-alkyleret) | | 415-930-6 | — | Repr. Cat. 3; R62
  R43 | Xn
  R: 43-62
  S: (2-)23-36/37 | | |
| 608-005-00-5 | n-butyronitril | | 203-700-6 | 109-74-0 | F; R11
  T; R23/24/25 | F; T
  R: 11-23/24/25
  S: (1/2-)16-36/37-45-63 | | |
| 608-011-00-8 | oxalonitril;
  cyanogen | | 207-306-5 | 460-19-5 | F+; R12
  T; R23
  N; R50-53 | F+; T; N
  R: 12-23-50/53
  S: (1/2-)9-16-23-33-45-63-60-61 | | |
| 608-044-00-8 | 2-cyclohexyliden-2-phenylacetonitril | | 423-740-1 | 10461-98-0 | Xn; R22
  N; R51-53 | Xn; N
  R; 22-51/53
  S: (2-)46-61 | | |
| 609-007-00-9 | 2,4-dinitrotoluen; [1]
  dinitrotoluen [2] | E | 204-450-0 [1]
  246-836-1 [2] | 121-14-2 [1]
  25321-14-6 [2] | Carc. Cat. 2; R45
  Muta. Cat. 3; R68
  Repr. Cat. 3; R62
  T; R23/24/25
  Xn; R48/22
  N; R50-53 | T; N
  R: 45-23/24/25-48/22-62-68-50/53
  S: 53-45-60-61 | | |
| 611-028-00-3 | C,C′-azodi(formamid) | | 204-650-8 | 123-77-3 | E; R2
  R42 | E; Xn
  R: 2-42
  S: (2-)22-24-37 | | |
| 611-035-00-1 | tetralithium-6-amino-4-hydroxy-3-[7-sulfonato-4-(5-sulfonato-2-naphthylazo)-1-naphthylazo]naphthalen-2,7-disulfonat | | 403-660-1 | 107246-80-0 | N; R51-53 | N
  R: 51/53
  S: 61 | | |
| 612-044-00-3 | N,N′-diacetylbenzidin | E | 210-338-2 | 613-35-4 | Carc. Cat. 2; R45
  Muta. Cat. 3; R68
  Xn; R20/21/22 | T
  R: 45-20/21/22-68
  S: 53-45 | | |
| 612-050-00-6 | cyclohexylamin | | 203-629-0 | 108-91-8 | R10
  Repr. Cat. 3; R62
  Xn; R21/22
  C; R34 | C
  R: 10-21/22-34-62
  S: (1/2-)26-36/37/39-45 | C ≥ 25 %: C; R21/22-34-62
  10 % ≤ C < 25 %: C; R34-62
  5 % ≤ C < 10 %: Xn; R36/38-62
  2% ≤ C < 5%: Xi; R36/38 | |
| 612-076-00-8 | ethyldimethylamin | | 209-940-8 | 598-56-1 | F; R11
  Xn; R20/22
  C; R34 | F; C
  R: 11-20/22-34
  S: (1/2-)3-16-26-36-45 | | |
| 612-099-00-3 | 4-methyl-m-phenylendiamin;
  2,4-toluendiamin | E | 202-453-1 | 95-80-7 | Carc. Cat. 2; R45
  Muta. Cat. 3; R68
  Repr. Cat. 3; R62
  T; R25
  Xn; R21-48/22
  R43
  N; R51-53 | T; N
  R: 45-21-25-43-48/22-62-68-51/53
  S: 53-45-61 | | |
| 612-101-00-2 | methenamin;
  hexamethylentetramin | | 202-905-8 | 100-97-0 | F; R11
  R43 | F; Xi
  R: 11-43
  S: (2-)24-37 | | |
| 612-151-00-5 | methyl-phenylendiamin;
  diaminotoluen;
  [teknisk produkt - blanding af 4-methyl-m-phenylendiamin (EF-nr. 202-453-1) og 2-methyl-m-phenylendiamin (EF-nr. 212-513-9)] | E | — | — | Carc. Cat. 2; R45
  Muta. Cat. 3; R68
  Repr. Cat. 3; R62
  T; R25
  Xn; R21-48/22
  Xi; R36
  R43
  N; R51-53 | T; N
  R: 45-21-25-36-43-48/22-62-68-51/53
  S: 53-45-61 | | |
| 612-237-00-2 | hydroxylammoniumhydrogensulfat;
  hydroxylaminphosphat; [1]
  hydroxylamine phosphate; [2]
  hydroxylamindihydrogenphosphat; [3]
  hydroxylamin-4-methylbenzensulfonat [4] | T | 233-154-4 [1]
  244-077-0 [2]
  242-818-2 [3]
  258-872-5 [4] | 10046-00-1 [1]
  20845-01-6 [2]
  19098-16-9 [3]
  53933-48-5 [4] | E; R2
  Carc. Cat. 3; R40
  Xn; R21/22-48/22
  Xi; R36/38
  R43
  N; R50 | E; Xn; N
  R: 21/22-36/38-40-43-48/22-50
  S: (2-)36/37-61 | | |
| 613-116-00-7 | tolylfluanid (ISO);
  dichlor-N-[(dimethylamino)sulfonyl]fluor-N-(p-tolyl)methansulfenamid;
  [indeholdende ≥ 0,1 % (w/w) partikler med en aerodynamisk diameter på mindre end 50 μm] | | 211-986-9 | 731-27-1 | T+; R26
  T; R48/23
  Xi; R36/37/38
  R43
  N; R50 | T+; N
  R: 26-36/37/38-43-48/23-50
  S: (1/2-)28-36/37/39-45-63-61 | C ≥ 20 %: T+, N; R26-36/37/38-43-48/23-50
  10 % ≤ C < 20 %: T+, N; R26-43-48/23-50
  7 % ≤ C < 10 %: T+, N; R26-43-48/20-50
  2,5 % ≤ C < 7 %: T, N; R23-43-48/20-50
  1 % ≤ C < 2,5 %: T; R23-43-48/20
  0,1 % ≤ C < 1 %: Xn; R20 | |
| 615-001-00-7 | methylisocyanat | | 210-866-3 | 624-83-9 | F; R11
  Repr. Cat. 3; R63
  T+; R26
  T; R24/25
  R42/43
  Xi; R37/38-41 | F; T+
  R: 11-24/25-26-37/38-41-42/43-63
  S: (1/2-)16-26-27/28-36/37/39-45-63 | | |
| 615-004-00-3 | salte af thiocyansyre, undtagen sådanne nævnt andetsteds i dette bilag | A | — | — | Xn; R20/21/22
  R32
  R52-53 | Xn
  R: 20/21/22-32-52/53
  S: (2-)13-36/37-46-61 | | |
| 615-028-00-4 | ethyl-2-(isocyanatosulfonyl)benzoat | | 410-220-2 | 77375-79-2 | R14
  Xn; R22-48/22
  Xi; R41
  R42/43 | Xn
  R: 14-22-41-42/43-48/22
  S: (2-)8-23-26-30-35-36/37/39 | | |
| 615-030-00-5 | alkalisalte og jordalkalisalte af thiocyansyre, undtagen sådanne nævnt andetsteds i dette bilag | A | — | — | Xn; R20/21/22
  R32
  R52-53 | Xn
  R: 20/21/22-32-52/53
  S: (2-)13-36/37-46-61 | | |
| 615-031-00-0 | thalliumthiocyanat | | 222-571-7 | 3535-84-0 | T+; R26/28
  Xn; R21
  R32
  R33
  N; R51-53 | T+; N
  R: 21-26/28-32-33-51/53
  S: (1/2-)13-28-36/37-45-61 | | |
| 615-032-00-6 | metalsalt af thiocyansyre, undtagen sådanne nævnt andetsteds i dette bilag | A | — | — | Xn; R20/21/22
  R32
  N; R50-53 | Xn; N
  R: 20/21/22-32-50/53
  S: (2-)13-36/37-46-60-61 | | |
| 616-124-00-9 | lithium-bis(trifluormethylsulfonyl)imid | | 415-300-0 | 90076-65-6 | T; R24/25
  Xn; R48/22
  C; R34
  R52-53 | T
  R: 24/25-34-48/22-52/53
  S: (1/2-)22-26-36/37/39-45-61 | | |
| 617-017-00-X | blanding af: 2,2′-bis(tert-pentylperoxy)-p-diisopropylbenzen;
  2,2′-bis(tert-pentylperoxy)-m-diisopropylbenzen | T | 412-140-3 | 32144-25-5 | E; R2
  O; R7
  R53 | E
  R: 2-7-53
  S: (2-)3/7-14-36/37/39-61 | | |
| 650-016-00-2 | mineraluld, undtagen sådan nævnt andetsteds i dette bilag;
  [syntetiske glasfibre (silikatfibre) uden bestemt orientering med indhold af alkalioxider og jordalkalioxider (Na2O+K2O+CaO+MgO+BaO) over 18 % (w/w)] | AQR | — | — | Carc. Cat. 3; R40 | Xn
  R: 40
  S: (2-)36/37 | | |
| 650-017-00-8 | ildfaste keramiske fibre, specialfibre, undtagen sådanne nævnt andetsteds i dette bilag;
  [syntetiske glasfibre (silikatfibre) uden bestemt orientering med indhold af alkalioxider og jordalkalioxider (Na2O+K2O+CaO+ MgO+BaO) over 18 % (w/w)] | AR | — | — | Carc. Cat. 2; R49 | T
  R: 49
  S: 53-45 | | |

Indeksnr.

Kemisk navn

Noter vedrørende stoffer

EF-nr.

CAS-nr.

Klassificering

Etikettering

Koncentrationsgrænser

Noter vedrørende tilberedninger

001-002-00-4

aluminiumlithiumhydrid

240-877-9

16853-85-3

F; R15

C; R35

F; C

R: 15-35

S: (1/2-)7/8-26-36/37/39-43-45

005-006-00-7

dibutyltinhydrogenborat

E

401-040-5

75113-37-0

Muta. Cat. 3; R68

Repr. Cat. 2; R60-61

T; R48/25

Xn; R21/22

Xi; R41

R43

N; R50-53

T; N

R: 60-61-21/22-41-43-48/25-68-50/53

S: 53-45-60-61

006-007-00-5

salte af hydrogencyanid med undtagelse af komplekse salte som cyanoferrat (II) og-(III) og kviksølv(II)oxidcyanid

A

—

—

T+; R26/27/28

R32

N; R50-53

T+; N

R: 26/27/28-32-50/53

S: (1/2-)7-28-29-45-60-61

006-015-00-9

diuron (ISO);

3-(3,4-dichlorphenyl)-1,1-dimethylurinstof

206-354-4

330-54-1

Carc. Cat. 3; R40

Xn; R22-48/22

N; R50-53

Xn; N

R: 22-40-48/22-50/53

S: (2-)13-36/37-46-60-61

C ≥ 25 %: Xn, N; R22-40-48/22-50/53

10 % ≤ C < 25 %: Xn, N; R40-48/22-50/53

2,5 % ≤ C < 10 %: Xn, N; R40-50/53

1 % ≤ C < 2,5 %: Xn, N; R40-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

006-076-00-1

mancozeb (ISO);

manganethylenbis(dithiocarbamat) (polymer), kompleks med zinksalt

—

8018-01-7

Repr. Cat. 3; R63

R43

N; R50

Xn; N

R: 43-63-50

S: (2-)36/37-46-61

C ≥ 5 %: Xn, N; R43-63-50

2,5 ≤ C < 5 %: Xi, N; R43-50

1 % ≤ C < 2,5 %: Xi; R43

006-077-00-7

maneb (ISO);

manganethylenbis(dithiocarbamat) (polymer)

235-654-8

12427-38-2

Repr. Cat. 3; R63

Xn; R20

Xi; R36

R43

N; R50-53

Xn; N

R: 20-36-43-63-50/53

S: (2-)36/37-46-60-61

C ≥ 25 %: Xn, N; R20-36-43-63-50/53

20 % ≤ C < 25 %: Xn, N; R36-43-63-50/53

5 % ≤ C < 20 %: Xn, N; R43-63-50/53

2,5 % ≤ C < 5 %: Xi, N; R43-50/53

1 % ≤ C < 2,5 %: Xi, N; R43-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

006-084-00-5

carbosulfan (ISO);

2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamat

259-565-9

55285-14-8

T+; R26

T; R25

R43

N; R50-53

T+; N

R: 25-26-43-50/53

S: (1/2-)28-36/37-38-45-63-60-61

006-088-00-7

benfuracarb (ISO);

ethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl-β-alaninat

—

82560-54-1

Repr. Cat. 3; R62

T; R23

Xn; R22

N; R50-53

T; N

R: 22-23-62-50/53

S: (1/2-)36/37-45-60-61

007-002-00-0

nitrogendioxid; [1]

dinitrogentetraoxid [2]

233-272-6 [1]

234-126-4 [2]

10102-44-0 [1]

10544-72-6 [2]

O; R8

T+; R26

C; R34

O; T+

R: 8-26-34

S: (1/2-)9-26-28-36/37/39-45

C ≥ 10 %: T+; R26-34

5 % ≤ C < 10 %: T; R23-34

1 % ≤ C < 5 %: T; R23-36/37/38

0,5 % ≤ C < 1 %: Xn; R20-36/37/38

0,1 % ≤ C < 0,5 %: Xn; R20

5

015-041-00-X

malathion (ISO);

1,2-bis(ethoxycarbonyl)ethyl-O,O-dimethylphosphordithioat;

[indeholdende ≤ 0,03 % isomalathion]

204-497-7

121-75-5

Xn; R22

R43

N; R50-53

Xn; N

R: 22-43-50/53

S: (2-)24-37-46-60-61

C ≥ 25 %: Xn, N; R22-43-50/53

1 % ≤ C < 25 %: Xi, N; R43-50/53

0,025 % ≤ C < 1 %: N; R50/53

0,0025 % ≤ C < 0,025 %: N; R51/53

0,00025 % ≤ C < 0,0025 %: R52/53

015-100-00-X

phoxim (ISO);

α-(diethoxyphosphinothioylimino)phenylacetonitril

238-887-3

14816-18-3

Repr. Cat. 3; R62

Xn; R22

R43

N; R50-53

Xn; N

R: 22-43-62-50/53

S: (2-)36/37-46-60-61

C ≥ 25 %: Xn, N; R22-43-62-50/53

5 % ≤ C < 25 %: Xn, N; R43-62-50/53

1 % ≤ C < 5 %: Xi, N; R43-50/53

0,025 % ≤ C < 1 %: N; R50/53

0,0025 % ≤ C < 0,025 %: N; R51/53

0,00025 % ≤ C < 0,0025 %: R52/53

015-102-00-0

tris(2-chlorethyl)phosphat

E

204-118-5

115-96-8

Carc. Cat. 3; R40

Repr. Cat. 2; R60

Xn; R22

N; R51-53

T; N

R: 60-22-40-51/53

S: 53-45-61

015-155-00-X

glufosinat ammonium (ISO);

ammonium-2-amino-4-(hydroxymethylphosphinyl)butyrat

E

278-636-5

77182-82-2

Repr. Cat. 2; R60

Repr. Cat. 3; R63

Xn; R20/21/22-48/20/22

T

R: 60-20/21/22-48/20/22-63

S: 53-45

016-009-00-8

dinatriumsulfid;

natriumsulfid

215-211-5

1313-82-2

T; R24

Xn; R22

C; R34

R31

N; R50

T; C; N

R: 22-24-31-34-50

S: (1/2-)26-36/37/39-45-61

017-009-00-0

ammoniumperchlorat;

[indeholdende ≥ 80 % partikler på 0-30 μm]

T

232-235-1

7790-98-9

E; R3

O; R9

E

R: 3-9

S: (2-)14-16-36/37

024-004-00-7

natriumdichromat

E

234-190-3

10588-01-9

O; R8

Carc. Cat. 2; R45

Muta. Cat. 2; R46

Repr. Cat. 2; R60-61

T+; R26

T; R25-48/23

Xn; R21

C; R34

R42/43

N; R50-53

O; T+; N

R: 45-46-60-61-8-21-25-26-34-42/43-48/23-50/53

S: 53-45-60-61

C ≥ 25 %: T+, N; R45-46-60-61-21-25-26-34-42/43-48/23-50/53

10 % ≤ C < 25 %: T+, N; R45-46-60-61-22-26-34-42/43-48/23-51/53

7 % ≤ C < 10 %: T+, N; R45-46-60-61-22-26-36/37/38-42/43-48/20-51/53

5 % ≤ C < 7 %: T, N; R45-46-60-61-22-23-36/37/38-42/43-48/20-51/53

3 % ≤ C < 5 %: T, N; R45-46-60-61-22-23-42/43-48/20-51/53

2,5 % ≤ C < 3 %: T, N; R45-46-60-61-23-42/43-48/20-51/53

1 % ≤ C < 2,5 %: T; R45-46-60-61-23-42/43-48/20-52/53

0,5 % ≤ C < 1 %: T; R45-46-60-61-20-42/43-52/53

0,25 % ≤ C < 0,5 %: T; R45-46-20-42/43-52/53

0,2 % ≤ C < 0,25 %: T; R45-46-20-42/43

0,1 % ≤ C < 0,2 %: T; R45-46-20

3

027-002-00-4

cobaltoxid

215-154-6

1307-96-6

Xn; R22

R43

N; R50-53

Xn; N

R: 22-43-50/53

S: (2-)24-37-60-61

C ≥ 25 %: Xn, N; R22-43-50/53

2,5 % ≤ C < 25 %: Xi, N; R43-50/53

1 % ≤ C < 2,5 %: Xi, N; R43-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

027-003-00-X

cobaltsulfid

215-273-3

1317-42-6

R43

N; R50-53

Xi; N

R: 43-50/53

S: (2-)24-37-60-61

C ≥ 2,5 %: Xi, N; R43-50/53

1 % ≤ C < 2,5 %: Xi, N; R43-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

028-003-00-2

nikkelmonoxid; [1]

nikkeloxid; [2]

bunsenit [3]

E

215-215-7 [1]

234-323-5 [2]

- [3]

1313-99-1 [1]

11099-02-8 [2]

34492-97-2 [3]

Carc. Cat. 1; R49

T; R48/23

R43

R53

T

R: 49-43-48/23-53

S: 53-45-61

028-004-00-8

nikkeldioxid

E

234-823-3

12035-36-8

Carc. Cat. 1; R49

T; R48/23

R43

R53

T

R: 49-43-48/23-53

S: 53-45-61

028-005-00-3

dinikkeltrioxid

E

215-217-8

1314-06-3

Carc. Cat. 1; R49

T; R48/23

R43

R53

T

R: 49-43-48/23-53

S: 53-45-61

028-006-00-9

nikkel(II)sulfid; [1]

nikkelsulfid; [2]

millerit [3]

E

240-841-2 [1]

234-349-7 [2]

- [3]

16812-54-7 [1]

11113-75-0 [2]

1314-04-1 [3]

Carc. Cat. 1; R49

Muta. Cat. 3; R68

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-68-50/53

S: 53-45-60-61

028-007-00-4

trinikkeldisulfid;

nikkelsubsulfid; [1]

heazlewoodit [2]

E

234-829-6 [1]

- [2]

12035-72-2 [1]

12035-71-1 [2]

Carc. Cat. 1; R49

Muta. Cat. 3; R68

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-68-50/53

S: 53-45-60-61

028-008-00-X

nikkeldihydroxid; [1]

nikkelhydroxid [2]

E

235-008-5 [1]

234-348-1 [2]

12054-48-7 [1]

11113-74-9 [2]

Carc. Cat. 1; R49

Repr. Cat. 2; R61

Muta. Cat. 3; R68

T; R48/23

Xn; R20/22

Xi; R38

R42/43

N; R50-53

T; N

R: 49-61-20/22-38-42/43-48/23-68-50/53

S: 53-45-60-61

029-013-00-X

trinatrium-(2-(α-(3-(4-chlor-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)benzylidenhydrazino)-4-sulfonatobenzoato)kobber(II)

407-580-8

130201-51-3

Xi; R41

Xi

R: 41

S: (2-)26-39

033-005-00-1

arsensyre og dets salte undtagen sådanne nævnt andetsteds i dette bilag

AE

—

—

Carc. Cat. 1; R45

T; R23/25

N; R50-53

T; N

R: 45-23/25-50/53

S: 53-45-60-61

034-002-00-8

selenforbindelser med undtagelse af cadmiumsulfoselenid (xCdS.yCdSe) undtagen sådanne nævnt andetsteds i dette bilag

A

—

—

T; R23/25

R33

N; R50-53

T; N

R: 23/25-33-50/53

S: (1/2-)20/21-28-45-60-61

047-001-00-2

sølvnitrat

231-853-9

7761-88-8

O; R8

C; R34

N; R50-53

O; C; N

R: 8-34-50/53

S: (1/2-)26-36/37/39-45-60-61

050-002-00-0

cyhexatin (ISO);

hydroxytricyclohexylstannan;

tri(cyclohexyl)tinhydroxid

236-049-1

13121-70-5

Xn; R20/21/22

N; R50-53

Xn; N

R: 20/21/22-50/53

S: (2-)13-60-61

C ≥ 25 %: Xn, N; R20/21/22-50/53

0,025 % ≤ C < 25 %: N; R50/53

0,0025 % ≤ C < 0,025 %: N; R51/53

0,00025 % ≤ C < 0,0025 %: R52/53

050-003-00-6

fentinacetat (ISO);

triphenyltinacetat

212-984-0

900-95-8

Carc. Cat. 3; R40

Repr. Cat. 3; R63

T+; R26

T; R24/25-48/23

Xi; R37/38-41

N; R50-53

T+; N

R: 24/25-26-37/38-40-41-48/23-63-50/53

S: (1/2-)26-28-36/37/39-45-60-61

C ≥ 25 %: T+, N; R24/25-26-37/38-40-41-48/23-63-50/53

20 % ≤ C < 25 %: T+, N; R21/22-26-37/38-40-41-48/23-63-50/53

10% ≤ C < 20 %: T+, N; R21/22-26-40-41-48/23-63-50/53

7 % ≤ C < 10 %: T+, N; R21/22-26-36-40-48/20-63-50/53

5 % ≤ C < 7 %: T, N; R21/22-23-36-40-48/20-63-50/53

3 % ≤ C < 5 %: T, N; R21/22-23-40-48/20-50/53

2,5 % ≤ C < 3 %: T, N; R23-40-48/20-50/53.

1 % ≤ C < 2,5 %: T, N; R23-40-48/20-51/53

0,25 % ≤ C < 1 %: Xn, N; R20-51/53

0,1 % ≤ C < 0,25 %: Xn; R20-52/53

0,025 % ≤ C < 0,1 %: R52/53

050-004-00-1

fentinhydroxid (ISO);

triphenyltinhydroxid

200-990-6

76-87-9

Carc. Cat. 3; R40

Repr. Cat. 3; R63

T+; R26

T; R24/25-48/23

Xi; R37/38-41

N; R50-53

T+; N

R: 24/25-26-37/38-40-41-48/23-63-50/53

S: (1/2-)26-28-36/37/39-45-60-61

C ≥ 25 %: T+, N; R24/25-26-37/38-40-41-48/23-63-50/53

20 % ≤ C < 25 %: T+, N; R21/22-26-37/38-40-41-48/23-63-50/53

10 % ≤ C < 20 %: T+, N; R21/22-26-40-41-48/23-63-50/53

7 % ≤ C < 10 %: T+, N; R21/22-26-36-40-48/20-63-50/53

5 % ≤ C < 7 %: T, N; R21/22-23-36-40-48/20-63-50/53

3 % ≤ C < 5 %: T, N; R21/22-23-40-48/20-50/53

2,5 % ≤ C < 3 %: T, N; R23-40-48/20-50/53

1 % ≤ C < 2,5 %: T, N; R23-40-48/20-51/53

0,25 % ≤ C < 1 %: Xn, N; R20-51/53

0,1 % ≤ C < 0,25 %: Xn; R20-52/53

0,025 % ≤ C < 0,1 %: R52/53

050-008-00-3

tributyltinforbindelser, undtagen sådanne nævnt andetsteds i dette bilag

A

—

—

T; R25-48/23/25

Xn; R21

Xi; R36/38

N; R50-53

T; N

R: 21-25-36/38-48/23/25-50/53

S: (1/2-)36/37/39-45-60-61

C ≥ 2,5 %: T, N; R21-25-36/38-48/23/25-50/53

1 % ≤ C < 2,5 %: T, N; R21-25-36/38-48/23/25-51/53

0,25 % ≤ C < 1 %: Xn, N; R22-48/20/22-51/53

0,025 % C < 0,25 %: R52/53

1

050-011-00-X

triphenyltinforbindelser, undtagen sådanne nævnt andetsteds i dette bilag

A

—

—

T; R23/24/25

N; R50-53

T; N

R: 23/24/25-50/53

S: (1/2-)26-27-28-45-60-61

C ≥ 1 %: T, N; R23/24/25-50/53

0,25 % ≤ C < 1 %: Xn, N; R20/21/22-50/53

0,025 % ≤ C < 0,25 %: N; R51/53

0,0025 % ≤ C < 0,025 %: R52/53

1

050-018-00-8

tin(II)methansulfonat

401-640-7

53408-94-9

C; R34

Xn; R22

R43

N; R51-53

C; N

R: 22-34-43-51/53

S: (1/2-)22-26-36/37/39-45-61

053-003-00-4

iodoxybenzen

—

696-33-3

E; R2

E

R: 2

S: (2-)35

053-004-00-X

calciumiodoxybenzoat

C

—

—

E; R2

E

R: 2

S: (2-)35

080-001-00-0

kviksølv

E

231-106-7

7439-97-6

Repr. Cat. 2; R61

T+; R26

T; R48/23

N; R50-53

T+; N

R: 61-26-48/23-50/53

S: 53-45-60-61

080-010-00-X

kviksølvdichlorid;

kviksølvchlorid

231-299-8

7487-94-7

Muta. Cat. 3; R68

Repr. Cat. 3; R62

T+; R28

T; R48/24/25

C; R34

N; R50-53

T+; N

R: 28-34-48/24/25-62-68-50/53

S: (1/2-)26-36/37/39-45-60-61

092-002-00-3

uranforbindelser, undtagen sådanne nævnt andetsteds i dette bilag

A

—

—

T+; R26/28

R33

N; R51-53

T+; N

R: 26/28-33-51/53

S: (1/2-)20/21-45-61

601-065-00-3

Blanding af: (1′α,3′α,6′α)-2,2,3′,7′,7′-pentamethylspiro(1,3-dioxan-5,2′-norcaran);

(1′α,3′β,6′α)-2,2,3′,7′,7′-pentamethylspiro(1,3-dioxan-5,2′-norcaran)

416-930-9

—

Xi; R38

N; R51-53

Xi; N

R: 38-51/53

S: (2-)36/37-61

602-007-00-X

bromoform;

tribrommethan

200-854-6

75-25-2

T; R23

Xn; R22

Xi; R36/38

N; R51-53

T; N

R: 22-23-36/38-51/53

S: (1/2-)28-45-63-61

602-030-00-5

1,3-dichlorpropen; [1]

(Z)-1,3-dichlorpropen [2]

C D

208-826-5 [1]

233-195-8 [2]

542-75-6 [1]

10061-01-5 [2]

R10

T; R24/25

Xn; R20-65

Xi; R36/37/38

R43

N; R50-53

T; N

R: 10-20-24/25-36/37/38-43-65-50/53

S: (1/2-)36/37-45-60-61

602-054-00-6

3-iodpropen;

allyliodid

209-130-4

556-56-9

F; R11

C; R34

F; C

R: 11-34

S: (1/2-)7-16-26-45

603-005-00-1

2-methylpropan-2-ol;

tert-butylalkohol

200-889-7

75-65-0

F; R11

Xn; R20

Xi; R36/37

F; Xn

R: 11-20-36/37

S: (2-)9-16-46

603-018-00-2

furfurylalkohol

202-626-1

98-00-0

Carc. Cat. 3; R40

T; R23

Xn; R21/22-48/20

Xi; R36/37

T

R: 21/22-23-36/37-40-48/20

S: (1/2-)36/37-45-63

603-023-00-X

ethylenoxid;

oxiran

E

200-849-9

75-21-8

F+; R12

R6

Carc. Cat. 2; R45

Muta. Cat. 2; R46

T; R23

Xi; R36/37/38

F+; T

R: 45-46-6-12-23-36/37/38

S: 53-45

603-029-00-2

bis(2-chlorethyl)ether

203-870-1

111-44-4

Carc. Cat. 3; R40

T+; R26/27/28

T+

R: 26/27/28-40

S: (1/2-)7/9-27-28-36/37-45

C ≥ 7 %: T+; R26/27/28-40

1 % ≤ C < 7 %: T; R23/24/25-40

0,1 % ≤ C < 1 %: Xn; R20/21/22

603-037-00-6

cellulosenitrat;

nitrocellulose

T

—

—

E; R3

E

R: 3

S: (2-)35

603-046-00-5

bis(chlormethyl)ether;

oxybis(chlormethan)

E

208-832-8

542-88-1

F; R11

Carc. Cat. 1; R45

T+; R26

T; R24

Xn; R22

F; T+

R: 45-11-22-24-26

S: 53-45

C ≥ 25 %: T+; R45-22-24-26

7 % ≤ C < 25 %: T+; R45-21-26

3 % ≤ C < 7 %: T; R45-21-23

1 % ≤ C < 3 %: T; R45-23

0,1 % ≤ C < 1 %: T; R45-20

0,001 % ≤ C < 0,1 %: T; R45

603-064-00-3

1-methoxy-2-propanol;

monopropylenglycolmethylether

203-539-1

107-98-2

R10

R67

R: 10-67

S: (2-)

603-066-00-4

1,2-epoxy-4-epoxyethylcyclohexan;

4-vinylcyclohexendiepoxid

203-437-7

106-87-6

Carc. Cat. 3; R40

T; R23/24/25

T

R: 23/24/25-40

S: (1/2-)36/37-45-63

C ≥ 1 %: T; R23/24/25-40

0,1 % ≤ C < 1 %: Xn; R20/21/22

605-004-00-1

2,4,6-trimethyl-1,3,5-trioxan;

paraldehyd

204-639-8

123-63-7

R10

R: 10

S: (2-)29

605-005-00-7

2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctan;

metaldehyd

203-600-2

108-62-3

F; R11

Xn; R22

F; Xn

R: 11-22

S: (2-)13-16-25-46

606-021-00-7

N-methyl-2-pyrrolidon;

1-methyl-2-pyrrolidon

212-828-1

872-50-4

Repr. Cat. 2; R61

Xi; R36/37/38

T

R: 61-36/37/38

S: 53-45

C ≥ 10 %: T; R61-36/37/38

5 % ≤ C < 10 %: T; R61

607-007-00-3

oxalsyrens salte undtagen sådanne nævnt andetsteds i dette bilag

A

—

—

Xn; R21/22

Xn

R: 21/22

S: (2-)24/25

C ≥ 5 %: Xn; R21/22

607-012-00-0

benzoylchlorid

202-710-8

98-88-4

Xn; R20/21/22

C; R34

R43

C

R: 20/21/22-34-43

S: (1/2-)26-36/37/39-45

607-037-00-7

2-ethoxyethylacetat;

ethylglycolacetat

E

203-839-2

111-15-9

R10

Repr. Cat. 2; R60-61

Xn; R20/21/22

T

R: 60-61-10-20/21/22

S: 53-45

607-051-00-3

MCPA (ISO);

4-chloro-o-tolyloxyeddikesyre

202-360-6

94-74-6

Xn; R22

Xi; R38-41

N; R50-53

Xn; N

R: 22-38-41-50/53

S: (2-)26-37-39-60-61

607-052-00-9

salte og estere af MCPA

A

—

—

Xn; R20/21/22

N; R50-53

Xn; N

R: 20/21/22-50/53

S: (2-)13-60-61

607-085-00-9

benzylbenzoat

204-402-9

120-51-4

Xn; R22

N; R51-53

Xn; N

R: 22-51/53

S: (2-)25-46-61

607-095-00-3

maleinsyre

203-742-5

110-16-7

Xn; R22

Xi; R36/37/38

R43

Xn

R: 22-36/37/38-43

S: (2-)24-26-28-37-46

C ≥ 25 %: Xn; R22-36/37/38-43

20 % ≤ C <25 %: Xi; R36/37/38-43

0,1 % ≤ C < 20 %: Xi; R43

607-103-00-5

ravsyreanhydrid

203-570-0

108-30-5

Xn; R22

Xi; R36/37

Xn

R: 22-36/37

S: (2-)25-46

C ≥ 5 %: Xn; R22-36/37

1 % ≤ C < 5 %: Xi; R36/37

607-142-00-8

propylchlorformiat;

chlormyresyrepropylester;

n-propylchlorformiat

203-687-7

109-61-5

F; R11

T; R23

C; R34

F; T

R: 11-23-34

S: (1/2-)16-26-36-45

607-195-00-7

2-methoxy-1-methylethylacetat

203-603-9

108-65-6

R10

R: 10

S: (2-)

607-216-00-X

glutaminsyre, reaktionsprodukter med N-(C12-14-alkyl)propylendiamin

403-950-8

—

T+; R26

Xn; R22

C; R34

N; R50

T+; N

R: 22-26-34-50

S: (1/2-)26-36/37/39-38-45-61

607-231-00-1

clopyralid (ISO);

3,6-dichlorpyridin-2-carboxylsyre

216-935-4

1702-17-6

Xi; R41

Xi

R: 41

S: (2-)26-39

607-245-00-8

tert-butylacrylat

D

216-768-7

1663-39-4

F; R11

Xn; R20/21/22

Xi; R37/38

R43

N; R51-53

F; Xn; N

R: 11-20/21/22-37/38-43-51/53

S: (2-)16-25-37-61

C ≥ 25 %: Xn; R20/21/22-37/38-43-51/53

20 % ≤ C < 25 %: Xi; R37/38-43-52/53

2,5 % ≤ C < 20 %: Xi; R43-52/53

1 % ≤ C < 2,5 %: Xi; R43

607-397-00-5

blanding af: Ca-salicylater (forgrenet C10-14- og C18-30-alkyleret);

Ca-phenater (forgrenet C10-14- og C18-30-alkyleret);

Ca-phenater, svovlbehandlede (forgrenet C10-14- og C18-30-alkyleret)

415-930-6

—

Repr. Cat. 3; R62

R43

Xn

R: 43-62

S: (2-)23-36/37

608-005-00-5

n-butyronitril

203-700-6

109-74-0

F; R11

T; R23/24/25

F; T

R: 11-23/24/25

S: (1/2-)16-36/37-45-63

608-011-00-8

oxalonitril;

cyanogen

207-306-5

460-19-5

F+; R12

T; R23

N; R50-53

F+; T; N

R: 12-23-50/53

S: (1/2-)9-16-23-33-45-63-60-61

608-044-00-8

2-cyclohexyliden-2-phenylacetonitril

423-740-1

10461-98-0

Xn; R22

N; R51-53

Xn; N

R; 22-51/53

S: (2-)46-61

609-007-00-9

2,4-dinitrotoluen; [1]

dinitrotoluen [2]

E

204-450-0 [1]

246-836-1 [2]

121-14-2 [1]

25321-14-6 [2]

Carc. Cat. 2; R45

Muta. Cat. 3; R68

Repr. Cat. 3; R62

T; R23/24/25

Xn; R48/22

N; R50-53

T; N

R: 45-23/24/25-48/22-62-68-50/53

S: 53-45-60-61

611-028-00-3

C,C′-azodi(formamid)

204-650-8

123-77-3

E; R2

R42

E; Xn

R: 2-42

S: (2-)22-24-37

611-035-00-1

tetralithium-6-amino-4-hydroxy-3-[7-sulfonato-4-(5-sulfonato-2-naphthylazo)-1-naphthylazo]naphthalen-2,7-disulfonat

403-660-1

107246-80-0

N; R51-53

N

R: 51/53

S: 61

612-044-00-3

N,N′-diacetylbenzidin

E

210-338-2

613-35-4

Carc. Cat. 2; R45

Muta. Cat. 3; R68

Xn; R20/21/22

T

R: 45-20/21/22-68

S: 53-45

612-050-00-6

cyclohexylamin

203-629-0

108-91-8

R10

Repr. Cat. 3; R62

Xn; R21/22

C; R34

C

R: 10-21/22-34-62

S: (1/2-)26-36/37/39-45

C ≥ 25 %: C; R21/22-34-62

10 % ≤ C < 25 %: C; R34-62

5 % ≤ C < 10 %: Xn; R36/38-62

2% ≤ C < 5%: Xi; R36/38

612-076-00-8

ethyldimethylamin

209-940-8

598-56-1

F; R11

Xn; R20/22

C; R34

F; C

R: 11-20/22-34

S: (1/2-)3-16-26-36-45

612-099-00-3

4-methyl-m-phenylendiamin;

2,4-toluendiamin

E

202-453-1

95-80-7

Carc. Cat. 2; R45

Muta. Cat. 3; R68

Repr. Cat. 3; R62

T; R25

Xn; R21-48/22

R43

N; R51-53

T; N

R: 45-21-25-43-48/22-62-68-51/53

S: 53-45-61

612-101-00-2

methenamin;

hexamethylentetramin

202-905-8

100-97-0

F; R11

R43

F; Xi

R: 11-43

S: (2-)24-37

612-151-00-5

methyl-phenylendiamin;

diaminotoluen;

[teknisk produkt - blanding af 4-methyl-m-phenylendiamin (EF-nr. 202-453-1) og 2-methyl-m-phenylendiamin (EF-nr. 212-513-9)]

E

—

—

Carc. Cat. 2; R45

Muta. Cat. 3; R68

Repr. Cat. 3; R62

T; R25

Xn; R21-48/22

Xi; R36

R43

N; R51-53

T; N

R: 45-21-25-36-43-48/22-62-68-51/53

S: 53-45-61

612-237-00-2

hydroxylammoniumhydrogensulfat;

hydroxylaminphosphat; [1]

hydroxylamine phosphate; [2]

hydroxylamindihydrogenphosphat; [3]

hydroxylamin-4-methylbenzensulfonat [4]

T

233-154-4 [1]

244-077-0 [2]

242-818-2 [3]

258-872-5 [4]

10046-00-1 [1]

20845-01-6 [2]

19098-16-9 [3]

53933-48-5 [4]

E; R2

Carc. Cat. 3; R40

Xn; R21/22-48/22

Xi; R36/38

R43

N; R50

E; Xn; N

R: 21/22-36/38-40-43-48/22-50

S: (2-)36/37-61

613-116-00-7

tolylfluanid (ISO);

dichlor-N-[(dimethylamino)sulfonyl]fluor-N-(p-tolyl)methansulfenamid;

[indeholdende ≥ 0,1 % (w/w) partikler med en aerodynamisk diameter på mindre end 50 μm]

211-986-9

731-27-1

T+; R26

T; R48/23

Xi; R36/37/38

R43

N; R50

T+; N

R: 26-36/37/38-43-48/23-50

S: (1/2-)28-36/37/39-45-63-61

C ≥ 20 %: T+, N; R26-36/37/38-43-48/23-50

10 % ≤ C < 20 %: T+, N; R26-43-48/23-50

7 % ≤ C < 10 %: T+, N; R26-43-48/20-50

2,5 % ≤ C < 7 %: T, N; R23-43-48/20-50

1 % ≤ C < 2,5 %: T; R23-43-48/20

0,1 % ≤ C < 1 %: Xn; R20

615-001-00-7

methylisocyanat

210-866-3

624-83-9

F; R11

Repr. Cat. 3; R63

T+; R26

T; R24/25

R42/43

Xi; R37/38-41

F; T+

R: 11-24/25-26-37/38-41-42/43-63

S: (1/2-)16-26-27/28-36/37/39-45-63

615-004-00-3

salte af thiocyansyre, undtagen sådanne nævnt andetsteds i dette bilag

A

—

—

Xn; R20/21/22

R32

R52-53

Xn

R: 20/21/22-32-52/53

S: (2-)13-36/37-46-61

615-028-00-4

ethyl-2-(isocyanatosulfonyl)benzoat

410-220-2

77375-79-2

R14

Xn; R22-48/22

Xi; R41

R42/43

Xn

R: 14-22-41-42/43-48/22

S: (2-)8-23-26-30-35-36/37/39

615-030-00-5

alkalisalte og jordalkalisalte af thiocyansyre, undtagen sådanne nævnt andetsteds i dette bilag

A

—

—

Xn; R20/21/22

R32

R52-53

Xn

R: 20/21/22-32-52/53

S: (2-)13-36/37-46-61

615-031-00-0

thalliumthiocyanat

222-571-7

3535-84-0

T+; R26/28

Xn; R21

R32

R33

N; R51-53

T+; N

R: 21-26/28-32-33-51/53

S: (1/2-)13-28-36/37-45-61

615-032-00-6

metalsalt af thiocyansyre, undtagen sådanne nævnt andetsteds i dette bilag

A

—

—

Xn; R20/21/22

R32

N; R50-53

Xn; N

R: 20/21/22-32-50/53

S: (2-)13-36/37-46-60-61

616-124-00-9

lithium-bis(trifluormethylsulfonyl)imid

415-300-0

90076-65-6

T; R24/25

Xn; R48/22

C; R34

R52-53

T

R: 24/25-34-48/22-52/53

S: (1/2-)22-26-36/37/39-45-61

617-017-00-X

blanding af: 2,2′-bis(tert-pentylperoxy)-p-diisopropylbenzen;

2,2′-bis(tert-pentylperoxy)-m-diisopropylbenzen

T

412-140-3

32144-25-5

E; R2

O; R7

R53

E

R: 2-7-53

S: (2-)3/7-14-36/37/39-61

650-016-00-2

mineraluld, undtagen sådan nævnt andetsteds i dette bilag;

[syntetiske glasfibre (silikatfibre) uden bestemt orientering med indhold af alkalioxider og jordalkalioxider (Na2O+K2O+CaO+MgO+BaO) over 18 % (w/w)]

AQR

—

—

Carc. Cat. 3; R40

Xn

R: 40

S: (2-)36/37

650-017-00-8

ildfaste keramiske fibre, specialfibre, undtagen sådanne nævnt andetsteds i dette bilag;

[syntetiske glasfibre (silikatfibre) uden bestemt orientering med indhold af alkalioxider og jordalkalioxider (Na2O+K2O+CaO+ MgO+BaO) over 18 % (w/w)]

AR

—

—

Carc. Cat. 2; R49

T

R: 49

S: 53-45

---

BILAG 1B

| Indeks nr. | Kemisk navn | Noter vedrørende stoffer | EF-nr. | CAS-nr. | Klassificering | Etikettering | Koncentrationsgrænser | Noter vedrørende tilberedninger |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 003-003-00-5 | (2-methylpropyl)lithium;
  isobutyllithium | | 440-620-2 | 920-36-5 | F; R15-17
  R14
  C; R35
  R67
  N; R50-53 | F; C; N
  R: 14/15-17-35-67-50/53
  S: (1/2-)6-16-26-30-33-36/37/39-43-45-60-61 | | |
| 005-013-00-5 | diethylmethoxyboran | | 425-380-9 | 7397-46-8 | F; R17
  Xn; R20/21/22-48/22
  C; R34
  R43
  R53 | F; C
  R: 17-20/21/22-34-43-48/22-53
  S: (1/2-)6-26-36/37/39-43-45-61 | | |
| 005-014-00-0 | 4-formylphenylboronsyre | | 438-670-5 | 87199-17-5 | R43 | Xi
  R: 43
  S: (2-)24-37 | | |
| 005-017-00-7 | natriumperborat; [1]
  perborsyre, natriumsalt; [2]
  perborsyre, natriumsalt, monohydrat; [3]
  natriumperoxometaborat; [4]
  perborsyre (HBO(O2)), natriumsalt, monohydrat; [5]
  natriumperoxoborat;
  [indeholdende < 0,1 % (w/w) partikler med en aerodynamisk diameter på mindre end 50 μm] | E | 239-172-9 [1]
  234-390-0 [2]
  - [3]
  231-556-4 [4]
  - [5] | 15120-21-5 [1]
  11138-47-9 [2]
  12040-72-1 [3]
  7632-04-4 [4]
  10332-33-9 [5] | O; R8
  Repr. Cat. 2; R61
  Repr. Cat. 3; R62
  Xn; R22
  Xi; R37-41 | O; T
  R: 61-8-22-37-41-62
  S: 53-45 | C ≥ 25 %: T; R61-22-37-41-62
  22 % ≤ C < 25 %: T; R61-37-41-62
  20 % ≤ C < 22 %: T; R61-36/37-62
  14 % ≤ C < 20 %: T; R61-36-62
  9 % ≤ C < 14 %: T; R61-62
  6,5 % ≤ C < 9 %: T; R61 | |
| 005-017-01-4 | natriumperborat; [1]
  perborsyre, natriumsalt; [2]
  perborsyre, natriumsalt, monohydrat; [3]
  natriumperoxometaborat; [4]
  perborsyre (HBO(O2)), natriumsalt, monohydrat; [5]
  natriumperoxoborat;
  [indeholdende ≥ 0,1 % (w/w) partikler med en aerodynamisk diameter på mindre end 50 μm] | E | 239-172-9 [1]
  234-390-0 [2]
  - [3]
  231-556-4 [4]
  - [5] | 15120-21-5 [1]
  11138-47-9 [2]
  12040-72-1 [3]
  7632-04-4 [4]
  10332-33-9 [5] | O; R8
  Repr. Cat. 2; R61
  Repr. Cat. 3; R62
  T; R23
  Xn; R22
  Xi; R37-41 | O; T
  R: 61-8-22-23-37-41-62
  S: 53-45 | C ≥ 25 %: T; R61-22-23-37-41-62
  22 % ≤ C < 25 %: T; R61-20-37-41-62
  20 % ≤ C < 22 %: T; R61-20-36/37-62
  14 % ≤ C < 20 %: T; R61-20-36-62
  9 % ≤ C < 14 %: T; R61-20-62
  6,5 % ≤ C < 9 %: T; R61-20
  3 % ≤ C < 6,5 %: Xn; R20 | |
| 005-018-00-2 | perborsyre (H3BO2(O2)), mononatriumsalt trihydrat; [1]
  perborsyre, natriumsalt, tetrahydrat; [2]
  perborsyre (HBO(O2)), natriumsalt tetrahydrat; [3]
  natriumperoxoborathexahydrat;
  [indeholdende < 0,1 % (w/w) partikler med en aerodynamisk diameter på mindre end 50 μm] | | - [1]
  - [2]
  - [3] | 13517-20-9 [1]
  37244-98-7 [2]
  10486-00-7 [3] | Repr. Cat. 2; R61
  Repr. Cat. 3; R62
  Xi; R37-41 | T
  R: 61-37-41-62
  S: 53-45-47 | C ≥ 36 %: T; R61-37-41-62
  22 % ≤ C < 36 %: T; R61-36/37-62
  20 % ≤ C < 22 %: T; R61-37-62
  14 % ≤ C < 20 %: T; R61-62
  10 % ≤ C < 14 %: T; R61 | |
| 005-018-01-X | perborsyre (H3BO2(O2)), mononatriumsalt trihydrat; [1]
  perborsyre, natriumsalt, tetrahydrat; [2]
  perborsyre (HBO(O2)), natriumsalt, tetrahydrat; [3]
  natriumperoxoborathexahydrat;
  [indeholdende ≥ 0,1 % (w/w) partikler med en aerodynamisk diameter på mindre end 50 μm] | E | - [1]
  - [2]
  - [3] | 13517-20-9 [1]
  37244-98-7 [2]
  10486-00-7 [3] | Repr. Cat. 2; R61
  Repr. Cat. 3; R62
  Xn; R20
  Xi; R37-41 | T
  R: 61-20-37-41-62
  S: 53-45-47 | C ≥ 36 %: T; R61-20-37-41-62
  25 % ≤ C < 36 %: T; R61-20-36/37-62
  22 % ≤ C < 25 %: T; R61-36/37-62
  20 % ≤ C < 22 %: T; R61-37-62
  14 % ≤ C < 20 %: T; R61-62
  10 % ≤ C < 14 %: T; R61 | |
| 006-097-00-6 | 1-phenyl-3-(p-toluensulfonyl)urinstof | | 424-620-1 | 13909-63-2 | Xn; R22-48/22
  R52-53 | Xn
  R: 22-48/22-52/53
  S: (2-)22-36-61 | | |
| 006-098-00-1 | tert-butyl-(1R,5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamat | | 429-170-8 | 134575-17-0 | Xn; R22-48/22
  Xi; R41
  R43 | Xn
  R: 22-41-43-48/22
  S: (2-)22-26-36/37/39 | | |
| 006-099-00-7 | N-(p-toluensulfonyl)-N′-(3-(p-toluensulfonyloxy)phenyl)urinstof;
  3-({[(4-methylphenyl)sulfonyl]carbamoyl}amino)phenyl 4-methylbenzensulfonat | | 432-520-2 | 232938-43-1 | N; R51-53 | N
  R: 51/53
  S: 22-61 | | |
| 006-101-00-6 | blanding af: N,N′′-(methylendi-4,1-phenylen)bis[N′-phenylurinstof];

  N-(4-[[4-[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]-N′-cyclohexylurinstof;

  N,N′′-(methylendi-4,1-phenylen)bis[N′-cyclohexylurinstof] | | 423-070-8 | — | R53 | R: 53
  S: 61 | | |
| 006-102-00-1 | O-hexyl-N-ethoxycarbonylthiocarbamat | E | 432-750-3 | — | Carc. Cat. 2; R45
  Muta. Cat. 2; R46
  Xn; R22-48/22
  R43
  N; R51-53 | T; N
  R: 45-46-22-43-48/22-51/53
  S: 53-45-61 | | |
| 006-103-00-7 | N,N′′-(methylendi-4,1-phenylen)bis[N′-octyl]urinstof | | 445-760-8 | — | Xi; R41
  R42
  N; R50-53 | Xn; N
  R: 41-42-50/53
  S: (2-)22-26-39-45-60-61 | C ≥10 %: Xn, N; R41-42-50/53
  5 % ≤ C < 10 %: Xn, N; R36-42-50/53
  1 % ≤ C < 5 %: Xn, N; R42-50/53
  0,25 % ≤ C < 1 %: N; R50/53
  0,025 % ≤ C < 0,25 %: N; R51/53
  0,0025 ≤ C < 0,025 %: R52/53 | |
| 007-029-00-8 | diethyldimethylammoniumhydroxid | | 419-400-5 | 95500-19-9 | Xn; R21/22
  C; R35 | C
  R: 21/22-35
  S: (1/2-)26-36/37/39-45 | | |
| 012-004-00-X | aluminium-magnesium-carbonat-hydroxid-perchlorat-hydrat | | 422-150-1 | — | N; R50-53 | N
  R: 50/53
  S: 60-61 | | |
| 014-036-00-X | (4-ethoxyphenyl)(3-(4-fluor-3-phenoxyphenyl)propyl)dimethylsilan | | 405-020-7 | 105024-66-6 | Repr.Cat.2; R60
  N; R50-53 | T; N
  R: 60-50/53
  S: 53-45-60-61 | C ≥ 0,5 %: T, N; R60-50/53
  0,025 % ≤ C < 0,5 %: N; R50/53
  0,0025 % ≤ C < 0,025 %: N; R51/53
  0,00025 % ≤ C < 0,0025 %: R52/53 | |
| 014-037-00-5 | 2-butanon-O,O′,O′′-(phenylsilylidyn)trioxim | | 433-360-6 | 34036-80-1 | Xn; R48/22
  R43
  R52-53 | Xn
  R: 43-48/22-52/53
  S: (2-)36/37-61 | | |
| 014-038-00-0 | S-(3-(triethoxysilyl)propyl)octanthioat | | 436-690-9 | 220727-26-4 | R43 | Xi
  R: 43
  S: (2-)24-37 | | |
| 014-039-00-6 | (2,3-dimethylbut-2-yl)-trimethoxysilan | | 439-360-2 | 142877-45-0 | Xi; R38-41
  R52-53 | Xi
  R: 38-41-52/53
  S: (2-)26-37/39-61 | | |
| 014-041-00-7 | N,N-bis(trimethylsilyl)aminopropylmethyldiethoxysilan | | 445-890-5 | 201290-01-9 | Xn; R22
  R43 | Xn
  R: 22-43
  S: (2-)24-37 | | |
| 014-042-00-2 | blanding af: O,O′,O′′,O′′′-silantetrayl-tetrakis(4-methyl-2-pentanonoxim) (3 stereoisomerer) | | 423-010-0 | — | Xi; R41 | Xi
  R: 41
  S: (2-)26-39 | | |
| 014-043-00-8 | reaktionsprodukt mellem amorf silica (50-85 %), butyl(1-methylpropyl)magnesium (3-15 %), tetraethylorthosilicat (5-15 %) og titantetrachlorid (5-20 %) | | 432-200-2 | — | F; R11
  Xi; R37/38-41
  R52-53 | F; Xi
  R: 11-37/38-41-52/53
  S: (2-)6-26-36/39-61 | | |
| 014-044-00-3 | 3-[(4′-acetoxy-3′-methoxyphenyl) propyl]trimethoxysilan | | 433-050-0 | — | N; R51-53 | N
  R: 51/53
  S: 61 | | |
| 014-045-00-9 | magnesiumnatriumfluoridsilicat | | 442-650-1 | — | Xn; R48/20 | Xn
  R: 48/20
  S: (2-)22-36 | | |
| 015-190-00-0 | bis(2,4-dicumylphenyl)neopentyldiphosphit;
  3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecan | | 421-920-2 | 154862-43-8 | R53 | R: 53
  S: 61 | | |
| 015-191-00-6 | dodecyldiphenylphosphat | | 431-760-5 | 27460-02-2 | Xi; R38
  R52-53 | Xi
  R: 38-52/53
  S: (2-)37-61 | | |
| 015-192-00-1 | tetrakis(2,6-dimethylphenyl)-m-phenylenbiphosphat | | 432-770-2 | 139189-30-3 | R43
  R53 | Xi
  R: 43-53
  S: (2-)24-37-61 | | |
| 015-193-00-7 | triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluor-N-methyl-1-butansulfonamid (1:1) | | 442-960-7 | 332350-93-3 | T; R25
  Xi; R41
  N; R50-53 | T; N
  R: 25-41-50/53
  S: (1/2-)26-39-45-60-61 | | |
| 015-194-00-2 | tetrabutylphosphonium-nonafluorbutan-1-sulfonat | | 444-440-5 | 220689-12-3 | Xn; R22
  R52-53 | Xn
  R: 22-52/53
  S: (2-)61 | | |
| 015-195-00-8 | blanding af: kalium-o-toluenphosphonat;
  kalium-m-toluenphosphonat;
  kalium-p-toluenphosphonat | | 433-860-4 | — | Xi; R36
  R43
  R52-53 | Xi
  R: 36-43-52/53
  S: (2-)24-26-37-61 | | |
| 015-196-00-3 | blanding af: dimethyl-(2-(hydroxymethylcarbamoyl)ethyl)phosphonat;
  diethyl-(2-(hydroxymethylcarbamoyl)ethyl)phosphonat;
  methylethyl-(2-(hydroxymethylcarbamoyl)ethyl)phosphonat | | 435-960-3 | — | Carc.Cat.2; R45
  Muta.Cat.2; R46
  R43 | T
  R: 45-46-43
  S: 53-45 | | |
| 015-197-00-9 | bis(2,4,4-trimethylpentyl)dithiophosphonsyre | | 420-160-9 | 107667-02-7 | R10
  T; R23
  Xn; R22
  C; R34
  N; R51-53 | T; N
  R: 10-22-23-34-51/53
  S: (1/2-)9-26-36/37/39-45-61 | | |
| 015-198-00-4 | (4-phenylbutyl)phosphinsyre | | 420-450-5 | 86552-32-1 | Carc.Cat.3; R40
  Xi; R41 | Xn
  R: 40-41
  S: (2-)23-26-36/37/39 | | |
| 016-094-00-1 | svovl | | 231-722-6 | 7704-34-9 | Xi; R38 | Xi
  R: 38
  S: (2-)46 | | |
| 016-097-00-8 | 1-amino-2-methyl-2-propanthiolhydrochlorid | | 434-480-1 | 32047-53-3 | Xn; R22
  C; R34
  R43
  R52-53 | C
  R: 22-34-43-52/53
  S: (1/2-)22-26-36/37/39-45-61 | | |
| 017-009-01-8 | ammoniumperchlorat;
  [indeholdende < 80 % partikler på 0-30 μm] | T | 232-235-1 | 7790-98-9 | E; R2
  O; R9 | E
  R: 2-9
  S: (2-)14-16-36/37 | | |
| 022-004-00-1 | kaliumtitanoxid (K2Ti6O13) | | 432-240-0 | 12056-51-8 | Carc.Cat.3; R40 | Xn
  R: 40
  S: (2-)22-36/37 | | |
| 022-005-00-7 | [N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-η)-2,3,4,5-tetramethyl-2,4-cyclopentadien-1-yl]silanaminato(2-)-κN][1,2,3,4-η)-1,3-pentadien]-titan | | 419-840-8 | 169104-71-6 | F; R11
  C; R34
  R43
  R53 | F; C
  R: 11-34-43-53
  S: (1/2-)6-9-16-26-36/37/39-45-61 | | |
| 028-002-01-4 | nikkelpulver;
  [partikeldiameter < 1 mm] | | 231-111-4 | 7440-02-0 | Carc. Cat. 3; R40
  T; R48/23
  R43
  R52-53 | T
  R: 40-43-48/23-52/53
  S: (2-)36/37/39-45-61 | | |
| 028-013-00-7 | nikkelsten | E, H | 273-749-6 | 69012-50-6 | Carc. Cat. 1; R49
  T; R48/23
  R43
  N; R50-53 | T; N
  R: 49-43-48/23-50/53
  S: 53-45-60-61 | | |
| 028-014-00-2 | mudder og slam, kobberraffineringselektrolyse-, renset for kobber, nikkelsulfat | E | 295-859-3 | 92129-57-2 | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  Repr. Cat. 2; R61
  T; R48/23
  Xn; R20/22
  Xi; R38
  R42/43
  N; R50-53 | T; N
  R: 49-61-20/22-38-42/43-48/23-68-50/53
  S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-20/22-38-42/43-48/23-68-50/53
  20 % ≤ C < 25 %: T, N; R49-61-38-42/43-48/23-68-51/53
  2,5 % ≤ C < 20 %: T, N; R49-61-42/43-48/23-68-51/53
  1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
  0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
  0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
  0,1 % ≤ C < 0,25 %: T; R49-43-48/20
  0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-015-00-8 | mudder og slam, kobberraffineringselektrolyse-, renset for kobber | E, H | 305-433-1 | 94551-87-8 | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  Repr. Cat. 1; R61
  Repr. Cat. 3; R62
  T; R48/23
  R42/43
  N; R50-53 | T; N
  R: 49-61-42/43-48/23-62-68-50/53
  S: 53-45-60-61 | | |
| 028-016-00-3 | nikkeldiperchlorat;
  perchlorsyre, nikkel(II)salt | E, H | 237-124-1 | 13637-71-3 | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  Repr. Cat. 2; R61
  T; R48/23
  C; R34
  R42/43
  N; R50-53 | T; N
  R: 49-61-34-42/43-48/23-68-50/53
  S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-34-42/43-48/23-68-50/53
  5 % ≤ C < 25 %: T, N; R49-61-34-42/43-48/23-68-51/53
  2,5 % ≤ C < 5 %: T, N; R49-61-36/38-42/43-48/23-68-51/53
  1 % ≤ C < 2,5 %: T; R49-61-36/38-42/43-48/23-68-52/53
  0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
  0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
  0,1 % ≤ C < 0,25 %: T; R49-43-48/20
  0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-017-00-9 | nikkeldikaliumbis(sulfat); [1]
  diammoniumnikkelbis(sulfat) [2] | E, H | 237-563-9 [1]
  239-793-2 [2] | 13842-46-1 [1]
  15699-18-0 [2] | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  Repr. Cat. 2; R61
  T; R48/23
  Xn; R20/22
  R42/43
  N; R50-53 | T; N
  R: 49-61-20/22-42/43-48/23-68-50/53
  S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-20/22-42/43-48/23-68-50/53
  2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
  1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
  0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
  0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
  0,1 % ≤ C < 0,25 %: T; R49-43-48/20
  0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-018-00-4 | nikkelbis(sulfamidat);
  nikkelsulfamat | E, H | 237-396-1 | 13770-89-3 | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  Repr. Cat. 2; R61
  T; R48/23
  R42/43
  N; R50-53 | T; N
  R: 49-61-42/43-48/23-68-50/53
  S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
  2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
  1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
  0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
  0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
  0,1 % ≤ C < 0,25 %: T; R49-43-48/20
  0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-019-00-X | nikkelbis(tetrafluorborat) | E, H | 238-753-4 | 14708-14-6 | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  Repr. Cat. 2; R61
  T; R48/23
  R42/43
  N; R50-53 | T; N
  R: 49-61-42/43-48/23-68-50/53
  S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
  2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
  1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
  0,5 % ≤ C < 1 %: T; 49-61-43-48/20-52/53
  0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
  0,1 % ≤ C < 0,25 %: T; R49-43-48/20
  0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-021-00-0 | nikkeldiformat; [1]
  myresyre, nikkelsalt; [2]
  myresyre, kobbernikkkelsalt [3] | E, H | 222-101-0 [1]
  239-946-6 [2]
  268-755-0 [3] | 3349-06-2 [1]
  15843-02-4 [2]
  68134-59-8 [3] | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  Repr. Cat. 2; R61
  T; R48/23
  R42/43
  N; R50-53 | T; N
  R: 49-61-42/43-48/23-68-50/53
  S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
  2,5 % C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
  1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
  0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
  0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
  0,1 % ≤ C < 0,25 %: T; R49-43-48/20
  0,01 % ≤ C 0,1 %: Xi; R43 | |
| 028-022-00-6 | nikkeldi(acetat); [1]
  nikkelacetat [2] | E, H | 206-761-7 [1]
  239-086-1 [2] | 373-02-4 [1]
  14998-37-9 [2] | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  Repr. Cat. 2; R61
  T; R48/23
  Xn; R20/22
  R42/43
  N; R50-53 | T; N
  R: 49-61-20/22-42/43-48/23-68-50/53
  S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-20/22-42/43-48/23-68-50/53
  2,5 % ≤ C < 25 %: T, N: R49-61-42/43-48/23-68-51/53
  1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
  0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
  0,25 % ≤ C 0,5 %: T; R49-43-48/20-52/53
  0,1 % ≤ C < 0,25 %: T; R49-43-48/20
  0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-024-00-7 | nikkeldibenzoat | E, H | 209-046-8 | 553-71-9 | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  Repr. Cat. 2; R61
  T; R48/23
  R42/43
  N; R50-53 | T; N
  R: 49-61-42/43-48/23-68-50/53
  S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
  2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
  1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
  0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
  0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
  0,1 % ≤C < 0,25 %: T; R49-43-48/20
  0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-025-00-2 | nikkelbis(4-cyclohexylbutyrat) | E, H | 223-463-2 | 3906-55-6 | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  Repr. Cat. 2; R61
  T; R48/23
  R42/43
  N; R50-53 | T; N
  R: 49-61-42/43-48/23-68-50/53
  S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
  2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
  1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
  0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
  0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
  0,1 % ≤ C < 0,25 %: T; R49-43-48/20
  0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-026-00-8 | nikkel(II)stearat;
  nikkel(II)octadecanoat | E, H | 218-744-1 | 2223-95-2 | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  Repr. Cat. 2; R61
  T; R48/23
  R42/43
  N; R50-53 | T; N
  R: 49-61-42/43-48/23-68-50/53
  S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
  2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
  1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
  0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
  0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
  0,1 % ≤ C < 0,25 %: T; R49-43-48/20
  0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-027-00-3 | nikkeldilactat | E, H | — | 16039-61-5 | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  Repr. Cat. 2; R61
  T; R48/23
  R42/43
  N; R50-53 | T; N
  R: 49-61-42/43-48/23-68-50/53
  S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
  2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
  1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
  0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
  0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
  0,1 % ≤ C < 0,25 %: T; R49-43-48/20
  0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-028-00-9 | nikkel(II)octanoat | E, H | 225-656-7 | 4995-91-9 | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  Repr. Cat 2; R61
  T; R48/23
  C; R35
  R42/43
  N; R50-53 | T; C; N
  R: 49-61-35-42/43-48/23-68-50/53
  S: 53-45-60-61 | C ≥ 25 %: T, C, N; R49-61-35-42/43-48/23-68-50/53
  10 % ≤ C < 25 %: T, C, N; R49-61-35-42/43-48/23-68-51/53
  5 % ≤ C < 10 %: T, N; R49-61-34-42/43-48/23-68-51/53
  2,5 % ≤ C < 5 %: T, N; R49-61-36/38-42/43-48/23-68-51/53
  1 % ≤ C < 2,5 %: T; R49-61-36/38-42/43-48/23-68-52/53
  0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
  0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
  0,1 % ≤ C < 0,25 %: T; R49-43-48/20
  0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-029-00-4 | nikkeldifluorid; [1]
  nikkeldibromid; [2]
  nikkeldiiodid; [3]
  nikkelkaliumfluorid [4] | E, H | 233-071-3 [1]
  236-665-0 [2]
  236-666-6 [3]
  - [4] | 10028-18-9 [1]
  13462-88-9 [2]
  13462-90-3 [3]
  11132-10-8 [4] | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  Repr. Cat. 2; R61
  T; R48/23
  R42/43
  N; R50-53 | T; N
  R: 49-61-42/43-48/23-68-50/53
  S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
  2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
  1 % ≤ C < 2,5 %: T; 49-61-42/43-48/23-68-52/53
  0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
  0,25 % ≤ C < 0,5 %: T; 49-43-48/20-52/53
  0,1 % ≤ C < 0,25 %: T; R49-43-48/20
  0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-030-00-X | nikkelhexafluorsilicat | E, H | 247-430-7 | 26043-11-8 | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  Repr. Cat. 2; R61
  T; R48/23
  R42/43
  N; R50-53 | T; N
  R: 49-61-42/43-48/23-68-50/53
  S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
  2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
  1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
  0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
  0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
  0,1 % ≤ C < 0,25 %: T; R49-43-48/20
  0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-031-00-5 | nikkelselenat | E, H | 239-125-2 | 15060-62-5 | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  Repr. Cat. 2; R61
  T; R48/23
  R42/43
  N; R50-53 | T; N
  R: 49-61-42/43-48/23-68-50/53
  S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
  2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
  1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
  0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
  0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
  0,1 % ≤ C < 0,25 %: T; R49-43-48/20
  0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-032-00-0 | nikkelhydrogenphosphat; [1]
  nikkelbis(dihydrogenphosphat); [2]
  trinikkelbis(orthophosphat); [3]
  dinikkeldiphosphat; [4]
  nikkelbis(phosphinat); [5]
  nikkelphosphinat; [6]
  phosphorsyre, calciumnikkelsalt;[7]
  diphosphorsyyre, nikkel(II)salt [8] | E, H | 238-278-2 [1]
  242-522-3 [2]
  233-844-5 [3]
  238-426-6 [4]
  238-511-8 [5]
  252-840-4 [6]
  - [7]
  - [8] | 14332-34-4 [1]
  18718-11-1 [2]
  10381-36-9 [3]
  14448-18-1 [4]
  14507-36-9 [5]
  36026-88-7 [6]
  17169-61-8 [7]
  19372-20-4 [8] | Carc. Cat. 1; R49
  T; R48/23
  R42/43
  N; R50-53 | T; N
  R: 49-42/43-48/23-50/53
  S: 53-45-60-61 | | |
| 028-033-00-6 | diammoniumnikkelhexacyanoferrat | E, H | — | 74195-78-1 | Carc. Cat. 1; R49
  T; R48/23
  R42/43
  N; R50-53 | T; N
  R: 49-42/43-48/23-50/53
  S: 53-45-60-61 | | |
| 028-034-00-1 | nikkeldicyanid | E, H | 209-160-8 | 557-19-7 | Carc. Cat. 1; R49
  T; R48/23
  R42/43
  R32
  N; R50-53 | T; N
  R: 49-32-42/43-48/23-50/53
  S: 53-45-60-61 | | |
| 028-035-00-7 | nikkelchromat | E, H | 238-766-5 | 14721-18-7 | Carc. Cat. 1; R49
  T; R48/23
  R42/43
  N; R50-53 | T; N
  R: 49-42/43-48/23-50/53
  S: 53-45-60-61 | | |
| 028-036-00-2 | nikkel(II)silicat; [1]
  dinikkelorthosilicat; [2]
  nikkelsilicat (3:4); [3]
  kiselsyre, nikkelsalt; [4]
  trihydrogenhydroxybis[orthosilicato(4-)]trinikkelat(3-) [5] | E, H | 244-578-4 [1]
  237-411-1 [2]
  250-788-7 [3]
  253-461-7 [4]
  235-688-3 [5] | 21784-78-1 [1]
  13775-54-7 [2]
  31748-25-1 [3]
  37321-15-6 [4]
  12519-85-6 [5] | Carc. Cat. 1; R49
  T; R48/23
  R43
  N; R50-53 | T; N
  R: 49-43-48/23-50/53
  S: 53-45-60-61 | | |
| 028-037-00-8 | dinikkelhexacyanoferrat | E, H | 238-946-3 | 14874-78-3 | Carc. Cat. 1; R49
  T; R48/23
  R43
  N; R50-53 | T; N
  R: 49-43-48/23-50/53
  S: 53-45-60-61 | | |
| 028-038-00-3 | trinikkel bis(arsenat);
  nikkel(II)arsenat | E, H | 236-771-7 | 13477-70-8 | Carc. Cat. 1; R45
  T; R48/23
  R43
  N; R50-53 | T; N
  R: 45-43-48/23-50/53
  S: 53-45-60-61 | | |
| 028-039-00-9 | nikkeloxalat; [1]
  oxalsyre, nikkelsalt [2] | E, H | 208-933-7 [1]
  243-867-2 [2] | 547-67-1 [1]
  20543-06-0 [2] | Carc. Cat. 1; R49
  T; R48/23
  R43
  N: R50-53 | T; N
  R: 49-43-48/23-50/53
  S: 53-45-60-61 | | |
| 028-040-00-4 | nikkeltellurid | E, H | 235-260-6 | 12142-88-0 | Carc. Cat. 1; R49
  T; R48/23
  R43
  N; R50-53 | T; N
  R: 49-43-48/23-50/53
  S: 53-45-60-61 | | |
| 028-041-00-X | trinikkeltetrasulfid | E, H | — | 12137-12-1 | Carc. Cat. 1; R49
  T; R48/23
  R43
  N; R50-53 | T; N
  R: 49-43-48/23-50/53
  S: 53-45-60-61 | | |
| 028-042-00-5 | trinikkelbis(arsenit) | E, H | — | 74646-29-0 | Carc. Cat. 1; R49
  T; R48/23
  R43
  N; R50-53 | T; N
  R: 49-43-48/23-50/53
  S: 53-45-60-61 | | |
| 028-043-00-0 | cobaltnikkelgrå periclas;
  C.I. Pigment Black 25;
  C.I. 77332; [1]
  cobaltnikkeldioxid; [2]
  cobaltnikkeloxid [3] | E, H | 269-051-6 [1]
  261-346-8 [2]
  - [3] | 68186-89-0 [1]
  58591-45-0 [2]
  12737-30-3 [3] | Carc. Cat. 1; R49
  T; R48/23
  R43 | T
  R: 49-43-48/23
  S: 53-45 | | |
| 028-044-00-6 | nikkeltintrioxid;
  nikkelstannat | E, H | 234-824-9 | 12035-38-0 | Carc. Cat. 1; R49
  T; R48/23
  R43 | T
  R: 49-43-48/23
  S: 53-45 | | |
| 028-045-00-1 | nikkeltriurandecaoxid | E, H | 239-876-6 | 15780-33-3 | Carc. Cat. 1; R49
  T; R48/23
  R43 | T
  R: 49-43-48/23
  S: 53-45 | | |
| 028-046-00-7 | nikkeldithiocyanat | E, H | 237-205-1 | 13689-92-4 | Carc. Cat. 1; R49
  Muta. Cat. 3;R68
  Repr. Cat. 2; R61
  T; R48/23
  R42/43
  R32
  N; R50-53 | T; N
  R: 49-61-32-42/43-48/23-68-50/53
  S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
  2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
  1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
  0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
  0,25 % ≤ C < 0,5 %: T: R49-61-43-48/20-52/53
  0,1 % ≤ C < 0,25 %: T; R49-43-48/20
  0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-047-00-2 | nikkeldichromat | E, H | 239-646-5 | 15586-38-6 | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  Repr. Cat. 2; R61
  T; R48/23
  R42/43
  N; R50-53 | T; N
  R: 49-61-42/43-48/23-68-50/53
  S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
  2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
  1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
  0,5 % ≤ C < 1 %: T; 49-61-43-48/20-52/53
  0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
  0,1 % ≤ C < 0,25 %: T; R49-43-48/20
  0,01 % ≤ C 0,1 %: Xi; R43 | |
| 028-048-00-8 | nikkel(II)selenit | E, H | 233-263-7 | 10101-96-9 | Carc. Cat. 1; R49
  T; R48/23
  R42/43
  N; R50-53 | T; N
  R: 49-42/43-48/23-50/53
  S: 53-45-60-61 | | |
| 028-049-00-3 | nikkelselenid | E, H | 215-216-2 | 1314-05-2 | Carc. Cat. 1; R49
  T; R48/23
  R43
  N; R50-53 | T; N
  R: 49-43-48/23-50/53
  S: 53-45-60-61 | | |
| 028-050-00-9 | kiselsyre, blynikkelsalt | E, H | — | 68130-19-8 | Carc. Cat. 1: R49
  Repr. Cat. 1: R61
  Repr. Cat. 3; R62
  T; R48/23
  R43
  N; R50-53 | T; N
  R: 49-61-43-48/23-62-50/53
  S: 53-45-60-61 | | |
| 028-051-00-4 | nikkeldiarsenid; [1]
  nikkelarsenid [2] | E, H | 235-103-1 [1]
  248-169-1 [2] | 12068-61-0 [1]
  27016-75-7 [2] | Carc. Cat. 1; R49
  T; R48/23
  R43
  N; R50-53 | T; N
  R: 49-43-48/23-50/53
  S: 53-45-60-61 | | |
| 028-052-00-X | nikkelbariumtitanprimulagul priderit;
  C.I. Pigment Yellow 157;
  C.I. 77900 | E, H | 271-853-6 | 68610-24-2 | Carc. Cat. 1: R49
  T; R48/23
  R43 | T
  R: 49-43-48/23
  S: 53-45 | | |
| 028-053-00-5 | nikkeldichlorat; [1]
  nikkeldibromat; [2]
  ethylhydrogensulfat, nikkel(II)salt [3] | E, H | 267-897-0 [1]
  238-596-1 [2]
  275-897-7 [3] | 67952-43-6 [1]
  14550-87-9 [2]
  71720-48-4 [3] | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  Repr. Cat. 2; R61
  T; R48/23
  R42/43
  N; R50-53 | T; N
  R: 49-61-42/43-48/23-68-50/53
  S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
  2,5 % ≤ C < 25 %: T, N: R49-61-42/43-48/23-68-51/53
  1 % ≤ C < 2,5 %: T: R49-61-42/43-48/23-68-52/53
  0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
  0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
  0,1 % ≤ C < 0,25 %: T: R49-43-48/20
  0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-054-00-0 | nikkel(II)trifluoracetat; [1]
  nikkel(II)propionat; [2]
  nikkelbis(benzensulfonat); [3]
  nikkel(II)hydrogencitrat; [4]
  citronsyre, ammoniumnikkelsalt; [5]
  citronsyre, nikkelsalt; [6]
  nikkelbis(2-ethylhexanoat); [7]
  2-ethylhexansyre, nikkelsalt; [8]
  dimethylhexansyre, nikkelsalt; [9]
  nikkel(II)isooctanoat; [10]
  nikkelisooctanoat; [11]
  nikkelbis(isononanoat); [12]
  nikkel(II)neononanoat; [13]
  nikkel(II)isodecanoat; [14]
  nikkel(II)neodecanoat; [15]
  neodecansyre, nikkelsalt; [16]
  nikkel(II)neoundecanoat; [17]
  bis(D-gluconato-O
  1,O
  2)nikkel; [18]
  nikkel-3,5-bis(tert-butyl)-4-hydroxybenzoat (1:2); [19]
  nikkel(II)palmitat; [20]
  (2-ethylhexanoato-O)(isononanoato-O)nikkel; [21]
  (isononanoato-O)(isooctanoato-O)nikkel; [22]
  (isooctanoato-O)(neodecanoato-O)nikkel; [23]
  (2-ethylhexanoato-O)(isodecanoato-O)nikkel; [24]
  (2-ethylhexanoato-O)(neodecanoato-O)nikkel; [25]
  (isodecanoato-O)(isooctanoato-O)nikkel; [26]
  (isodecanoato-O)(isononanoato-O)nikkel; [27]
  (isononanoato-O)(neodecanoato-O)nikkel; [28]
  fedtsyrer, C6-19-forgrenede, nikkelsalte; [29]
  fedtsyrer, C8-18 og C18-umættede, nikkelsalte; [30]
  2,7-naphthalendisulfonsyre, nikkel(II)salt; [31] | E, H | 240-235-8 [1]
  222-102-6 [2]
  254-642-3 [3]
  242-533-3 [4]
  242-161-1 [5]
  245-119-0 [6]
  224-699-9 [7]
  231-480-1 [8]
  301-323-2 [9]
  249-555-2 [10]
  248-585-3 [11]
  284-349-6 [12]
  300-094-6 [13]
  287-468-1 [14]
  287-469-7 [15]
  257-447-1 [16]
  300-093-0 [17]
  276-205-6 [18]
  258-051-1 [19]
  237-138-8 [20]
  287-470-2 [21]
  287-471-8 [22]
  284-347-5 [23]
  284-351-7 [24]
  285-698-7 [25]
  285-909-2 [26]
  284-348-0 [27]
  287-592-6 [28]
  294-302-1 [29]
  283-972-0 [30]
  - [31] | 16083-14-0 [1]
  3349-08-4 [2]
  39819-65-3 [3]
  18721-51-2 [4]
  18283-82-4 [5]
  22605-92-1 [6]
  4454-16-4 [7]
  7580-31-6 [8]
  93983-68-7 [9]
  29317-63-3 [10]
  27637-46-3 [11]
  84852-37-9 [12]
  93920-10-6 [13]
  85508-43-6 [14]
  85508-44-7 [15]
  51818-56-5 [16]
  93920-09-3 [17]
  71957-07-8 [18]
  52625-25-9 [19]
  13654-40-5 [20]
  85508-45-8 [21]
  85508-46-9 [22]
  84852-35-7 [23]
  84852-39-1 [24]
  85135-77-9 [25]
  85166-19-4 [26]
  84852-36-8 [27]
  85551-28-6 [28]
  91697-41-5 [29]
  84776-45-4 [30]
  72319-19-8 [31] | Carc. Cat. 1; R49
  Muta. Cat. 3; R68
  Repr. Cat. 2; R61
  T; R48/23
  R42/43
  N; R50-53 | T; N
  R: 49-61-42/43-48/23-68-50/53
  S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
  2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
  1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
  0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
  0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
  0,1 % ≤ C < 0,25 %: T; R49-43-48/20
  0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-055-00-6 | nikkel(II)sulfit; [1]
  nikkeltellurtrioxid; [2]
  nikkeltellurtetraoxid; [3]
  molybdennikkelhydroxidoxidphosphat [4] | E, H | 231-827-7 [1]
  239-967-0 [2]
  239-974-9 [3]
  268-585-7 [4] | 7757-95-1 [1]
  15851-52-2 [2]
  15852-21-8 [3]
  68130-36-9 [4] | Carc. Cat. 1; R49
  T; R48/23
  R42/43
  N; R50-53 | T; N
  R: 49-42/43-48/23-50/53
  S: 53-45-60-61 | | |
| 028-056-00-1 | nikkelborid (NiB); [1]
  dinikkelborid; [2]
  trinikkelborid; [3]
  nikkelborid; [4]
  dinikkelsilicid; [5]
  nikkeldisilicid; [6]
  dinikkelphosphid; [7]
  nikkelborphosphid [8] | E, H | 234-493-0 [1]
  234-494-6 [2]
  234-495-1 [3]
  235-723-2 [4]
  235-033-1 [5]
  235-379-3 [6]
  234-828-0 [7]
  - [8] | 12007-00-0 [1]
  12007-01-1 [2]
  12007-02-2 [3]
  12619-90-8 [4]
  12059-14-2 [5]
  12201-89-7 [6]
  12035-64-2 [7]
  65229-23-4 [8] | Carc. Cat. 1; R49
  T; R48/23
  R43
  N; R50-53 | T; N
  R: 49-43-48/23-50/53
  S: 53-45-60-61 | | |
| 028-057-00-7 | dialuminiumnikkeltetraoxid; [1]
  nikkeltitantrioxid; [2]
  nikkeltitanoxid; [3]
  nikkeldivanadiumhexaoxid; [4]
  cobaltdimolybdennikkeloctaoxid; [5]
  nikkelzirkoniumtrioxid; [6]
  molybdennikkeltetraoxid; [7]
  nikkelwolframtetraoxid; [8]
  olivin, nikkelgrøn; [9]
  lithiumnikkeldioxid; [10]
  molybdennikkeloxid; [11] | E, H | 234-454-8 [1]
  234-825-4 [2]
  235-752-0 [3]
  257-970-5 [4]
  268-169-5 [5]
  274-755-1 [6]
  238-034-5 [7]
  238-032-4 [8]
  271-112-7 [9]
  - [10]
  - [11] | 12004-35-2 [1]
  12035-39-1 [2]
  12653-76-8 [3]
  52502-12-2 [4]
  68016-03-5 [5]
  70692-93-2 [6]
  14177-55-0 [7]
  14177-51-6 [8]
  68515-84-4 [9]
  12031-65-1 [10]
  12673-58-4 [11] | Carc. Cat. 1; R49
  T; R48/23
  R43 | T
  R: 49-43-48/23
  S: 53-45 | | |
| 028-058-00-2 | cobaltlithiumnikkeloxid | E | 442-750-5 | — | Carc. Cat. 1; R49
  T+; R26
  T; R48/23
  R43
  N; R50-53 | T+; N
  R: 49-26-43-48/23-50/53
  S: 53-45-60-61 | | |
| 029-014-00-5 | blanding af: 2,2′-[[cis-1,2-cyclohexandiylbis(nitrilomethyliden)]bis[phenolat]](2-)-N,N′,O,O′-kobberkompleks;
  2,2′-[[trans-1,2-cyclohexandiylbis(nitrilomethylidyn)]bis[phenolat]](2-)-N,N′,O,O′-kobberkompleks | | 419-610-7 | 171866-24-3 | Xn; R48/22
  N; R51-53 | Xn; N
  R: 48/22-51/53
  S: (2-)22-36-61 | | |
| 030-012-00-1 | aluminium-magnesium-zink-carbonat-hydroxid | | 423-570-6 | 169314-88-9 | R52-53 | R: 52/53
  S: 61 | | |
| 030-015-00-8 | tetrazink(2+)-bis(hexacyanocobalt(3+))diacetat | | 440-060-9 | — | N; R51-53 | N
  R: 51/53
  S: 61 | | |
| 042-005-00-0 | blanding af: mono-og di-glyceroler af rapsolie;
  rapsoliefedtsyreamid af forgrenet 1,3-propandiamin, N-[3-(tridecyloxy)-propyl]-;

  N,N-diorgano-dithiocarbamat molybdenkompleks-diorgano dithiocarbamate molybdenum complex | | 434-240-6 | — | R43
  N; R51-53 | Xi; N
  R: 43-51/53
  S: (2-)24-37-61 | | |
| 050-023-00-5 | blanding af: bis[(2-ethyl-1-oxohexyl)oxy]dioctylstannan;
  bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxid;
  bis(1-phenyl-1,3-decandionyl)dioctylstannan;
  ((2-ethyl-1-oxohexyl)oxy)-(1-phenyl-1,3-decandionyl)dioctylstannan | | 422-920-5 | — | Xn; R48/22
  N; R50-53 | Xn; N
  R: 48/22-50/53
  S: (2-)23-36-60-61 | C ≥ 10 %: Xn, N; R48/22-50/53
  2,5 % ≤ C < 10 %: N; R50/53
  0,25 % ≤ C < 2,5 %: N; R51/53
  0,025 % ≤ C < 0,25 %: R52/53 | |
| 050-024-00-0 | blanding af: tri-p-tolyltinhydroxid;
  hexa-p-tolyl-distannoxan | | 432-230-6 | — | T; R48/25
  Xn; R22
  Xi; R38-41
  R43
  N; R50-53 | T; N
  R: 22-38-41-43-48/25-50/53
  S: (1/2-)22-26-36/37/39-45-60-61 | | |
| 064-001-00-8 | gadolinium(III)sulfittrihydrat | | 456-900-2 | 51285-81-5 | N; R51-53 | N
  R: 51/53
  S: 61 | | |
| 078-011-00-5 | hydroxydisulfitoplatin(II)syre | | 423-310-1 | 61420-92-6 | Xn; R22-48/20/21/22
  C; R35
  R42/43
  R52-53 | C
  R: 22-35-42/43-48/20/21/22-52/53
  S: (1/2-)23-24-26-28-36/37/39-45-61 | | |
| 078-012-00-0 | platin(IV)nitrat/salpetersyreopløsning | | 432-400-1 | — | C; R35
  N; R50-53 | C; N
  R: 35-50/53
  S: (1/2-)26-36/37/39-45-60-61 | | |
| 082-012-00-6 | barium-bly-calcium-caesium-samarium-strontium-bromid-chlorid-fluorid-iodid, europium-doteret | | 431-780-4 | 199876-46-5 | Xn; R22-48/22
  N; R51-53 | Xn; N
  R: 22-48/22-51/53
  S: (2-)22-36-61 | | |
| 601-080-00-5 | blanding af: sec-butylphenyl(phenyl)methan, blandede isomerer;
  1-(sec-butylphenyl(phenyl)-2-phenylethan, blandede isomerer;
  1-(sec-butylphenyl-1-phenylethan, blandede isomerer | | 431-100-6 | — | N; R50-53 | N
  R: 50/53
  S: 60-61 | | |
| 601-081-00-0 | cyclohexadeca-1,9-dien | | 431-730-1 | 4277-06-9 | Xi; R38
  R43
  R53 | Xi
  R: 38-43-53
  S: (2-)36/37-61 | | |
| 601-082-00-6 | blanding af: endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptan;

  exo-2-methyl-exo-3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptan | | 434-420-4 | — | Xi; R38-41
  N; R50-53 | Xi; N
  R: 38-41-50/53
  S: (2-)23-26-37/39-57-60-61 | | |
| 601-083-00-1 | 5-endo-hexyl-bicyclo[2.2.1]hept-2-en | | 435-000-3 | 22094-83-3 | Xn; R65
  Xi; R38
  R53 | Xn
  R: 38-65-53
  S: (2-)37-62-61 | | |
| 601-084-00-7 | blanding af: 5-endo-butyl-bicyclo[2.2.1]hept-2-en;
  5-exo-butyl-bicyclo[2.2.1]hept-2-en (80:20) | | 435-180-3 | — | Xn; R65
  Xi; R38
  N; R50-53 | Xn; N
  R: 38-65-50/53
  S: (2-)37-62-60-61 | | |
| 602-105-00-2 | natrium-1,1,2,2,3,3,4,4,4-nonafluor-1-butansulfinat | | 422-100-7 | 102061-82-5 | Xi; R41
  R43 | Xi
  R: 41-43
  S: (2-)24-26-37/39 | | |
| 602-106-00-8 | 2-brom-4,6-difluoranilin | | 429-430-0 | 444-14-4 | Xn; R22
  N; R51-53 | Xn; N
  R: 22-51/53
  S: (2-)25-61 | | |
| 602-107-00-3 | 3,3,4,4-tetrafluor-4-iod-1-buten | | 439-500-2 | 33831-83-3 | Xn; R22
  Xi; R38
  N; R51-53 | Xn; N
  R: 22-38-51/53
  S: (2-)37-61 | | |
| 602-108-00-9 | (2,3,5,6-tetrafluorphenyl)methanol | | 443-840-7 | 4084-38-2 | Xn; R22
  Xi; R36
  R43 | Xn
  R: 22-36-43
  S: (2-)26-36/37 | | |
| 603-211-00-1 | 2,3-epoxypropyltrimethylammoniumchlorid ...%;
  glycidyltrimethylammoniumchlorid ...% | B E | 221-221-0 | 3033-77-0 | Carc. Cat. 2; R45
  Muta. Cat. 3; R68
  Repr. Cat. 3; R62
  Xn; R21/22-48/22
  Xi; R41
  R43
  R52-53 | T
  R: 45-21/22-41-43-48/22-62-68-52/53
  S: 53-45-61 | | |
| 603-212-00-7 | 1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyran;
  galaxolid;
  (HHCB) | | 214-946-9 | 1222-05-5 | N; R50-53 | N
  R: 50/53
  S: 60-61 | | |
| 603-213-00-2 | 2-methoxy-2-methylbutan;

  tert-amylmethylether | | 213-611-4 | 994-05-8 | F; R11
  Xn; R22
  R67 | F; Xn
  R: 11-22-67
  S: (2-)9-16-23-33 | | |
| 603-214-00-8 | 1,1-diisopropoxycyclohexan | | 413-740-8 | 1132-95-2 | C; R34 | C
  R: 34
  S: (1/2-)23-26-36/37/39-45 | | |
| 603-215-00-3 | 1-hydroxy-4-fluor-1,4-diazoniabicyclo[2.2.2]octan-bis(tetrafluorborat) | | 418-330-2 | 162241-33-0 | E; R2
  Xn; R22-48/22
  Xi; R41
  R43
  N; R50-53 | E; Xn; N
  R: 2-22-41-43-48/22-50/53
  S: (2-)22-26-36/37/39-60-61 | | |
| 603-216-00-9 | cis-1-amino-2,3-dihydro-1H-inden-2-ol | | 422-660-2 | 7480-35-5 | Xi; R41
  R43
  R52-53 | Xi
  R: 41-43-52/53
  S: (2-)24-26-37/39-61 | | |
| 603-217-00-4 | 2,4,6-tri-tert-butylphenyl-2-butyl-2-ethyl-1,3-propandiolphosphit | | 423-560-1 | 161717-32-4 | R43
  R53 | Xi
  R: 43-53
  S: (2-)24-37/39-61 | | |
| 603-220-00-0 | 1-{benzyl[2-(2-methoxyphenoxy)ethyl]amino}-3-(9H-carbazol-4-yloxy)propan-2-ol | | 432-890-5 | 72955-94-3 | R53 | R: 53
  S: 61 | | |
| 603-221-00-6 | 1-(2-amino-5-chlorphenyl)-2,2,2-trifluor-1,1-ethandiolhydrochlorid;
  [indeholdende < 0,1 % 4-chloranilin (EF-nr. 203-401-0)] | | 433-580-2 | 214353-17-0 | Xn; R22
  C; R34
  N; R51-53 | C; N
  R: 22-34-51/53
  S: (1/2-)26-36/37/39-45-61 | | |
| 603-221-01-3 | 1-(2-amino-5-chlorphenyl)-2,2,2-trifluor-1,1-ethandiolhydrochlorid;
  [indeholdende ≥ 0,1 % 4-chloranilin (EF-nr. 203-401-0)] | E | 433-580-2 | 214353-17-0 | Carc. Cat. 2; R45
  Xn; R22
  C; R34
  N; R51-53 | T; N
  R: 45-22-34-51/53
  S: 53-45-61 | | |
| 603-222-00-1 | (2R,3S,4R,5R,7R,9R,10R,11S,12S,13R)10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-oxo-1-oxacyclotetradecan | | 433-820-6 | 118058-74-5 | Xi; R36 | Xi
  R: 36
  S: (2-)26 | | |
| 603-223-00-7 | 2-cyclopentylidencyclopentanol;
  1,1′-bi(cyclopentyliden)-2-ol | | 434-270-1 | 6261-30-9 | Xi; R38-41
  R52-53 | Xi
  R: 38-41-52/53
  S: (2-)26-37/39-61 | | |
| 603-224-00-2 | 3-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluor-2-(trifluormethyl)-hexan | | 435-790-1 | 297730-93-9 | R53 | R: 53
  S: 61 | | |
| 603-225-00-8 | erythromycin A9-oxim (E);
  (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-((2,6,-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-trideoxy-3-dimethylamino-β-D-xylohexapyranosyl)oxy)oxacyclotetradecan-2-on-10-oxim (E) | | 437-070-0 | 13127-18-9 | N; R51-53 | N
  R: 51/53
  S: 61 | | |
| 603-226-00-3 | 4,4′(4-(4-methoxyphenyl)-1,3,5-triazin-2,4-diyl)bisbenzen-1,3-diol | | 444-500-0 | 1440-00-2 | R52-53 | R: 52/53
  S: 61 | | |
| 603-227-00-9 | α-hydro-ω-[[[(1,1-dimethylethyl)dioxy]carbonyl]oxy]-poly[oxy(methyl-1,2-ethanediyl)]ether med 2,2-bis(hydroxymethyl)-1,3-propandiol (4:1);
  reaktionsprodukt af α-hydro-ω-((chlorcarbonyl)oxy)-poly(oxy(methyl-1,2-ethandiyl))ether med 2,2-bis(hydroxymethyl)-1,3-propandiol og kalium-1,1-dimethylethylperoxalat | | 445-060-2 | 203574-04-3 | O; R7
  N; R50-53 | O; N
  R: 7-50/53
  S: (2-)3/7-14-36/37/39-60-61 | | |
| 603-228-00-4 | (+/-)-(R*,R*)-6-fluor-3,4-dihydro-2-oxiranyl-2H-1-benzopyran;
  6-fluor-2-(2-oxiranyl)chroman | | 419-620-1 | — | R43
  N; R51-53 | Xi; N
  R: 43-51/53
  S: (2-)36/37-61 | | |
| 603-229-00-X | natrium-(Z)-3-chlor-3-(4-chlorphenyl)-1-hydroxy-2-propen-1-sulfonat | | 420-800-7 | — | Xi; R38-41
  R43
  N; R50-53 | Xi; N
  R: 38-41-43-50/53
  S: (2-)24-26-37/39-60-61 | | |
| 603-230-00-5 | 2,6,6,7,8,8-hexamethyldecahydro-2H-indeno[4,5-b]furan | | 440-030-5 | — | Xi; R38-41
  R53 | Xi
  R: 38-41-53
  S: (2-)26-37/39-61 | | |
| 603-231-00-0 | (S)-1,1-diphenyl-1,2-propandiol | | 443-220-6 | — | R52-53 | R: 52/53
  S: 22-61 | | |
| 603-232-00-6 | 3,3,8,8,10,10-hexamethyl-9-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-1,5-dioxa-9-aza-spiro[5.5]undecan | | 444-420-6 | — | R53 | R: 53
  S: 61 | | |
| 603-233-00-1 | blanding af: 4-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-yliden)-3-methylbutan-2-ol;
  4-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-yliden)-3-methylbutan-2-ol;
  1-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-yliden)pentan-3-ol;
  1-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-yliden)pentan-3-ol;
  (E)-4-(3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol;
  (E)-4-(3a,4,5,6,7,7a-hexahydro-3H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol | | 444-430-0 | — | N; R51-53 | N
  R: 51/53
  S: 61 | | |
| 603-234-00-7 | (1R,4R)-4-methoxy-2,2,7,7-tetramethyltricyclo(6.2.1.0(1,6))undec-5-en | | 444-480-3 | — | Xi; R38
  N; R51-53 | Xi; N
  R: 38-51/53
  S: (2-)37-61 | | |
| 604-074-00-0 | tetrabrombisphenol-A;
  2,2′,6,6′-tetrabrom-4,4′-isopropylidendiphenol | | 201-236-9 | 79-94-7 | N; R50-53 | N
  R: 50/53
  S: 60-61 | | |
| 604-075-00-6 | 4-(1,1,3,3-tetramethylbutyl)phenol;
  4-tert-octylphenol | | 205-426-2 | 140-66-9 | Xi; R38-41
  N; R50-53 | Xi; N
  R: 38-41-50/53
  S: (2-)26-37/39-60-61 | C ≥ 20 %: Xi, N; R38-41-50/53
  10 % ≤ C < 20 %: Xi, N; R41-50/53
  5 % ≤ C < 10 %: Xi, N; R36-50/53
  2,5 % ≤ C < 5 %: N; R50/53
  0,25 % ≤ C < 2,5 %: N; R51/53
  0,025 % ≤ C < 0,25 %: R52/53 | |
| 604-076-00-1 | phenolphthalein | | 201-004-7 | 77-09-8 | Carc. Cat. 2; R45
  Muta. Cat. 3; R68
  Repr. Cat. 3; R62 | T
  R: 45-62-68
  S: 53-45 | C ≥ 5 %: T; R45-62-68
  1 % ≤ C < 5 %: T; R45-68 | |
| 604-077-00-7 | 2-benzotriazol-2-yl-4-methyl-6-(2-methylallyl)phenol | | 419-750-9 | 98809-58-6 | R53 | R: 53
  S: 61 | | |
| 604-079-00-8 | 4,4′-(1,3-phenylen-bis(1-methylethyliden))bis-phenol | | 428-970-4 | 13595-25-0 | Repr.Cat.3; R62
  R43
  N; R51-53 | Xn; N
  R: 43-62-51/53
  S: (2-)22-36/37-61 | | |
| 604-080-00-3 | 4-fluor-3-trifluormethylphenol | | 432-560-0 | 61721-07-1 | Xn; R20
  C; R35
  R43
  N; R51-53 | C; N
  R: 20-35-43-51/53
  S: (1/2-)26-28-36/37/39-45-61 | | |
| 604-081-00-9 | 1,1-bis(4-hydroxyphenyl)-1-phenylethan | | 433-130-5 | 1571-75-1 | N; R50-53 | N
  R: 50/53
  S: 25-60-61 | | |
| 604-082-00-4 | 2-chlor-6-fluorphenol | E | 433-890-8 | 2040-90-6 | Muta.Cat.2; R46
  Repr.Cat.3; R62
  Xn; R22
  C; R34
  R43
  N; R51-53 | T; N
  R: 46-22-34-43-62-51/53
  S: 53-45-61 | | |
| 604-083-00-X | 4,4′-sulfonylbisphenol, polymer med ammoniumchlorid (NH4Cl), pentachlorphosphoran og phenol | | 439-270-3 | 260408-02-4 | R53 | R: 53
  S: 61 | | |
| 604-084-00-5 | 1-ethoxy-2,3-difluorbenzen | | 441-000-4 | 121219-07-6 | Xn; R22
  R52-53 | Xn
  R: 22-52/53
  S: (2-)23-61 | | |
| 604-087-00-1 | blanding af: 1,2-naphthoquinondiazid-5-sulfonylchlorid (eller sulfonsyre)monoester og 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethyliden)bisphenol;
  1,2-naphthoquinondiazid-5-sulfonylchlorid (eller sulfonsyre)diester og 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethyliden)bisphenol;
  1,2-naphthoquinondiazid-5-sulfonylchlorid (eller sulfonsyre)triester og 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethyliden)bisphenol | | 433-640-8 | — | F; R17
  R44
  R53 | F
  R: 17-44-53
  S: (2-)15-22-61 | | |
| 604-089-00-2 | 2-methyl-5-tert-butylthiophenol | | 444-970-7 | — | R10
  Repr.Cat.3; R63
  Xn; R48/20/22-65
  Xi; R36/38
  R43
  R67
  N; R50-53 | Xn; N
  R: 10-36/38-43-48/20/22-63-65-67-50/53
  S: (2-)26-36/37-62-60-61 | | |
| 605-037-00-1 | trans-3-[2-(7-chlor-2-quinolinyl)vinyl]benzaldehyd;
  3-[(E)-2-(7-chlor-2-quinolinyl)vinyl]benzaldehyd | | 421-800-1 | 120578-03-2 | R53 | R: 53
  S: 22-61 | | |
| 605-038-00-7 | 3-methyl-5-phenylpentan-1-al | | 433-900-0 | 55066-49-4 | Xn; R22
  Xi; R38
  R43
  N; R51-53 | Xn; N
  R: 22-38-43-51/53
  S: (2-)36/37-61 | | |
| 605-039-00-2 | 3,4-dihydroxy-5-nitrobenzaldehyd | | 441-810-8 | 116313-85-0 | Xn; R22
  Xi; R41
  R43 | Xn
  R: 22-41-43
  S: (2-)22-24-26-37/39 | | |
| 606-124-00-7 | 1-cyclopropyl-3-(2-methylthio-4-trifluormethylphenyl)-1,3-propandion | | 421-080-7 | 161462-35-7 | Xn; R48/22
  N; R50-53 | Xn; N
  R: 48/22-50/53
  S: (2-)36-60-61 | | |
| 606-125-00-2 | 1-benzylimidazolidin-2,4-dion | | 421-340-1 | 6777-05-5 | Xn; R22 | Xn
  R: 22
  S: (2-)22 | | |
| 606-126-00-8 | 1,4-bis(2,3-dihydroxypropylamino)anthraquinon | | 421-470-7 | 99788-75-7 | N; R51-53 | N
  R: 51/53
  S: 61 | | |
| 606-128-00-9 | 2,2′-(1,3-phenylen)bis[5-chlor-1H-isoindol]-1,3(2H)-dion | | 422-650-8 | 148935-94-8 | R53 | R: 53
  S: 61 | | |
| 606-129-00-4 | 5-amino-[2S-di(methylphenyl)amino]-1,6-diphenyl-4Z-hexen-3-on;
  (2S,4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-on | | 423-090-7 | 156732-13-7 | R53 | R: 53
  S: 61 | | |
| 606-130-00-X | 4-(1,4-dioxa-spiro[4.5]dec-8-yl)-cyclohexanon | | 423-860-2 | 56309-94-5 | R43
  R52-53 | Xi
  R: 43-52/53
  S: (2-)24-37-61 | | |
| 606-131-00-5 | cyclisk 3-(1,2-ethandiylacetal)-estra-5(10),9(11)-dien-3,17-dion | E | 427-230-8 | 5571-36-8 | Repr. Cat. 2; R60
  Xn; R48/22
  N; R51-53 | T; N
  R: 60-48/22-51/53
  S: 53-45-61 | | |
| 606-132-00-0 | (6β)-6,19-epoxyandrost-4-en-3,17-dion | | 433-490-3 | 6563-83-3 | R43
  R52-53 | Xi
  R: 43-52/53
  S: (2-)24-37-61 | | |
| 606-134-00-1 | androsta-1,4,9(11)-trien-3,17-dion | | 433-560-3 | 15375-21-0 | Repr. Cat.3; R62 | Xn
  R: 62
  S: (2-)22-36/37 | | |
| 606-135-00-7 | cyclohexadecanon | | 438-930-8 | 2550-52-9 | R53 | R: 53
  S: 61 | | |
| 606-136-00-2 | (3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosan-2,5,8,11,14,17,20,23-octaon | | 444-350-6 | 133413-70-4 | Xi; R36
  R53 | Xi
  R: 36-53
  S: (2-)26-61 | | |
| 606-137-00-8 | trans-7,7′-dimethyl-(4H,4H′)-(2,2′)bi[benzo[1,4]thiazinyliden]-3,3′-dion | | 444-750-0 | 211387-26-7 | R53 | R: 53
  S: 22-61 | | |
| 606-138-00-3 | (2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanon | | 444-800-1 | 141645-23-0 | R10
  Xn; R22-48/22
  Xi; R38-41
  R43
  N; R50-53 | Xn; N
  R: 10-22-38-41-43-48/22-50/53
  S: (2-)23-26-36/37/39-60-61 | C ≥ 25 %: Xn, N; R22-38-41-43-48/22-50/53
  20 % ≤ C < 25 %: Xn, N; R38-41-43-48/22-50/53
  10 % ≤ C < 20 %: Xn, N; R41-43-48/22-50/53
  5 % ≤ C < 10 %: Xi, N; R36-43-50/53
  2,5 % ≤ C < 5 %: Xi, N; R43-50/53
  1 % ≤ C < 2,5 %: Xi, N; R43-51/53
  0,25 % ≤ C < 1 %: N; R51/53
  0,025 % ≤ C < 0,25 %: R52/53 | |
| 606-139-00-9 | (S)-4-(3,4-dichlorphenyl)-3,4-dihydro-2H-naphthalen-1-on | | 444-830-5 | 124379-29-9 | R53 | R: 53
  S: 61 | | |
| 606-140-00-4 | 2-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-on | | 444-860-9 | 474510-57-1 | Xn; R48/22
  N; R50-53 | Xn; N
  R: 48/22-50/53
  S: (2-)22-36-60-61 | | |
| 606-141-00-X | natrium-3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolat | | 418-410-7 | — | Xi; R36 | Xi
  R: 36
  S: (2-)26 | | |
| 606-142-00-5 | blanding af: (1RS,2SR,7SR,8SR,E)-9-og 10-ethyliden-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-on;
  (1RS,2SR,7SR,8SR,Z)-10-ethyliden-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-on;
  (1RS,2SR,7SR,8SR,Z)-9-ethyliden-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-on | | 434-290-9 | — | Xn; R22
  N; R51-53 | Xn; N
  R: 22-51/53
  S: (2-)61 | | |
| 607-580-00-X | ethyl-7-chlor-1-(2,4-difluorphenyl)-6-fluor-1,4-dihydro-4-oxo-1,8-naphthyridin-3-carboxylat | | 422-360-1 | 100491-29-0 | R43
  N; R51-53 | Xi; N
  R: 43-51/53
  S: (2-)22-24-37-61 | | |
| 607-618-00-5 | menadionnatriumbisulfit;
  2-naphthalensulfonsyre, 1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, natriumsalt | | 204-987-0 | 130-37-0 | Xi; R36/38
  N; R50-53 | Xi; N
  R: 36/38-50/53
  S: (2-)24/25-60-61 | | |
| 607-619-00-0 | menadionnicotinamidbisulfit;
  1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalen-2-sulfonsyre, forbindelse med nicotin-3-amid (1:1) | | 277-543-7 | 73581-79-0 | Xi; R36/38
  N; R50-53 | Xi; N
  R: 36/38-50/53
  S: (2-)24/25-60-61 | | |
| 607-620-00-6 | trinatriumnitrilotriacetat | | 225-768-6 | 5064-31-3 | Carc. Cat. 3; R40
  Xn; R22
  Xi; R36 | Xn
  R: 22-36-40
  S: (2-)26-36/37-46 | C ≥ 25 %: Xn; R22-36-40
  20 ≤ % C < 25 %: Xn; R36-40
  5 ≤ % C < 20 %: Xn; R40 | |
| 607-621-00-1 | milbemectin (ISO);
  [blanding af milbemycin A3 (CAS-nr. 51596-10-2) og milbemycin A4 (CAS-nr. 51596-11-3) (30:70)] | | — | — | Xn; R20/22
  N; R50-53 | Xn; N
  R: 20/22-50/53
  S: (2-)46-60-61 | C ≥ 25 %: Xn, N; R20/22-50/53
  0,25 % ≤ C < 25 %: N; R50/53
  0,025 % ≤ C < 0,25 %: N; R51/53
  0,0025 % ≤ C < 0,025 %: R52/53 | |
| 607-622-00-7 | 2-ethylhexyl-2-ethylhexanoat | | 231-057-1 | 7425-14-1 | Repr. Cat. 3; R63 | Xn
  R: 63
  S: (2-)36/37 | | |
| 607-623-00-2 | diisobutylphthalat | | 201-553-2 | 84-69-5 | Repr. Cat. 2; R61
  Repr. Cat. 3; R62 | T
  R: 61-62
  S: 53-45 | C ≥ 25 %: T; R61-62
  5 % ≤ C < 25 %: Xn; R62 | |
| 607-624-00-8 | perfluoroctansulfonsyre;
  heptadecafluoroctan-1-sulfonsyre; [1]
  kaliumperfluoroctansulfonat;
  kaliumheptadecafluoroctan-1-sulfonat; [2]
  diethanolaminperfluoroctansulfonat; [3]
  ammoniumperfluoroctansulfonat;
  ammoniumheptadecafluoroctansulfonat; [4]
  lithiumperfluoroctansulfonat;
  lithiumheptadecafluoroctansulfonat [5] | E | 217-179-8 [1]
  220-527-1 [2]
  274-460-8 [3]
  249-415-0 [4]
  249-644-6 [5] | 1763-23-1 [1]
  2795-39-3 [2]
  70225-14-8 [3]
  29081-56-9 [4]
  29457-72-5 [5] | Carc. Cat. 3; R40
  Repr. Cat. 2; R61
  T; R48/25
  Xn; R20/22
  R64
  N; R51-53 | T; N
  R: 61-20/22-40-48/25-64-51/53
  S: 53-45-61 | | |
| 607-625-00-3 | clodinafop-propargyl (ISO) | | — | 105512-06-9 | Xn; R22-48/22
  R43
  N; R50-53. | Xn; N
  R: 22-43-48/22-50/53
  S: (2-)24-36/37-46-60-61 | C ≥ 25 %: Xn, N; R22-43-48/22-50/53
  10 % ≤ C < 25 %: Xn, N; R43-48/22-51/53
  2,5 % ≤ C < 10 %: Xi, N; R43-51/53
  0,25 % ≤ C < 2,5 %: Xi; R43-52/53
  0,001 % ≤ C < 0,25 %: Xi; R43 | |
| 607-626-00-9 | ethyl-1-(2,4-dichlorphenyl)-5-(trichlormethyl)-1H-1,2,4-triazol-3-carboxylat | | 401-290-5 | 103112-35-2 | Carc.Cat.2; R45
  N; R50-53 | T; N
  R: 45-50/53
  S: 53-45-60-61 | | |
| 607-627-00-4 | [(4S,5S)-4-benzyl-2-oxo-5-oxazolidinyl]methyl 4-nitrobenzensulfonat | | 416-360-0 | 162221-28-5 | R43 | Xi
  R: 43
  S: (2-)22-24-37 | | |
| 607-628-00-X | 4-oxo-4-(p-tolyl)smørsyre, addukt med 4-ethylmorpholin | | 419-240-6 | 171054-89-0 | Xi; R41 | Xi
  R: 41
  S: (2-)26-39 | | |
| 607-629-00-5 | [[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl]eddikesyre | | 419-270-1 | 123599-82-6 | Xi; R36 | Xi
  R: 36
  S: (2-)26 | | |
| 607-630-00-0 | acrylsyre, 3-(trimethoxysilyl)propylester | | 419-560-6 | 4369-14-6 | Xn; R20
  C; R34
  R43
  R52-53 | C
  R: 20-34-43-52/53
  S: (1/2-)26-36/37/39-45-61 | | |
| 607-631-00-6 | blanding af: 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl-oxo(phenyl)acetat;
  (2-(2-hydroxyethoxy)ethyl)-oxo(phenyl)acetat | | 442-300-8 | — | R43 | Xi
  R: 43
  S: (2-)24-37 | | |
| 607-632-00-1 | N-[3-(2,4-di-(1,1-dimethyl-propyl)phenoxy)-propyl]-1-hydroxy-5-(2-methylpropyl-oxycarbonylamino)-naphthamid | | 420-210-1 | 111244-14-5 | R53 | R: 53
  S: 61 | | |
| 607-633-00-7 | trinatrium-5-{[4-chlor-6-(1-naphthylamino)-1,3,5-triazin-2-yl]amino}-4-hydroxy-3-[(E)-(4-methoxy-2-sulfonatophenyl)diazenyl]-2,7-naphthalendisulfonat | | 440-480-2 | 341026-59-3 | Xi; R41
  R43 | Xi
  R: 41-43
  S: (2-)22-24-26-37/39 | | |
| 607-634-00-2 | (S)-(-)-2-acetoxypropionylchlorid;
  (1S)-2-chlor-1-methyl-2-oxoethylacetat | | 420-610-4 | 36394-75-9 | Xn; R22
  C; R34
  R43 | C
  R: 22-34-43
  S: (1/2-)23-26-36/37/39-45 | | |
| 607-635-00-8 | trinatrium-N-(3-propionato)-L-aspartat | | 422-090-4 | 172737-80-3 | Xi; R41 | Xi
  R: 41
  S: (2-)26-39 | | |
| 607-636-00-3 | 1-brom-2-methylpropylpropionat | | 422-900-6 | 158894-67-8 | R10
  Carc.Cat.3; R40
  C; R34
  R43 | C
  R: 10-34-40-43
  S: (1/2-)7/9-8-23-26-36/37/39-45 | | |
| 607-637-00-9 | dinatrium-8-amino-5-{4-[2-(sulfonatoethoxy)sulfonyl]phenylazo}naphthalen-2-sulfonat | | 423-730-5 | 250688-43-8 | Xi; R41 | Xi
  R: 41
  S: (2-)26-39 | | |
| 607-638-00-4 | 2-hydroxybenzoesyre-2-butyloctylester | | 431-090-3 | 190085-41-7 | R53 | R: 53
  S: 61 | | |
| 607-639-00-X | 2-(2-oxo-5-(1,1,3,3-tetramethylbutyl)-2,3-dihydro-1-benzofuran-3-yl)-4-(1,1,3,3-tetramethylbutyl)phenylacetat | | 431-770-1 | 216698-07-6 | R53 | R: 53
  S: 61 | | |
| 607-641-00-0 | 2-(formylamino)-3-thiophencarboxylsyre;
  2-formamido-3-thiophencarboxylsyre | | 431-930-9 | 43028-69-9 | Xn; R22
  R43 | Xn
  R: 22-43
  S: (2-)22-24-37 | | |
| 607-642-00-6 | 3,6,9-trithiaundecamethylen-1,11-dimethacrylat | | 432-210-7 | 141631-22-3 | N; R50-53 | N
  R: 50/53
  S: 60-61 | | |
| 607-643-00-1 | dimethyl (2S)-2-hydroxysuccinat | | 432-310-0 | 617-55-0 | R10
  Xi; R41
  R43 | Xi
  R: 10-41-43
  S: (2-)24-26-37/39-43 | | |
| 607-644-00-7 | methyl-2,2-dimethyl-6-methylencyclohexancarboxylat | | 432-350-9 | 81752-87-6 | Xi; R38 | Xi
  R: 38
  S: (2-)37 | | |
| 607-645-00-2 | tetranatrium-2-(4-fluor-6-(methyl-(2-(sulfatoethylsulfonyl)ethyl)amino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatophenylazo)naphthalen-1,7-disulfonat | | 432-550-6 | 243858-01-7 | Xi; R41 | Xi
  R: 41
  S: (2-)22-26-39 | | |
| 607-646-00-8 | D-erythro-hexansyre-2,4-dideoxy-3,5-O-(1-methylethyliden)-1,1-dimethylethylester;

  tert-butyl-2-[(4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetat | | 432-960-5 | 124655-09-0 | Xn; R22 | Xn
  R: 22
  S: (2-)25 | | |
| 607-647-00-3 | 5-acetoxy-2-(R,S)butyryloxymethyl-1,3-oxathiolan | | 433-530-1 | 143446-73-5 | Xn; R22
  R43
  N; R50 | Xn; N
  R: 22-43-50
  S: (2-)24-37-57-61 | | |
| 607-649-00-4 | [3-(chlorcarbonyl)-2-methylphenyl]acetat | | 433-690-0 | 167678-46-8 | C; R35
  R43 | C
  R: 35-43
  S: (1/2-)7/8-26-36/37/39-45 | | |
| 607-650-00-X | 2-methyl-1,5-pentandiamin-1,3-benzendicarboxylat | | 433-910-5 | 145153-52-2 | R43 | Xi
  R: 43
  S: (2-)24-37 | | |
| 607-651-00-5 | natrium-2-(nonanoyloxy)benzensulfonat | | 434-360-9 | 91125-43-8 | Xi; R41
  R43 | Xi
  R: 41-43
  S: (2-)24-26-37/39 | | |
| 607-652-00-0 | ethyl-N
  2-dodecanoyl-L-argininathydrochlorid | | 434-630-6 | 60372-77-2 | Xi; R41
  N; R50 | Xi; N
  R: 41-50
  S: (2-)26-39-61 | | |
| 607-653-00-6 | tetrakis(bis(2-hydroxyethyl)methylammonium)-3-(4-(7-acetylamino-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-5-methoxy-2-sulfonatophenylazo)-7-(4-amino-3-sulfonatophenylamino)-4-hydroxynaphthalen-2-sulfonat | | 434-840-8 | 225786-91-4 | N; R51-53 | N
  R: 51/53
  S: 61 | | |
| 607-654-00-1 | (S)-3-hydroxy-γ-butyrolacton | | 434-990-4 | 7331-52-4 | R43 | Xi
  R: 43
  S: (2-)23-24-37 | | |
| 607-655-00-7 | ethyl-6,8-dichloroctanoat | | 435-080-1 | 1070-64-0 | R43
  N; R51-53 | Xi; N
  R: 43-51/53
  S: (2-)24-37-61 | | |
| 607-656-00-2 | natriumsalt af 4-amino-3,6-bis[[5-[[4-chlor-6-[(2-methyl-4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-2,7-naphthalendisulfonsyre | | 435-350-7 | 141250-43-3 | Xi; R41
  R52-53 | Xi
  R: 41-52/53
  S: (2-)22-26-39-61 | | |
| 607-657-00-8 | pentanatrium-7-(4-(4-(3-(2-sulfatoethansulfonyl)phenylamino)-6-(4-(2-sulfatoethansulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalen-1,3,6-trisulfonat | | 436-920-8 | 172399-10-9 | Xi; R41 | Xi
  R: 41
  S: (2-)22-26-39 | | |
| 607-658-00-3 | 3,10-diamino-6,13-dichlor-2-((6-(((4-(1,1-dimethylethyl)phenyl)sulfonyl)amino)-2-naphthalenyl)sulfonyl)-4,11-triphenodioxazindisulfonsyre, lithiumkaliumnatriumsalt | | 440-770-9 | 371921-63-0 | Xi; R41
  R52-53 | Xi
  R: 41-52/53
  S: (2-)26-39-61 | | |
| 607-659-00-9 | pentanatrium-N-[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-6-chlor-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl] sulfonyl]phenyl]azo]phenyl]-3-aminopropansyre | | 442-030-0 | 321912-47-4 | Xi; R41 | Xi
  R: 41
  S: (2-)22-26-39 | | |
| 607-660-00-4 | 2-{4-[4-[4-fluor-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino]phenylazo]phenylazo}naphthalen-4,6,8-trisulfonat, trinatriumsalt | | 442-230-8 | 321679-52-1 | Xi; R41 | Xi
  R: 41
  S: (2-)22-26-39 | | |
| 607-661-00-X | 1,1-dimethylethyl-4′-(brommethyl)biphenyl-2-carboxylat | | 442-850-9 | 114772-40-6 | R43
  R53 | Xi
  R: 43-53
  S: (2-)22-24-37-61 | | |
| 607-662-00-5 | methyl-2-(acetylamino)-3-chlorpropionat | | 442-860-3 | 87333-22-0 | R43
  N; R50-53 | Xi; N
  R: 43-50/53
  S: (2-)24-37-60-61 | | |
| 607-663-00-0 | bis(2-ethylhexyl)-naphthalen-2,6-dicarboxylat | | 442-980-6 | 127474-91-3 | R53 | R: 53
  S: 61 | | |
| 607-664-00-6 | methyl-2-chlorsulfonyl-4-(methansulfonylaminomethyl)benzoat | | 443-120-2 | 393509-79-0 | Xi; R41
  N; R51-53 | Xi; N
  R: 41-51/53
  S: (2-)26-39-61 | | |
| 607-665-00-1 | trans-methyl-2-ethyl-but-2-enoat | | 443-150-6 | 101226-85-1 | R10 | R: 10
  S: 23 | | |
| 607-666-00-7 | (2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentansyre | | 443-560-5 | 88784-33-2 | Xi; R36 | Xi
  R: 36
  S: (2-)26 | | |
| 607-667-00-2 | chlor-1-ethylcyclohexylcarbonat | | 444-950-8 | 99464-83-2 | Muta.Cat.3; R68
  R43 | Xn
  R: 43-68
  S: (2-)23-36/37 | | |
| 607-668-00-8 | trans-2-isopropyl-5-carboxy-1,3-dioxan | | 445-770-2 | 42031-28-7 | Xi; R41
  R52-53 | Xi
  R: 41-52/53
  S: (2-)22-26-39-61 | | |
| 607-669-00-3 | methyl-(9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoat | | 445-990-9 | 376588-17-9 | R43
  R53 | Xi
  R: 43-53
  S: (2-)24-37-61 | | |
| 607-670-00-9 | dibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propylammoniumoxalat;
  (5-amino-2-butylbenzofuran-3-yl)-[4-(3-dibutylaminopropoxy)phenyl]methanon, dioxalat | | 448-700-9 | 500791-70-8 | Xn; R48/22
  Xi; R41
  R43
  N; R50-53 | Xn; N
  R: 41-43-48/22-50/53
  S: (2-)22-26-36/37/39-60-61 | C ≥ 10 %: Xn, N; R41-43-48/22-50/53
  5 % ≤ C < 10 %: Xi, N; R36-43-50/53
  2,5 % ≤ C < 5 %: Xi, N; R43-50/53
  1 % ≤ C < 2,5 %: Xi, N; R43-51/53
  0,25 % ≤ C < 1 %: N; R51/53
  0,025 % ≤ C < 0,25 %: R52/53 | |
| 607-671-00-4 | diethyl-1,4-cyclohexandicarboxylat | | 417-310-0 | 72903-27-6 | N; R51-53 | N
  R: 51/53
  S: 61 | | |
| 607-672-00-X | blanding af: 2-hydroxy-3-(methacryloyloxy)propyl-(2-benzoyl)benzoat;
  1-hydroxymethyl-2-(methacryloyloxy)ethyl-(2-benzoyl)benzoat;
  x-hydroxy-y-(methacryloyloxy)propyl(eller -ethyl)-(2-benzoyl)benzoat | | 419-000-0 | — | R43
  N; R51-53 | Xi; N
  R: 43-51/53
  S: (2-)24-37-61 | | |
| 607-673-00-5 | 1-ethyl-5,6,7,8-tetrahydroquinoliniumtosylat | | 419-570-0 | — | Xn; R22
  R52-53 | Xn
  R: 22-52/53
  S: (2-)61 | | |
| 607-674-00-0 | branched C10-alkyl benzoates | | 421-090-1 | 131298-44-7 | Xn; R20 | Xn
  R: 20
  S: (2-)23 | | |
| 607-675-00-6 | blanding af: cis-9-octadecendisyre;

  cis-9-cis-12-octadecadiendisyre;
  hexadecandisyre;
  octadecandisyre | | 422-260-8 | — | Xi; R41
  N; R50-53 | Xi; N
  R: 41-50/53
  S: (2-)26-39-60-61 | | |
| 607-676-00-1 | blanding af: 2-methylnonandisyre;
  2,4-dimethyl-4-methoxycarbonylundecanedioic acid;
  2,4,6-trimethyl-4,6-dimethoxycarbonyltridecandisyre;
  8,9-dimethyl-8,9-dimethoxycarbonylhexadecandisyre | | 423-670-1 | — | Xi; R41
  R43 | Xi
  R: 41-43
  S: (2-)24-26-37/39 | | |
| 607-677-00-7 | 2,5-dioxopyrrolidin-1-yl N-{[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl}-L-valinat | | 424-660-8 | — | Xn; R48/22
  Xi; R41
  R43 | Xn
  R: 41-43-48/22
  S: (2-)22-26-36/37/39 | | |
| 607-678-00-2 | blanding af: ethyl-(2R,3R)-3-isopropylbicyclo[2.2.1]hept-5-en-2-carboxylat;
  ethyl-(2S,3S)-3-isopropylbicyclo[2.2.1]hept-5-en-2-carboxylat | | 427-090-8 | — | R43
  N; R51-53 | Xi; N
  R: 43-51/53
  S: (2-)23-25-36/37-61 | | |
| 607-679-00-8 | blanding af: 3-{5-[3-(4-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(methyl)ammoniumdi(acetat);
  3-{5-[4-(3-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido]phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammoniumdi(acetat);
  3-{5-[3-(4-{1-[3-(dimethylammonio)propyl]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammoniumdi(acetat) | | 431-440-5 | — | Xi; R41
  N; R51-53 | Xi; N
  R: 41-51/53
  S: (2-)22-26-39-61 | | |
| 607-680-00-3 | tert-butyl(6-{2-[4-(4-fluorphenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]vinyl}(4S,6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetat | | 432-810-9 | — | R53 | R: 53
  S: 61 | | |
| 607-681-00-9 | blanding af: 9-nonyl-10-octyl-19-carbonyloxyhexadecylnonadecansyre;
  9-nonyl-10-octyl-19-carbonyloxyoctadecylnonadecansyre;
  dihexadecyl-9-nonyl-10-octylnonadecandioat;
  1-octadecyl-19-hexadecyl-9-nonyl-10-octylnonadecandioat;
  dioctadecyl-9-nonyl-10-octylnonadecandioat | | 432-910-2 | — | R53 | R: 53
  S: 61 | | |
| 607-682-00-4 | kompleks blanding af kinesisk gummiharpiks, efterfølgende behandlet med acrylsyre | | 434-230-1 | 144413-22-9 | R53 | R: 53
  S: 61 | | |
| 607-683-00-X | blanding af: methyl-3-((1E)-2-methylprop-1-enyl)-2,2-dimethylcyclopropancarboxylat;
  methyl-3-((1Z)-2-methylprop-1-enyl)-2,2-dimethylcyclopropancarboxylat (20:80) | | 435-450-0 | — | R43
  N; R51-53 | Xi; N
  R: 43-51/53
  S: (2-)24-37-61 | | |
| 607-684-00-5 | alkener, C12-14, hydroformyleringsprodukter, destillationsrester, C-(hydrogensulfobutandioater), dinatriumsalte | | 435-660-2 | 243662-67-1 | Xi; R38
  R43 | Xi
  R: 38-43
  S: (2-)24-37 | | |
| 607-685-00-0 | ammonium-2-cocoyloxyethansulfonat | | 441-050-7 | — | Xi; R38-41 | Xi
  R: 38-41
  S: (2-)26-37/39 | | |
| 607-686-00-6 | 6,6′-bis(diazo-5,5′,6,6′-tetrahydro-5,5′-dioxo)[methylen-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonyloxy)-6-methyl-2-phenylen]di(naphthalen-1-sulfonat) | | 441-550-5 | — | E; R2
  F; R11
  Carc. Cat. 3; R40 | E; Xn
  R: 2-11-40
  S: (2-)7-22-36/37 | | |
| 607-687-00-1 | blanding af: 2-{3,6-bis-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (2-10 %);
  2-{3,6-bis-[(2,3-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (2-10 %);
  2-{3,6-bis-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (2-10 %);
  2-{3,6-bis-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (2-10 %);
  2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (7-20 %);
  2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (7-20 %);
  2-{3-[(2,5-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (7-20 %);
  2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (7-20 %);
  2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (7-20 %);
  2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (7-20 %) | | 442-800-6 | — | Xi; R38
  N; R51-53 | Xi; N
  R: 38-51/53
  S: (2-)37-61 | | |
| 607-688-00-7 | (R)-1-cyclohexa-1,4-dienyl-1-methoxycarbonyl-methylammoniumchlorid | | 444-320-2 | — | Xn; R22 | Xn
  R: 22
  S: (2-) | | |
| 607-689-00-2 | blanding af: methyl-1,4-dimethylcyclohexancarboxylat (»para-isomer« inkl. cis-og trans-isomerer);
  methyl-1,3-dimethylcyclohexancarboxylat (»meta-isomer« inkl. cis-og trans-isomerer) | | 444-920-4 | — | R52-53 | R: 52/53
  S: 61 | | |
| 607-690-00-8 | dimethyl-[2S,2S′]-6,6,6′6′-tetramethoxy-2,2′-[N,N′-bis(trifluoracetyl)-S,S′-bi(L-homocysteinyl) diimino]dihexanoat | | 432-860-1 | 255387-46-3 | R43 | Xi
  R: 43
  S: (2-)24-37 | | |
| 607-691-00-3 | magnesiumsalte, fedtsyrer, C16-18-og C18-umættede, forgrenede og lineære | | 448-690-6 | — | R53 | R: 53
  S: 61 | | |
| 607-692-00-9 | zinksalte, fedtsyrer, C16-18-og C18-umættede, forgrenede og lineære | | 446-470-4 | — | R53 | R: 53
  S: 61 | | |
| 607-693-00-4 | hexyl-2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoat | | 443-860-6 | 302776-68-7 | R53 | R: 53
  S: 61 | | |
| 607-694-00-X | ethyl-5,5-diphenyl-2-isoxazolin-3-carboxylat | | 443-870-0 | 163520-33-0 | Xn; R22
  R43
  N; R50-53 | Xn; N
  R: 22-43-50/53
  S: (2-)22-36/37-60-61 | | |
| 608-042-00-7 | (S)-2,2-diphenyl-2-(3-pyrrolidinyl)acetonitrilhydrobromid | | 421-810-4 | 194602-27-2 | Xn; R22
  Xi; R41
  R43
  N; R51-53 | Xn; N
  R: 22-41-43-51/53
  S: (2-)24-26-37/39-61 | | |
| 608-059-00-X | 5-amino-1-(2,6-dichlor-4-(trifluormethyl)phenyl)-1H-pyrazol-3-carbonitril | | 421-240-6 | 120068-79-3 | N; R51-53 | N
  R: 51/53
  S: 22-61 | | |
| 608-060-00-5 | 5-methyl-2-[(2-nitrophenyl)amino]-3-thiophencarbonitril | | 421-300-1 | 138564-59-7 | N; R50-53 | N
  R: 50/53
  S: 22-60-61 | | |
| 608-062-00-6 | 2-fluor-4-hydroxybenzonitril | | 422-810-7 | 82380-18-5 | Xn; R22
  Xi; R41
  N; R51-53 | Xn; N
  R: 22-41-51/53
  S: (2-)22-26-39-61 | | |
| 608-063-00-1 | (S)-α-hydroxy-3-phenoxy-benzenacetonitril | | 441-070-6 | 61826-76-4 | T; R25
  Xi; R41
  R43
  N; R50-53 | T; N
  R: 25-41-43-50/53
  S: (1/2-)9-26-36/37/39-45-60-61 | | |
| 608-064-00-7 | cyanmethyltrimethylammoniummethylsulfat | | 433-720-2 | — | R52-53 | R: 52/53
  S: 61 | | |
| 609-069-00-7 | moskusketon;
  3,5-dinitro-2,6-dimethyl-4-tert-butylacetophenon;
  4′-tert-butyl-2′,6′-dimethyl-3′,5′-dinitroacetophenon | | 201-328-9 | 81-14-1 | Carc. Cat. 3; R40
  N; R50-53 | Xn; N
  R: 40-50/53
  S: (2-)36/37-46-60-61 | | |
| 611-154-00-9 | trinatrium-5-benzamido-4-hydroxy-3-(4-methyl-2-sulfonatophenylazo)naphthalen-2,7-disulfonat | | 403-670-6 | 92408-46-3 | R52-53 | R: 52/53
  S: 61 | | |
| 611-155-00-4 | 4,4′-oxybis(benzensulfonylazid) | | 431-850-4 | 7456-68-0 | E; R3
  F; R11
  Xn; R48/22
  N; R50-53 | E; Xn; N
  R: 3-11-48/22-50/53
  S: (2-)14-22-33-35-36-60-61 | | |
| 611-156-00-X | triammonium-4-[4-[7-(4-carboxylatoanilino)-1-hydroxy-3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoat | | 432-270-4 | 221354-37-6 | Repr. Cat. 3; R62
  Xn; R48/22
  N; R51-53 | Xn; N
  R: 48/22-62-51/53
  S: (2-)36/37-61 | | |
| 611-157-00-5 | benzensulfonsyre, 3,3′-(methylenbis((dihydroxyphenylen)azo))bis-, kaliumnatriumsalt;
  kaliumnatrium-3-[(E)-(6-{3,4-dihydroxy-2-[(Z)-(3-sulfonatophenyl)diazenyl]benzyl}-2,3-dihydroxyphenyl)diazenyl]benzensulfonat | | 432-590-4 | 243869-48-9 | Xi; R36
  R52-53 | Xi
  R: 36-52/53
  S: (2-)26-61 | | |
| 611-158-00-0 | reaktionsblanding af: 2,3,4,2′,3′,4′-hexahydroxy-5,5′-diacetyl-diphenylmethan og 6-diazo-5,6-dihydro-5-oxo-1-naphthalensulfonylchlorid og 3-diazo-3,4-dihydro-6-methoxy-4-oxo-1-naphthalensulfonylchlorid | | 421-520-8 | — | F; R11
  R53 | F
  R: 11-53
  S: (2-)3-12-16-33-61 | | |
| 611-159-00-6 | dinatrium-4-amino-6-((4-((4-(2,4-diaminophenyl)azo)phenylsulfamoyl)phenyl)azo)-5-hydroxy-3-((4-nitrophenyl)azo)naphthalen-2,7-disulfonat | | 421-880-6 | — | Xi; R41
  R52-53 | Xi
  R: 41-52/53
  S: (2-)26-39-61 | | |
| 611-160-00-1 | blanding af: 1,1,1-tris(phenyl-4′-(3′′-diazo-3′′,4′′-dihydro-4′′-oxo-naphthalen-1′′-sulfonato)ethan;
  1,1,1-tris(phenyl-4′-(6′′-diazo-5′′,6′′-dihydro-5′′-oxo-naphthalen-1′′-sulfonato)ethan;
  reaktionsprodukt af 1,1,1-tris(p-hydroxyphenyl)ethan med 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchlorid og 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchlorid (2:1);
  reaktionsprodukt af 1,1,1-tris(p-hydroxyphenyl)ethan med 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchlorid og 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchlorid (1:2) | | 422-760-6 | — | F; R11
  R53 | F
  R: 11-53
  S: (2-)3-12-33-61 | | |
| 611-161-00-7 | trinatrium-[1,2′-(2-(8-amino-3,5-disulfonatonaphthalen)azo)-(4′-nitrobenzen)diolato-O,O,N][(Z)-2,2-((phenylcarbamoylprop-1′-enyl)azo)-5-sulfamoylbenzen)diolato-O,O,N]chromat(III) | | 423-100-1 | — | Xi; R41 | Xi
  R: 41
  S: (2-)26-39 | | |
| 611-162-00-2 | 2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzen-1,3-diolbis(methansulfonat) | | 429-600-4 | — | Xn; R22
  Xi; R41
  N; R51-53 | Xn; N
  R: 22-41-51/53
  S: (2-)22-26-39-61 | | |
| 611-163-00-8 | 2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzen-1,3-diolsulfat | | 429-610-9 | — | Xn; R22
  Xi; R41
  N; R51-53 | Xn; N
  R: 22-41-51/53
  S: (2-)22-26-39-61 | | |
| 611-164-00-3 | blanding af: 2,2′-dimethyl-2,2′-azobutannitril;
  2-methylpentannitril-2-azo-2′-(2′-methylpropannitril);
  2,2′-dimethyl-2,2′-azoheptannitril;
  2-methylheptannitril-2-azo-2′-(2′-methylpropannitril);
  2-methylheptannitril-2-azo-2′-(2′-methylbutannitril) | | 429-710-2 | — | R10
  R32
  R44
  Xn; R22
  N; R51-53 | Xn; N
  R: 10-22-32-44-51/53
  S: (2-)12-15-16-47-51-61 | | |
| 611-165-00-9 | blanding af: tetranatrium-4-amino-6-(5-(2,6-difluorpyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(sulfatoethylsulfonyl)phenylazo)naphthalen-2,7-disulfonat;
  tetranatrium-4-amino-6-(5-(4,6-difluorpyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethylsulfonyl)phenylazo)naphthalen-2,7-disulfonat | | 431-830-5 | — | R52-53 | R: 52/53
  S: 61 | | |
| 611-166-00-4 | blanding af: pentanatrium-4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalen-2,7-disulfonat;
  tetranatrium-4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat;
  tetranatrium-4-amino-5-hydroxy-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat | | 432-100-9 | — | Xi; R41
  R52-53 | Xi
  R: 41-52/53
  S: (2-)26-39-61 | | |
| 611-167-00-X | natrium-bis[tris(2-hydroxyethyl)ammonium][6-anilino-4′-(4,8-disulfonato-2-naphthylazo)-5′-methyl-3-sulfonatonaphthalen-2-azobenzen-1,2′-diolato]cuprat(II) | | 435-240-9 | — | R52-53 | R: 52/53
  S: 61 | | |
| 611-168-00-5 | blanding af: 3-[[4-chlor-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-5-[[4-chlor-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfophenyl)azo]-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoesyre;
  3,5-bis[[4-chlor-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoesyre | | 435-440-6 | — | Xi; R41 | Xi
  R: 41
  S: (2-)22-26-39 | | |
| 611-169-00-0 | natrium-5-(2-carboxyphenylazo)-6-hydroxynaphthalen-2-sulfonat | | 435-800-2 | — | R52-53 | R: 52/53
  S: 61 | | |
| 611-170-00-6 | blanding af: trinatrium-2-((1-(2-hydroxy-κ-O-5-(2-sulfonatoethansulfonyl)phenylazo-κ-N
  2)-1-phenylmethyl)azo-κ-N
  1)-4-sulfonatobenzoat(5-)-κ-O)cuprat(II);
  dinatrium-2-((1-(5-ethensulfonyl-2-hydroxy-κ-O-phenylazo-κ-N
  2)-1-phenylmethyl)azo-κ-N
  1)-4-sulfonatobenzoat-κ-O-(5-))cuprat(II) | | 435-880-9 | — | R52-53 | R: 52/53
  S: 22-61 | | |
| 611-171-00-1 | blanding af: trinatrium-3-(5-(2,6-difluorpyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-(4-fluor-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalendisulfonat;
  trinatrium-3-(5-(4,6-difluorpyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-(4-fluor-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalendisulfonat | | 436-890-6 | — | Xi; R41
  R52-53 | Xi
  R: 41-52/53
  S: (2-)22-26-39-61 | | |
| 611-172-00-7 | blanding af: triammonium-6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)phenyl)azo-4-hydroxy-2-naphthalensulfonat;
  diammonium-3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)azo)-2,5-diethoxyphenyl)azo)benzoat | | 438-310-7 | — | E; R2
  Repr. Cat. 3; R62
  Xn; R22-48/22
  R52-53 | E; Xn
  R: 2-22-48/22-62-52/53
  S: (2-)22-35-36/37-61 | | |
| 611-173-00-2 | blanding af: 3-[3-carbamoyl-5-(5-{4-chlor-6-[4-(2-sulfonatooxyethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propansyre, trinatriumsalt;
  3-[3-carbamoyl-5-(5-{4-chlor-6-[4-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propansyre, dinatriumsalt | | 440-510-4 | — | Xi; R41
  R43 | Xi
  R: 41-43
  S: (2-)22-26-36/37/39 | | |
| 611-174-00-8 | blanding af: 3-[5-(4-ethensulfonylbutyrylamino)-2-sulfophenylazo]-5-{4-chlor-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalen-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalen-2,7-disulfonsyre, natriumsalt;
  3-[5-(4-(2-chlorethansulfonyl)butyrylamino)-2-sulfophenylazo]-5-{4-chlor-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalen-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalen-2,7-disulfonsyre, natriumsalt | | 442-290-5 | 457624-86-1 | Xi; R41 | Xi
  R: 41
  S: (2-)22-26-39 | | |
| 611-175-00-3 | blanding af: trinatrium-5-{4-chlor-6-[N-ethyl-(3-(2-sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat;
  trinatrium-5-{4-chlor-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]naphthalen-2,7-disulfonat;
  dinatrium-5-{4-chlor-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[(4-vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat;
  tetranatrium-5-{4-chlor-6-[N-ethyl-3-(2-(sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]-4-hydroxynaphthalen-2,7-disulfonat | | 444-050-5 | — | Xi; R41
  R52-53 | Xi
  R: 41-52/53
  S: (2-)22-26-39-61 | | |
| 611-176-00-9 | 2,6-bis(2,3,4-trihydroxybenzyl)-p-cresol, ester med 6-diazo-5,6-dihydro-5-oxo-1-naphthalensulfonat | | 444-250-2 | — | E; R2
  F; R11
  N; R51-53 | E; N
  R: 2-11-51/53
  S: (2-)22-61 | | |
| 611-177-00-4 | blanding af: pentanatrium-bis[6-anilino-3,5′-disulfonatonaphthalen-2-azobenzen-1,2′-diolato]cobaltat(III);
  tetranatrium-[6-anilino-3,5′-disulfonatonaphthalen-2-azobenzen-1,2′-diolato][6-anilino-5′-sulfamoyl-3-sulfonatonaphthalen-2-azobenzen-1,2′-diolato]cobaltat(III);
  trinatrium-bis[6-anilino-5′-sulfamoyl-3-sulfonatonaphthalen-2-azobenzen-1,2′-diolato]cobaltat(III) | | 444-290-0 | 508202-43-5 | Xi; R41
  R43
  R52-53 | Xi
  R: 41-43-52/53
  S: (2-)22-24-26-37/39-61 | | |
| 611-178-00-X | blanding af: pentanatrium-4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalen-2,7-disulfonat;
  tetranatrium-4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat;
  tetranatrium-4-amino-5-hydroxy-6-[(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat;
  trinatrium-4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat;
  trinatrium-4-amino-5-hydroxy-3-[(2-hydroxyethylsulfonyl)-phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat;
  trinatrium-4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[2-sulfonato-4-(2-hydroxyethylsulfonyl)phenylazo]naphthalen-2,7-disulfonat | | 445-280-9 | — | Xi; R41
  R43
  R52-53 | Xi
  R: 41-43-52/53
  S: (2-)24-26-37/39-61 | | |
| 611-179-00-5 | blanding af: pentanatrium-2-[[8-[[4-chlor-6-[[4-(2-sulfonatoethylsulfonyl)]phenyl]amino]-1,3,5-triazin-2-yl]amino-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalen-1,5-disulfonat;
  2-[[8-[[4-chlor-6-[[4-[[2-ethenyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalen-1,5-disulfonat | | 450-010-8 | — | Xi; R41
  R43 | Xi
  R: 41-43
  S: (2-)22-24-26-37/39 | | |
| 611-180-00-0 | jern, komplekser med diazoteret 4-aminobenzensulfonamid, diazoteret 3-aminobenzensulfonsyre, diazoteret 3-amino-4-hydroxybenzensulfonamid,diazoteret 3-amino-4-hydroxy-N-phenylbenzensulfonamid, diazoteret 5-amino-2-(phenylamino)benzensulfonsyre og resorcinol, natriumsalte | | 417-850-7 | — | N; R51-53 | N
  R: 51/53
  S: 22-61 | | |
| 612-238-00-8 | (3-chlor-2-hydroxypropyl)trimethylammoniumchlorid ...% | B | 222-048-3 | 3327-22-8 | Carc. Cat. 3, R40
  R52-53 | Xn
  R: 40-52/53
  S: 36/37-61 | | |
| 612-239-00-3 | biphenyl-3,3′,4,4′-tetrayltetraamin;
  diaminobenzidin | | 202-110-6 | 91-95-2 | Carc. Cat. 2; R45
  Muta. Cat. 3; R68 | T
  R: 45-68
  S: 53-45 | | |
| 612-240-00-9 | pyrimethanil (ISO);

  N-(4,6-dimethylpyrimidin-2-yl)anilin | | — | 53112-28-0 | N; R51-53 | N
  R: 51/53
  S: 61 | | |
| 612-241-00-4 | piperazinhydrochlorid; [1]
  piperazindihydrochlorid; [2]
  piperazinphosphat [3] | | 228-042-7 [1]
  205-551-2 [2]
  217-775-8 [3] | 6094-40-2 [1]
  142-64-3 [2]
  1951-97-9 [3] | Repr. Cat. 3; R62-63
  Xi; R36/38
  R42/43
  R52-53 | Xn
  R: 36/38-42/43-62-63-52/53
  S: (1/2-)22-36/37-45-63-61 | | |
| 612-242-00-X | cyprodinil (ISO);
  4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amin | | — | 121552-61-2 | R43
  N; R50-53 | Xi; N
  R: 43-50/53
  S: (2-)24-37-46-60-61 | C ≥ 2,5 %: Xi, N; R43-50/53
  1 % ≤ C < 2,5 %: Xi, N; R43-51/53
  0,25 % ≤ C < 1 %: N; R51/53
  0,025 % ≤ C < 0,25 %: R52/53 | |
| 612-243-00-5 | (1S-cis)-4-(3,4-dichlorphenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamin-2-hydroxy-2-phenylacetat | | 420-560-3 | 79617-97-3 | Xi; R41
  N; R50-53 | Xi; N
  R: 41-50/53
  S: (2-)26-39-60-61 | C ≥ 10 %: Xi, N; R41-50/53
  5 % ≤ C < 10 %: Xi, N; R36-50/53
  2,5 % ≤ C < 5 %: N; R50/53
  0,25 % ≤ C < 2, 5 %: N; R51/53
  0,025 % ≤ C < 0,25 %: R52/53 | |
| 612-244-00-0 | 3-(piperazin-1-yl)-benzo[d]isothiazolhydrochlorid | | 421-310-6 | 87691-88-1 | Repr. Cat. 3; R62
  Xn; R22
  Xi; R36
  R43
  N; R50-53 | Xn; N
  R: 22-36-43-62-50/53
  S: (2-)22-26-36/37/39-60-61 | | |
| 612-245-00-6 | 2-ethylphenylhydrazinhydrochlorid | | 421-460-2 | 19398-06-2 | Carc. Cat. 3; R40
  T; R48/25
  Xn; R22
  Xi; R41
  R43
  N; R50-53 | T; N
  R: 22-40-41-43-48/25-50/53
  S: (1/2-)22-26-36/37/39-45-60-61 | C ≥ 25 %: T, N; R22-40-41-43-48/25-50/53
  10 % ≤ C < 25 %: T, N; R40-41-43-48/25-50/53
  5 % ≤ C < 10 %: Xn, N; R36-40-43-48/22-50/53
  2,5 % ≤ C < 5 %: Xn, N; R40-43-48/22-50/53
  1 % ≤ C < 2,5 %: Xn, N; R40-43-48/22-51/53
  0,25 % ≤ C < 1 %: N; R51/53
  0,025 % ≤ C < 0,25 %: R52/53 | |
| 612-246-00-1 | (2-chlorethyl)(3-hydroxypropyl)ammoniumchlorid | E | 429-740-6 | 40722-80-3 | Carc. Cat. 2; R45
  Muta. Cat. 2; R46
  Xn; R48/22
  R43
  R52-53 | T
  R: 45-46-43-48/22-52/53
  S: 53-45-61 | | |
| 612-247-00-7 | N-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N′-hydroxy-4-nitrobenzencarboximidamid | | 423-530-8 | 152828-23-4 | T; R48/25
  Xn; R22
  R52-53 | T
  R: 22-48/25-52/53
  S: (1/2-)22-36-45-61 | | |
| 612-248-00-2 | reaktionsprodukt af diphenylamin, phenothiazin og alkener, forgrenede (C8-10, C9-rige) | | 439-540-0 | — | Xi; R38
  R43
  R53 | Xi
  R: 38-43-53
  S: (2-)24-37-61 | | |
| 612-249-00-8 | 4-[(3-chlorphenyl)(1H-imidazol-1-yl)methyl]-1,2-benzendiamindihydrochlorid | | 425-030-5 | 159939-85-2 | Repr. Cat. 3; R62
  Xn; R22
  C; R34
  R43
  N; R51-53 | C; N
  R: 22-34-43-62-51/53
  S: (1/2-)22-26-36/37/39-45-61 | | |
| 612-250-00-3 | chlor-N,N-dimethylformiminiumchlorid | E | 425-970-6 | 3724-43-4 | R14
  Repr. Cat. 2; R61
  Xn; R22
  C; R35 | T; C
  R: 61-14-22-35
  S: 53-45 | | |
| 612-251-00-9 | cis-1-(3-chlorallyl)-3,5,7-triaza-1-azoniaadamantanchlorid | | 426-020-3 | 51229-78-8 | F; R11
  Repr. Cat. 3; R63
  Xn; R22
  Xi; R38
  R43
  N; R51-53 | F; Xn; N
  R: 11-22-38-43-63-51/53
  S: (2-)7-22-33-36/37-61 | | |
| 612-252-00-4 | imidacloprid (ISO);
  1-(6-chlorpyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamin | | 428-040-8 | 138261-41-3 | Xn; R22
  N; R50-53 | Xn; N
  R: 22-50/53
  S: (2-)22-57-60-61 | | |
| 612-253-00-X | 7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-on;
  [indeholdende < 0,5 % formamid (EF-nr. 200-842-0)] | | 429-400-7 | 199327-61-2 | R52-53 | R: R52/53
  S: 61 | | |
| 612-253-01-7 | 7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-on;
  [indeholdende ≥ 0,5 % formamid (EF-nr. 200-842-0) ] | | 429-400-7 | 199327-61-2 | Repr. Cat. 2; R61
  R52-53 | T
  R: 61-52/53
  S: 53-45-61 | | |
| 612-254-00-5 | reaktionsprodukter af diisopropanolamin med formaldehyd (1:4) | | 432-440-8 | 220444-73-5 | Carc. Cat. 3; R40
  Xn; R22
  C; R34
  R43
  N; R51-53 | C; N
  R: 22-34-40-43-51/53
  S: (1/2-)13-25-26-36/37/39-45-61 | | |
| 612-255-00-0 | 1-(3-methoxypropyl)-4-piperidinamin | | 431-950-8 | 179474-79-4 | Xn; R21/22
  C; R34
  R52-53 | C
  R: 21/22-34-52/53
  S: (1/2-)26-36/37/39-45-61 | | |
| 612-256-00-6 | benzyl(S)-2-[(2′-cyanbiphenyl-4-ylmethyl)pentanoylamino]-3-methylbutyrat | | 427-470-3 | 137864-22-3 | Xn; R22
  R43 | Xn
  R: 22-43
  S: (2-)36/37 | | |
| 612-257-00-1 | tripropylammoniumdihydrogenphosphat | | 433-700-3 | 35687-90-2 | Xn; R22 | Xn
  R: 22
  S: (2-)22 | | |
| 612-259-00-2 | N-ethyl-3-trimethoxysilyl-2-methyl-propanamin | | 437-720-3 | 227085-51-0 | Xi; R41 | Xi
  R: 41
  S: (2-)26-39 | | |
| 612-261-00-3 | 3,5-dichlor-2-fluor-4-(1,1,2,3,3,3-hexafluorpropoxy)anilin | | 441-190-9 | 121451-05-6 | Xn; R22
  R43
  N; R50-53 | Xn; N
  R: 22-43-50/53
  S: (2-)24-37-60-61 | C ≥ 25 %: Xn, N; R22-43-50/53
  2,5 % ≤ C < 25 %: Xi, N; R43-50/53
  1 % ≤ C < 2,5 %: Xi, N; R43-51/53
  0,25 % ≤ C < 1 %: N; R51/53
  0,025 % ≤ C < 0,25 %: R52/53 | |
| 612-265-00-5 | bis(2-hydroxyethyl)-(2-hydroxypropyl)ammoniumacetat | | 444-360-0 | 191617-13-7 | R52-53 | R: 52/53
  S: 61 | | |
| 612-266-00-0 | 3-chlor-4-(3-fluorbenzyloxy)anilin | | 445-590-4 | 202197-26-0 | Muta. Cat. 3; R68
  Xn; R22-48/22
  N; R50-53 | Xn; N
  R: 22-48/22-68-50/53
  S: (2-)22-36/37-60-61 | | |
| 612-267-00-6 | bis(hydrogeneret C16-18-talgalkyl)hydroxylamin | | 418-370-0 | — | R43
  R53 | Xi
  R: 43-53
  S: (2-)36/37-61 | | |
| 612-269-00-7 | blanding af: 1-[di(4-octylphenyl)aminomethyl]-5-methyl-1H-benzotriazol;
  1-[di(4-octylphenyl)aminomethyl]-4-methyl-1H-benzotriazol;
  blanding af: N-[(5-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)anilin;

  N-[(4-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)anilin | | 420-720-2 | — | R53 | R: 53
  S: 22-61 | | |
| 612-270-00-2 | (S)-azetidin-2-carboxylsyre-4-cyanbenzylamidhydrochlorid | | 433-010-2 | — | Xn; R22
  R43
  R52-53 | Xn
  R: 22-43-52/53
  S: (2-)22-36/37-61 | | |
| 612-271-00-8 | blanding af: ethyl-2-((4-(5,6-dichlorbenzothiazol-2-ylazo)phenyl)ethylamino)benzoat;
  ethyl-2-((4-(6,7-dichlorbenzothiazol-2-ylazo)phenyl)ethylamino)benzoat | | 434-970-5 | 160987-57-5 | R53 | R: 53
  S: 61 | | |
| 612-272-00-3 | ammonium-(η-6-2-(2-(1,2-dicarboxylatoethylamino)ethylamino)butan-1,4-dioato(4-))jern(3+)monohydrat | | 435-210-5 | — | N; R51-53 | N
  R: 51/53
  S: 61 | | |
| 612-273-00-9 | alkyl(rapsolie), bis(2-hydroxyethyl)ammoniumfluorid | | 435-650-8 | — | Xn; R22
  C; R35
  N; R50-53 | C; N
  R: 22-35-50/53
  S: (1/2-)26-36/37/39-45-60-61 | | |
| 612-274-00-4 | (R,S)-1-[2-amino-1(4-methoxyphenyl)ethyl]cyclohexanolacetat | | 445-750-3 | — | Xn; R22
  Xi; R41
  R43
  R52-53 | Xn
  R: 22-41-43-52/53
  S: (2-)22-24-26-37/39-61 | | |
| 612-275-00-X | fedtsyrer, C18-umættede, dimerer, reaktionsprodukter med 1-piperazinethanamin og tallolie | | 447-880-6 | 206565-89-1 | Xi; R38-41
  R43
  N; R50-53 | Xi; N
  R: 38-41-43-50/53
  S: (2-)23-26-36/37/39-60-61 | C ≥ 20 %: Xi, N; R38-41-43-50/53
  10 % ≤ C < 20 %: Xi, N; R41-43-50/53
  5 % ≤ C < 10 %: Xi, N; R36-43-50/53
  2,5 % ≤ C < 5 %: Xi, N; R43-50/53
  1 % ≤ C < 2,5 %: Xi, N; R43-51/53
  0,25 % ≤ C < 1 %: N; R51/53
  0,025 % ≤ C < 0,25 %: R52/53 | |
| 612-276-00-5 | 1-amino-4-[(4-amino-2-sulfophenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracensulfonsyre, dinatriumsalt, reaktionsprodukter med 2-[[3-[(4,6-dichlor-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethylhydrogensulfat, natriumsalte | | 451-430-4 | 500717-36-2 | Xi; R41
  R43
  R52-53 | Xi
  R: 41-43-52/53
  S: (2-)22-24-26-36/37/39-61 | | |
| 612-277-00-0 | blanding af: 4-amino-3-(4-ethensulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{4-chlor-6-[4-(2-sulfonatooxyethansulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)naphthalen-2,7-disulfonat kalium/natrium;
  4-amino-5-hydroxy-6-(5-{4-chlor-6-[4-(2-sulfonatooxyethansulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethansulfonyl)phenylazo)naphthalen-2,7-disulfonat kalium/natrium | | 451-440-9 | 586372-44-3 | Xi; R41 | Xi
  R: 41
  S: (2-)22-26-39 | | |
| 612-278-00-6 | ethidiumbromid;
  3,8-diamino-1-ethyl-6-phenylphenantridiniumbromid | | 214-984-6 | 1239-45-8 | Muta. Cat. 3; R68
  T+; R26
  Xn; R22 | T+
  R: 22-26-68
  S: (1/2-)28-36/37-45-63 | | |
| 612-279-00-1 | (R,S)-2-amino-3,3-dimethylbutanamid | | 447-860-7 | 144177-62-8 | Repr. Cat. 3; R62
  Xn; R48/22
  Xi; R36/38
  R43 | Xn
  R: 36/38-43-48/22-62
  S: (2-)22-26-36/37 | | |
| 612-280-00-7 | 3-amino-9-ethylcarbazol;
  9-ethylcarbazol-3-ylamin | H | 205-057-7 | 132-32-1 | Carc. Cat. 2; R45 | T
  R: 45
  S: 53-45 | | |
| 613-116-01-4 | tolylfluanid (ISO);
  dichlor-N-[(dimethylamino)sulfonyl]fluor-N-(p-tolyl)methansulfenamid;
  [indeholdende < 0,1 % (w/w) partikler med en aerodynamisk diameter på mindre end 50 μm] | | 211-986-9 | 731-27-1 | Xi; R36/37/38
  R43
  N; R50 | Xi; N
  R: 36/37/38-43-50
  S: (2-)25-36/37-46-61 | C ≥ 20 %: Xi, N; R36/37/38-43-50
  2,5 % ≤ C < 20 %: Xi, N; R43-50
  1 % ≤ C < 2,5 %: Xi; R43 | |
| 613-280-00-X | tetrahydro-1,3-dimethyl-1H-pyrimidin-2-on;
  dimethylpropylenurinstof | | 230-625-6 | 7226-23-5 | Repr. Cat. 3; R62
  Xn; R22
  Xi; R41 | Xn
  R: 22-41-62
  S: 26-36/37/39 | | |
| 613-281-00-5 | quinolin | E | 202-051-6 | 91-22-5 | Carc. Cat. 2; R45
  Muta. Cat. 3; R68
  Xn; R21/22
  Xi; R36/38
  N; R51-53 | T; N
  R: 45-21/22-36/38-68-51/53
  S: 53-45-61 | | |
| 613-282-00-0 | triticonazol (ISO);
  (RS)-(E)-5-(4-chlorbenzyliden)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol | | — | 131983-72-7 | N; R51-53 | N
  R: 51/53
  S: 61 | | |
| 613-283-00-6 | ketoconazol;
  1-[4-[4-[[(2SR,4RS)-2-(2,4-dichlorphenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanon | E | 265-667-4 | 65277-42-1 | Repr. Cat. 2; R60
  T; R25
  Xn; R48/22
  N; R50-53 | T; N
  R: 60-25-48/22-50/53
  S: 53-45-60-61 | | |
| 613-284-00-1 | metconazol (ISO);
  (1RS,5RS;1RS,5SR)-5-(4-chlorbenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol | | — | 125116-23-6 | Repr. Cat. 3; R63
  Xn; R22
  N; R51-53 | Xn; N
  R: 22-63-51/53
  S: (2-)36/37-46-61 | | |
| 613-285-00-7 | 1-hydroxybenzotriazol, vandfri; [1]
  1-hydroxybenzotriazol, monohydrat [2] | | 219-989-7 [1]
  219-989-7 [2] | 2592-95-2 [1]
  123333-53-9 [2] | E; R2 | E
  R: 2
  S: 16-35 | | |
| 613-286-00-2 | kalium-1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-yliden)-1-propenyl]pyrazol-5-olat;
  [indeholdende < 0,5 % N,N-dimethylformamid (EF-nr. 200-679-5)] | | 418-260-2 | 183196-57-8 | R43 | Xi
  R: 43
  S: (2-)24-37 | | |
| 613-286-01-X | kalium-1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-yliden)-1-propenyl]pyrazol-5-olat;
  [indeholdende ≥ 0,5 % N,N -dimethylformamid (EF-nr. 200-679-5)] | | 418-260-2 | 183196-57-8 | Repr. Cat. 2; R61
  R43 | T
  R: 61-43
  S: 53-45 | | |
| 613-287-00-8 | 1-(3-iod-4-aminobenzyl)-1H-1,2,4-triazol | | 419-540-7 | 160194-26-3 | Xn; R22
  R43
  N; R51-53 | Xn; N
  R: 22-43-51/53
  S: (2-)24-37-61 | | |
| 613-288-00-3 | 1,3-bis(dimethylcarbamoyl)-imidazoliumchlorid | | 420-930-4 | 135756-61-5 | Xn; R22
  Xi; R41
  R52-53 | Xn
  R: 22-41-52/53
  S: (2-)22-26-37/39-61 | | |
| 613-289-00-9 | 3-(4-chlor-2-fluor-5-methylphenyl)-1-methyl-5-(trifluormethyl)-1H-pyrazol | | 432-020-4 | 142623-48-1 | N; R50-53 | N
  R: 50/53
  S: 60-61 | | |
| 613-290-00-4 | 4-hydroxy-7-(2-aminoethyl)-1,3-benzothiazol-2(3H)-onhydrochlorid | | 432-470-1 | 189012-93-9 | Xi; R41
  R43
  N; R50-53 | Xi; N
  R: 41-43-50/53
  S: (2-)24-26-37/39-60-61 | | |
| 613-291-00-X | 2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3H-1,2,4-triazol-3-on | | 434-820-9 | 106461-41-0 | Xn; R48/22
  N; R50-53 | Xn; N
  R: 48/22-50/53
  S: (2-)22-36-60-61 | | |
| 613-292-00-5 | N,N′,N′′-tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazin | | 435-010-8 | 26157-73-3 | Muta. Cat. 3; R68
  R52-53 | Xn
  R: 68-52/53
  S: (2-)36/37-61 | | |
| 613-293-00-0 | 2-(4-tert-butylphenyl)-6-cyan-5-[bis(ethoxycarbonylmethyl)carbamoyloxy]-1H-pyrrolo[1,2-b][1,2,4] triazol-7-carboxylsyre-2,6-di-tert-butyl-4-methylcyclohexylester | | 448-050-6 | 444065-11-6 | R53 | R: 53
  S: 61 | | |
| 613-294-00-6 | 2-hexyldecansyre-[4-(6-tert-butyl-7-chlor-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenylcarbamoyl]methylester | | 448-260-8 | 379268-96-9 | R53 | R: 53
  S: 61 | | |
| 613-295-00-1 | 11-amino-3-chlor-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]thiazepinhydrochlorid | | 448-720-8 | 363138-44-7 | Xn; R22
  Xi; R41
  R52-53 | Xn
  R: 22-41-52/53
  S: (2-)22-26-39-61 | | |
| 613-296-00-7 | pentakalium-2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-yliden]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1-yl)benzen-1,4-disulfonat | | 418-270-7 | — | R43
  R52-53 | Xi
  R: 43-52/53
  S: (2-)24-37-47-61 | | |
| 613-297-00-2 | 5-(2-bromphenyl)-2-tert-butyl-2H-tetrazol | | 420-820-6 | — | R10
  Xn; R22
  N; R51-53 | Xn; N
  R: 10-22-51/53
  S: (2-)16-61 | | |
| 613-298-00-8 | bis-(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-phenylazo)-1H-pyridin-2-on)ethylendilactat | | 421-560-6 | — | Xn; R48/22
  Xi; R41
  N; R51-53 | Xn; N
  R: 41-48/22-51/53
  S: (2-)22-26-36/39-61 | | |
| 613-299-00-3 | hovedkomponent 1 (isomer 1): 2-{6-fluor-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonapht-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluor-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}propan natriumsalt;
  hovedkomponent 1 (isomer 2): 2-{6-fluor-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluor-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}propan natriumsalt;
  hovedkomponent 2: 2,3-bis-{6-fluor-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}propan natriumsalt;
  hovedkomponent 3: 2,3-bis-{6-fluor-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}propan natriumsalt | | 422-610-1 | — | Xi; R41 | Xi
  R: 41
  S: (2-)22-26-39 | | |
| 613-300-00-7 | 1-imidazol-1-yl-octadecan-2-ol | | 434-120-3 | — | R43
  R53 | Xi
  R: 43-53
  S: (2-)24-37-61 | | |
| 613-301-00-2 | dimethyl-1-{[2-methoxy-5-(2-methyl-butoxycarbonyl)phenylcarbamoyl]-[2-octadecyl-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]methyl}imidazol-4,5-dicarboxylat | | 443-910-7 | — | R53 | R: 53
  S: 61 | | |
| 613-302-00-8 | dinatrium-2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydro-pyridin-3-ylazo)-4-(4-fluor-6-(4-(2-sulfonyloxy-ethylsulfonyl)-phenylamino)-1,3,5-triazin-2-ylamino)benzensulfonat | | 432-980-4 | 243858-60-8 | Xi; R41 | Xi
  R: 41
  S: (2-)22-26-39 | | |
| 613-303-00-3 | 2-(1-methyl-2-(4-phenoxyphenoxy)ethoxy)pyridin | | 429-800-1 | 95737-68-1 | N; R50-53 | N
  R: 50/53
  S: 60-61 | | |
| 613-304-00-9 | 5,6-dihydroxy-2,3-dihydro-1H-indoliumbromid | | 421-170-6 | 138937-28-7 | Xn; R22
  Xi; R41 | Xn
  R: 22-41
  S: (2-)22-26-39 | | |
| 613-305-00-4 | 2-(2-hydroxy-4-octyloxyphenyl)-2H-benzotriazol | | 448-630-9 | 3147-77-1 | R53 | R: 53
  S: 61 | | |
| 613-306-00-X | (2,5-dioxopyrrolidin-1-yl)-9H-fluoren-9-ylmethylcarbonat | | 433-520-5 | 82911-69-1 | Xn; R22
  R43
  N; R51-53 | Xn; N
  R: 22-43-51/53
  S: (2-)24-37-61 | | |
| 613-307-00-5 | clothianidin (ISO);
  3-[(2-chlor-1,3-thiazol-5-yl)methyl]-2-methyl-1-nitroguanidin | | — | 210880-92-5 | Xn; R22
  N; R50-53 | Xn; N
  R: 22-50/53
  S: (2-)46-60-61 | C ≥ 25 %: Xn, N; R22-50/53
  2,5 % ≤ C < 25 %: N; R50/53
  0,25 % ≤ C < 2,5 %: N; R51/53
  0,025 % ≤ C < 0,25 %: R52/53 | |
| 613-308-00-0 | 2-amino-5-methylthiazol | | 423-800-5 | 7305-71-7 | Xn; R22-48/22
  N; R50-53 | Xn; N
  R: 22-48/22-50/53
  S: (2-)22-36-60-61 | | |
| 613-309-00-6 | 1-methyl-3-phenyl-1-piperazin | | 431-180-2 | 5271-27-2 | Xn; R21/22
  Xi; R38-41
  R52-53 | Xn
  R: 21/22-38-41-52/53
  S: (2-)26-36/37/39-61 | | |
| 613-310-00-1 | (-)(3S,4R)-4-(4-fluorphenyl)-3-(3,4-methylendioxy-phenoxymethyl)-N-benzylpiperidinhydrochlorid | | 432-360-3 | 105813-13-6 | Xn; R22
  R43
  N; R50-53 | Xn; N
  R: 22-43-50/53
  S: (2-)22-24-37-60-61 | | |
| 613-311-00-7 | methyl-5-nitrophenyl-guanidin | | 435-500-1 | 152460-07-6 | Xn; R22
  Xi; R36
  R43
  R52-53 | Xn
  R: 22-36-43-52/53
  S: (2-)22-24-26-37-61 | | |
| 613-312-00-2 | 2-(4-methyl-2-phenyl-1-piperazinyl)benzenmethanolmonohydrochlorid | | 420-200-5 | — | Xn; R22
  Xi; R41
  R43
  R52-53 | Xn
  R: 22-41-43-52/53
  S: (2-)22-26-36/37/39-61 | | |
| 613-313-00-8 | 2-(4-(4-(3-pyridinyl)-1H-imidazol-1-yl)butyl)-1H-isoindol-1,3(2H)-dion | | 442-780-9 | 173838-67-0 | R52-53 | R: 52/53
  S: 61 | | |
| 613-314-00-3 | 4-decyloxazolidin-2-on;
  4-decyl-1,3-oxazolidin-2-on | | 443-770-7 | 7693-82-5 | N; R50-53 | N
  R: 50/53
  S: 22-24-60-61 | | |
| 613-315-00-9 | tetrakalium-4-[5-[3-carboxylato-4,5-dihydro-5-oxo-1-(4-sulfonatophenyl)pyrazol-4-yliden]-3-(piperidinocarbonyl)penta-1,3-dienyliden]-5-hydroxy-1-(4-sulfonatophenyl)pyrazol-3-carboxylat | | 430-390-1 | — | Xn; R20
  R52-53 | Xn
  R: 20-52/53
  S: (2-)25-61 | | |
| 613-316-00-4 | trimethylopropan-tri(3-aziridinylpropanoat);
  (TAZ) | H | 257-765-0 | 52234-82-9 | Muta. Cat. 3; R68
  Xi; R41
  R43 | Xn
  R: 41-43-68
  S: 26-36/37/39-42 | | |
| 615-044-00-1 | 4-chlorphenylisocyanat | | 203-176-9 | 104-12-1 | T+; R26
  Xn; R22
  Xi; R37/38-41
  R42
  N; R50-53 | T+; N
  R: 22-26-37/38-41-42-50/53
  S: (1/2-)26-28-36/37/39-45-63-60-61 | | |
| 615-045-00-7 | 4,4′-methylen-bis(3-chlor-2,6-di-ethylphenylisocyanat) | | 420-530-1 | — | R42/43
  R53 | Xn
  R: 42/43-53
  S: (2-)23-24-37-45-61 | | |
| 616-126-00-X | 1-methyl-4-nitro-3-propyl-1H-pyrazol-5-carboxamid | | 423-960-6 | 139756-01-7 | Xn; R22-48/22
  R52-53 | Xn
  R: 22-48/22-52/53
  S: (2-)22-36/37-61 | | |
| 616-164-00-7 | dimoxystrobin (ISO);
  (E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamid | | — | 149961-52-4 | Carc. Cat. 3; R40
  Repr. Cat. 3; R63
  Xn; R20
  N; R50-53 | Xn; N
  R: 20-40-63-50/53
  S: (2-)36/37-46-60-61 | C ≥ 25 %: Xn, N; R20-40-63-50/53
  5 % ≤ C < 25 %: Xn, N; R40-63-50/53
  2,5 % ≤ C < 5 %: Xn, N; R40-50/53
  1 % ≤ C < 2,5 %: Xn, N; R40-51/53
  0,25 % ≤ C < 1 %: N; R51/53
  0,025 % ≤ C < 0,25 %: R52-53 | |
| 616-165-00-2 | beflubutamid (ISO);
  (RS)-N-benzyl-2-(α,α,α,4-tetrafluor-m-tolyoxy)butyramid | | — | 113614-08-7 | N; R50-53 | N
  R: 50/53
  S: 60-61 | C ≥ 0,25 %: N; R50/53
  0,025 % ≤ C < 0,25 %: N; R51/53
  0,0025 % ≤ C < 0,025 %: R52/53 | |
| 616-166-00-8 | cyazofamid (ISO);
  4-chlor-2-cyan-N,N-dimethyl-5-p-tolylimidazol-1-sulfonamid | | — | 120116-88-3 | N; R50-53 | N
  R: 50/53
  S: 60-61 | C ≥ 2,5 %: N; R50/53
  0,25 % ≤ C < 2,5 %: N; R51-53
  0,025 % ≤ C < 0,25 %: R52/53 | |
| 616-167-00-3 | N,N-dibutyl-(2,5-dihydro-5-thioxo-1H-tetrazol-1-yl)acetamid | | 418-290-6 | 168612-06-4 | Xi; R36
  R43 | Xi
  R: 36-43
  S: (2-)24-26-37 | | |
| 616-168-00-9 | 1-dimethylcarbamoyl-4-(2-sulfonatoethyl)pyridinium | | 418-440-0 | 136997-71-2 | R43 | Xi
  R: 43
  S: (2-)22-24-37 | | |
| 616-169-00-4 | 4-[4-(2,2-dimethyl-propanamido)]phenylazo-3-(2-chlor-5-(2-(3-pentadecylphenoxy)butylamido)anilino)-1-(2,4,6-trichlorphenyl)-2-pyrazolin-5-on | | 420-220-4 | 92771-56-7 | R43
  R53 | Xi
  R: 43-53
  S: (2-)24-37-61 | | |
| 616-170-00-X | (2R)-2-amino-2-phenylacetamid | | 420-370-0 | 6485-67-2 | Xi; R36
  R43 | Xi
  R: 36-43
  S: (2-)22-26-36/37 | | |
| 616-171-00-5 | 2-(p-chlorphenyl)glycinamid | | 420-830-0 | 102333-75-5 | Xi; R41
  R43 | Xi
  R: 41-43
  S: (2-)24-26-37/39 | | |
| 616-172-00-0 | N-(2,2,6,6,-tetramethyl-1-oxylpiperidin-4-yl)acetamid;
  (4-acetamido-2,2,6,6-tetramethyl-1-piperidinyl)oxidanyl | | 423-840-3 | 14691-89-5 | Xn; R22 | Xn
  R: 22
  S: (2-)22 | | |
| 616-174-00-1 | 2-butyl-1,3-diazaspiro[4.4]non-1-en-4-onhydrochlorid | | 424-560-4 | 151257-01-1 | Xn; R22
  Xi; R36 | Xn
  R: 22-36
  S: (2-)22-26 | | |
| 616-175-00-7 | 2-(2-hexyldecyloxy)benzamid | | 431-230-3 | 202483-62-3 | R53 | R: 53
  S: 61 | | |
| 616-176-00-2 | 3-N,N-bis(methoxyethyl)aminoacetanilid | | 432-530-7 | 24294-01-7 | Xn; R22
  R52-53 | Xn
  R: 22-52/53
  S: (2-)22-24-61 | | |
| 616-177-00-8 | (3-(4-(2-(butyl-(4-methylphenylsulfonyl)-amino)-phenylthio)-5-oxo-1-(2,4,6-trichlorphenyl)-4,5-dihydro-1H-pyrazol-3-ylamino)-4-chlorphenyl)tetradecanamid;

  N-[3-({4-[(2-{butyl[(4-methylphenyl)sulfonyl]amino}phenyl)thio]-5-oxo-1-(2,4,6-trichlorphenyl)-4,5-dihydro-1H-pyrazol-3-yl}amino)-4-chlorphenyl]tetradecanamid | | 432-970-1 | 217324-98-6 | R53 | R: 53
  S: 61 | | |
| 616-178-00-3 | N-(5-(bis(2-methoxyethyl)amino)-2-((2-cyan-4,6-dinitrophenyl)azo)phenyl)acetamid | | 434-500-9 | 52583-35-4 | R53 | R: 53
  S: 22-61 | | |
| 616-179-00-9 | 2-chlor-N-(4-methylphenyl)acetamid | | 435-170-9 | 16634-82-5 | Xi; R41
  R43
  N; R50-53 | Xi; N
  R: 41-43-50/53
  S: (2-)22-26-36/37/39-60-61 | | |
| 616-180-00-4 | N,N-(dimethylamino)thioacetamidhydrochlorid | | 435-470-1 | 27366-72-9 | Repr. Cat. 2; R61
  N; R50-53 | T; N
  R: 61-50/53
  S: 53-45-60-61 | | |
| 616-181-00-X | 4′-methyldodecan-1-sulfonanilid | | 435-490-9 | 17417-32-2 | N; R50-53 | N
  R: 50/53
  S: 60-61 | | |
| 616-182-00-5 | N′-(1,3-dimethylbutyliden)-3-hydroxy-2-naphthohydrazid | | 435-860-1 | 214417-91-1 | R43
  N; R51-53 | Xi; N
  R: 43-51/53
  S: (2-)24-37-61 | | |
| 616-183-00-0 | N-dodecyl-4-methoxybenzamid | | 442-340-6 | 1854-15-5 | R53 | R: 53
  S: 61 | | |
| 616-184-00-6 | 3-methyl-N-(5,8,13,14-tetrahydro-5,8,14-trioxonaphth[2,3-c]acridin-6-yl)benzamid | | 442-560-2 | 105043-55-8 | R53 | R: 53
  S: 61 | | |
| 616-186-00-7 | N,N′-(2-chlor-1,4-phenylen)bis(3-oxobutanamid) | | 443-010-4 | 53641-10-4 | R52-53 | R: 52/53
  S: 61 | | |
| 616-188-00-8 | 2-(5,5-dimethyl-2,4-dioxooxazolidin-3-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-octadecanoylaminophenyl)pentansyreamid | | 443-980-9 | 221215-20-9 | R43
  R53 | Xi
  R: 43-53
  S: (2-)24-37-61 | | |
| 616-189-00-3 | N-[5-(bis-(2-methoxy-ethyl)-amino]-2-(6-brom-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-phenyl]acetamid | | 444-780-4 | 452962-97-9 | R53 | R: 53
  S: 61 | | |
| 616-190-00-9 | N-decyl-4-nitrobenzamid | | 445-880-0 | 64026-19-3 | R53 | R: 53
  S: 61 | | |
| 616-191-00-4 | 2-ethyl-N-methyl-N-(3-methylphenyl)butanamid | | 446-190-2 | 406488-30-0 | Xn; R22
  Xi; R36/38
  R43
  N; R51-53 | Xn; N
  R: 22-36/38-43-51/53
  S: (2-)24-26-37-61 | | |
| 616-192-00-X | 2-[2-(3-butoxypropyl)-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]-5′-tert-butyl-2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-2′-[(2-ethylhexyl)thio]acetanilid | | 448-060-0 | 727678-39-9 | R53 | R: 53
  S: 61 | | |
| 616-193-00-5 | N-[2-(2-butyl-4,6-dicyan-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-5-diethylamino-phenyl]acetamid | | 449-940-7 | 368450-39-9 | R53 | R: 53
  S: 61 | | |
| 616-194-00-0 | 2,2-diethoxy-N,N-dimethylacetamid | | 449-950-1 | 34640-92-1 | Xi; R36 | Xi
  R: 36
  S: (2-)26 | | |
| 616-196-00-1 | dinatriumsalt af 1-hydroxy-4-(β-(4-(1-hydroxy-3,6-disulfo-8-acetylamino-2-naphthylazo)phenoxy)ethoxy)-N-dodecyl-2-naphthamid | | 419-990-4 | — | N; R50-53 | N
  R: 50/53
  S: 60-61 | | |
| 616-197-00-7 | blanding af: kalium-N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoroctansulfonamidat;

  N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoroctansulfonamid | | 422-500-1 | — | Xn; R48/22 | Xn
  R: 48/22
  S: (2-)22-36 | | |
| 616-198-00-2 | 1,3-bis[12-hydroxy-octadecamid-N-methylen]benzen | | 423-300-7 | — | R43
  R53 | Xi
  R: 43-53
  S: (2-)24-37-61 | | |
| 616-200-00-1 | blanding af: N,N′-ethan-1,2-diylbis(hexanamid);
  12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamid;

  N,N′-ethan-1,2-diylbis(12-hydroxyoctadecanamid) | | 432-430-3 | — | R43
  R53 | Xi
  R: 43-53
  S: (2-)24-37-61 | | |
| 616-201-00-7 | 12-hydroxyoctadecansyre, reaktionsprodukter med 1,3-benzendimethanamin og hexamethylendiamin | | 432-840-2 | 220926-97-6 | Xn; R20
  R53 | Xn
  R: 20-53
  S: (2-)22-61 | | |
| 616-202-00-2 | blanding af: 2,2′-[(3,3′-dichlor[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)]-3-oxo-butanamid;
  2-[[3,3′-dichlor-4′-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′-biphenyl]-4-yl]azo]-N-(2-methylphenyl)-3-oxo-butanamid;
  2-[[3,3′-dichlor-4′-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′-biphenyl]-4-yl]azo]-N-(2-carboxylphenyl)-3-oxo-butanamid | | 434-330-5 | — | Carc. Cat. 3; R40
  R43
  R53 | Xn
  R: 40-43-53
  S: (2-)36/37-61 | | |
| 616-203-00-8 | blanding af: N-[5-[bis-(2-methoxy-ethyl)-amino]-2-(2-butyl-4,6-dicyan-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl-azo)-phenyl]-acetamid;

  N-[2-(2-butyl-4,6-dicyan-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-5-diethylamino-phenyl]-acetamid | | 442-280-0 | — | R53 | R: 53
  S: 61 | | |
| 616-204-00-3 | N,N′′-(methylendi-4,1-phenylen)bis[N′-octylurinstof] | | 451-060-3 | 122886-55-9 | R53 | R: 53
  S: 61 | | |
| 617-022-00-7 | blanding af: 1,2-dimethylpropylidendihydroperoxid;
  dimethyl-1,2-benzendicarboxylat | | 442-480-8 | — | O; R7
  Xn; R22
  C; R34
  R43
  N; R51-53 | O; C; N
  R: 7-22-34-43-51/53
  S: (1/2-)3/7-14-26-36/37/39-45-50-61 | | |
| 647-017-00-5 | laccase | | 420-150-4 | 80498-15-3 | R42 | Xn
  R: 42
  S: (2-)23-45 | | |

Indeks nr.

Kemisk navn

Noter vedrørende stoffer

EF-nr.

CAS-nr.

Klassificering

Etikettering

Koncentrationsgrænser

Noter vedrørende tilberedninger

003-003-00-5

(2-methylpropyl)lithium;

isobutyllithium

440-620-2

920-36-5

F; R15-17

R14

C; R35

R67

N; R50-53

F; C; N

R: 14/15-17-35-67-50/53

S: (1/2-)6-16-26-30-33-36/37/39-43-45-60-61

005-013-00-5

diethylmethoxyboran

425-380-9

7397-46-8

F; R17

Xn; R20/21/22-48/22

C; R34

R43

R53

F; C

R: 17-20/21/22-34-43-48/22-53

S: (1/2-)6-26-36/37/39-43-45-61

005-014-00-0

4-formylphenylboronsyre

438-670-5

87199-17-5

R43

Xi

R: 43

S: (2-)24-37

005-017-00-7

natriumperborat; [1]

perborsyre, natriumsalt; [2]

perborsyre, natriumsalt, monohydrat; [3]

natriumperoxometaborat; [4]

perborsyre (HBO(O2)), natriumsalt, monohydrat; [5]

natriumperoxoborat;

[indeholdende < 0,1 % (w/w) partikler med en aerodynamisk diameter på mindre end 50 μm]

E

239-172-9 [1]

234-390-0 [2]

- [3]

231-556-4 [4]

- [5]

15120-21-5 [1]

11138-47-9 [2]

12040-72-1 [3]

7632-04-4 [4]

10332-33-9 [5]

O; R8

Repr. Cat. 2; R61

Repr. Cat. 3; R62

Xn; R22

Xi; R37-41

O; T

R: 61-8-22-37-41-62

S: 53-45

C ≥ 25 %: T; R61-22-37-41-62

22 % ≤ C < 25 %: T; R61-37-41-62

20 % ≤ C < 22 %: T; R61-36/37-62

14 % ≤ C < 20 %: T; R61-36-62

9 % ≤ C < 14 %: T; R61-62

6,5 % ≤ C < 9 %: T; R61

005-017-01-4

natriumperborat; [1]

perborsyre, natriumsalt; [2]

perborsyre, natriumsalt, monohydrat; [3]

natriumperoxometaborat; [4]

perborsyre (HBO(O2)), natriumsalt, monohydrat; [5]

natriumperoxoborat;

[indeholdende ≥ 0,1 % (w/w) partikler med en aerodynamisk diameter på mindre end 50 μm]

E

239-172-9 [1]

234-390-0 [2]

- [3]

231-556-4 [4]

- [5]

15120-21-5 [1]

11138-47-9 [2]

12040-72-1 [3]

7632-04-4 [4]

10332-33-9 [5]

O; R8

Repr. Cat. 2; R61

Repr. Cat. 3; R62

T; R23

Xn; R22

Xi; R37-41

O; T

R: 61-8-22-23-37-41-62

S: 53-45

C ≥ 25 %: T; R61-22-23-37-41-62

22 % ≤ C < 25 %: T; R61-20-37-41-62

20 % ≤ C < 22 %: T; R61-20-36/37-62

14 % ≤ C < 20 %: T; R61-20-36-62

9 % ≤ C < 14 %: T; R61-20-62

6,5 % ≤ C < 9 %: T; R61-20

3 % ≤ C < 6,5 %: Xn; R20

005-018-00-2

perborsyre (H3BO2(O2)), mononatriumsalt trihydrat; [1]

perborsyre, natriumsalt, tetrahydrat; [2]

perborsyre (HBO(O2)), natriumsalt tetrahydrat; [3]

natriumperoxoborathexahydrat;

[indeholdende < 0,1 % (w/w) partikler med en aerodynamisk diameter på mindre end 50 μm]

- [1]

- [2]

- [3]

13517-20-9 [1]

37244-98-7 [2]

10486-00-7 [3]

Repr. Cat. 2; R61

Repr. Cat. 3; R62

Xi; R37-41

T

R: 61-37-41-62

S: 53-45-47

C ≥ 36 %: T; R61-37-41-62

22 % ≤ C < 36 %: T; R61-36/37-62

20 % ≤ C < 22 %: T; R61-37-62

14 % ≤ C < 20 %: T; R61-62

10 % ≤ C < 14 %: T; R61

005-018-01-X

perborsyre (H3BO2(O2)), mononatriumsalt trihydrat; [1]

perborsyre, natriumsalt, tetrahydrat; [2]

perborsyre (HBO(O2)), natriumsalt, tetrahydrat; [3]

natriumperoxoborathexahydrat;

[indeholdende ≥ 0,1 % (w/w) partikler med en aerodynamisk diameter på mindre end 50 μm]

E

- [1]

- [2]

- [3]

13517-20-9 [1]

37244-98-7 [2]

10486-00-7 [3]

Repr. Cat. 2; R61

Repr. Cat. 3; R62

Xn; R20

Xi; R37-41

T

R: 61-20-37-41-62

S: 53-45-47

C ≥ 36 %: T; R61-20-37-41-62

25 % ≤ C < 36 %: T; R61-20-36/37-62

22 % ≤ C < 25 %: T; R61-36/37-62

20 % ≤ C < 22 %: T; R61-37-62

14 % ≤ C < 20 %: T; R61-62

10 % ≤ C < 14 %: T; R61

006-097-00-6

1-phenyl-3-(p-toluensulfonyl)urinstof

424-620-1

13909-63-2

Xn; R22-48/22

R52-53

Xn

R: 22-48/22-52/53

S: (2-)22-36-61

006-098-00-1

tert-butyl-(1R,5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamat

429-170-8

134575-17-0

Xn; R22-48/22

Xi; R41

R43

Xn

R: 22-41-43-48/22

S: (2-)22-26-36/37/39

006-099-00-7

N-(p-toluensulfonyl)-N′-(3-(p-toluensulfonyloxy)phenyl)urinstof;

3-({[(4-methylphenyl)sulfonyl]carbamoyl}amino)phenyl 4-methylbenzensulfonat

432-520-2

232938-43-1

N; R51-53

N

R: 51/53

S: 22-61

006-101-00-6

blanding af: N,N′′-(methylendi-4,1-phenylen)bis[N′-phenylurinstof];

N-(4-[[4-[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]-N′-cyclohexylurinstof;

N,N′′-(methylendi-4,1-phenylen)bis[N′-cyclohexylurinstof]

423-070-8

—

R53

R: 53

S: 61

006-102-00-1

O-hexyl-N-ethoxycarbonylthiocarbamat

E

432-750-3

—

Carc. Cat. 2; R45

Muta. Cat. 2; R46

Xn; R22-48/22

R43

N; R51-53

T; N

R: 45-46-22-43-48/22-51/53

S: 53-45-61

006-103-00-7

N,N′′-(methylendi-4,1-phenylen)bis[N′-octyl]urinstof

445-760-8

—

Xi; R41

R42

N; R50-53

Xn; N

R: 41-42-50/53

S: (2-)22-26-39-45-60-61

C ≥10 %: Xn, N; R41-42-50/53

5 % ≤ C < 10 %: Xn, N; R36-42-50/53

1 % ≤ C < 5 %: Xn, N; R42-50/53

0,25 % ≤ C < 1 %: N; R50/53

0,025 % ≤ C < 0,25 %: N; R51/53

0,0025 ≤ C < 0,025 %: R52/53

007-029-00-8

diethyldimethylammoniumhydroxid

419-400-5

95500-19-9

Xn; R21/22

C; R35

C

R: 21/22-35

S: (1/2-)26-36/37/39-45

012-004-00-X

aluminium-magnesium-carbonat-hydroxid-perchlorat-hydrat

422-150-1

—

N; R50-53

N

R: 50/53

S: 60-61

014-036-00-X

(4-ethoxyphenyl)(3-(4-fluor-3-phenoxyphenyl)propyl)dimethylsilan

405-020-7

105024-66-6

Repr.Cat.2; R60

N; R50-53

T; N

R: 60-50/53

S: 53-45-60-61

C ≥ 0,5 %: T, N; R60-50/53

0,025 % ≤ C < 0,5 %: N; R50/53

0,0025 % ≤ C < 0,025 %: N; R51/53

0,00025 % ≤ C < 0,0025 %: R52/53

014-037-00-5

2-butanon-O,O′,O′′-(phenylsilylidyn)trioxim

433-360-6

34036-80-1

Xn; R48/22

R43

R52-53

Xn

R: 43-48/22-52/53

S: (2-)36/37-61

014-038-00-0

S-(3-(triethoxysilyl)propyl)octanthioat

436-690-9

220727-26-4

R43

Xi

R: 43

S: (2-)24-37

014-039-00-6

(2,3-dimethylbut-2-yl)-trimethoxysilan

439-360-2

142877-45-0

Xi; R38-41

R52-53

Xi

R: 38-41-52/53

S: (2-)26-37/39-61

014-041-00-7

N,N-bis(trimethylsilyl)aminopropylmethyldiethoxysilan

445-890-5

201290-01-9

Xn; R22

R43

Xn

R: 22-43

S: (2-)24-37

014-042-00-2

blanding af: O,O′,O′′,O′′′-silantetrayl-tetrakis(4-methyl-2-pentanonoxim) (3 stereoisomerer)

423-010-0

—

Xi; R41

Xi

R: 41

S: (2-)26-39

014-043-00-8

reaktionsprodukt mellem amorf silica (50-85 %), butyl(1-methylpropyl)magnesium (3-15 %), tetraethylorthosilicat (5-15 %) og titantetrachlorid (5-20 %)

432-200-2

—

F; R11

Xi; R37/38-41

R52-53

F; Xi

R: 11-37/38-41-52/53

S: (2-)6-26-36/39-61

014-044-00-3

3-[(4′-acetoxy-3′-methoxyphenyl) propyl]trimethoxysilan

433-050-0

—

N; R51-53

N

R: 51/53

S: 61

014-045-00-9

magnesiumnatriumfluoridsilicat

442-650-1

—

Xn; R48/20

Xn

R: 48/20

S: (2-)22-36

015-190-00-0

bis(2,4-dicumylphenyl)neopentyldiphosphit;

3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecan

421-920-2

154862-43-8

R53

R: 53

S: 61

015-191-00-6

dodecyldiphenylphosphat

431-760-5

27460-02-2

Xi; R38

R52-53

Xi

R: 38-52/53

S: (2-)37-61

015-192-00-1

tetrakis(2,6-dimethylphenyl)-m-phenylenbiphosphat

432-770-2

139189-30-3

R43

R53

Xi

R: 43-53

S: (2-)24-37-61

015-193-00-7

triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluor-N-methyl-1-butansulfonamid (1:1)

442-960-7

332350-93-3

T; R25

Xi; R41

N; R50-53

T; N

R: 25-41-50/53

S: (1/2-)26-39-45-60-61

015-194-00-2

tetrabutylphosphonium-nonafluorbutan-1-sulfonat

444-440-5

220689-12-3

Xn; R22

R52-53

Xn

R: 22-52/53

S: (2-)61

015-195-00-8

blanding af: kalium-o-toluenphosphonat;

kalium-m-toluenphosphonat;

kalium-p-toluenphosphonat

433-860-4

—

Xi; R36

R43

R52-53

Xi

R: 36-43-52/53

S: (2-)24-26-37-61

015-196-00-3

blanding af: dimethyl-(2-(hydroxymethylcarbamoyl)ethyl)phosphonat;

diethyl-(2-(hydroxymethylcarbamoyl)ethyl)phosphonat;

methylethyl-(2-(hydroxymethylcarbamoyl)ethyl)phosphonat

435-960-3

—

Carc.Cat.2; R45

Muta.Cat.2; R46

R43

T

R: 45-46-43

S: 53-45

015-197-00-9

bis(2,4,4-trimethylpentyl)dithiophosphonsyre

420-160-9

107667-02-7

R10

T; R23

Xn; R22

C; R34

N; R51-53

T; N

R: 10-22-23-34-51/53

S: (1/2-)9-26-36/37/39-45-61

015-198-00-4

(4-phenylbutyl)phosphinsyre

420-450-5

86552-32-1

Carc.Cat.3; R40

Xi; R41

Xn

R: 40-41

S: (2-)23-26-36/37/39

016-094-00-1

svovl

231-722-6

7704-34-9

Xi; R38

Xi

R: 38

S: (2-)46

016-097-00-8

1-amino-2-methyl-2-propanthiolhydrochlorid

434-480-1

32047-53-3

Xn; R22

C; R34

R43

R52-53

C

R: 22-34-43-52/53

S: (1/2-)22-26-36/37/39-45-61

017-009-01-8

ammoniumperchlorat;

[indeholdende < 80 % partikler på 0-30 μm]

T

232-235-1

7790-98-9

E; R2

O; R9

E

R: 2-9

S: (2-)14-16-36/37

022-004-00-1

kaliumtitanoxid (K2Ti6O13)

432-240-0

12056-51-8

Carc.Cat.3; R40

Xn

R: 40

S: (2-)22-36/37

022-005-00-7

[N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-η)-2,3,4,5-tetramethyl-2,4-cyclopentadien-1-yl]silanaminato(2-)-κN][1,2,3,4-η)-1,3-pentadien]-titan

419-840-8

169104-71-6

F; R11

C; R34

R43

R53

F; C

R: 11-34-43-53

S: (1/2-)6-9-16-26-36/37/39-45-61

028-002-01-4

nikkelpulver;

[partikeldiameter < 1 mm]

231-111-4

7440-02-0

Carc. Cat. 3; R40

T; R48/23

R43

R52-53

T

R: 40-43-48/23-52/53

S: (2-)36/37/39-45-61

028-013-00-7

nikkelsten

E, H

273-749-6

69012-50-6

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-014-00-2

mudder og slam, kobberraffineringselektrolyse-, renset for kobber, nikkelsulfat

E

295-859-3

92129-57-2

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

Xn; R20/22

Xi; R38

R42/43

N; R50-53

T; N

R: 49-61-20/22-38-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-20/22-38-42/43-48/23-68-50/53

20 % ≤ C < 25 %: T, N; R49-61-38-42/43-48/23-68-51/53

2,5 % ≤ C < 20 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-015-00-8

mudder og slam, kobberraffineringselektrolyse-, renset for kobber

E, H

305-433-1

94551-87-8

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 1; R61

Repr. Cat. 3; R62

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-62-68-50/53

S: 53-45-60-61

028-016-00-3

nikkeldiperchlorat;

perchlorsyre, nikkel(II)salt

E, H

237-124-1

13637-71-3

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

C; R34

R42/43

N; R50-53

T; N

R: 49-61-34-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-34-42/43-48/23-68-50/53

5 % ≤ C < 25 %: T, N; R49-61-34-42/43-48/23-68-51/53

2,5 % ≤ C < 5 %: T, N; R49-61-36/38-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-36/38-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-017-00-9

nikkeldikaliumbis(sulfat); [1]

diammoniumnikkelbis(sulfat) [2]

E, H

237-563-9 [1]

239-793-2 [2]

13842-46-1 [1]

15699-18-0 [2]

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

Xn; R20/22

R42/43

N; R50-53

T; N

R: 49-61-20/22-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-20/22-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-018-00-4

nikkelbis(sulfamidat);

nikkelsulfamat

E, H

237-396-1

13770-89-3

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-019-00-X

nikkelbis(tetrafluorborat)

E, H

238-753-4

14708-14-6

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; 49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-021-00-0

nikkeldiformat; [1]

myresyre, nikkelsalt; [2]

myresyre, kobbernikkkelsalt [3]

E, H

222-101-0 [1]

239-946-6 [2]

268-755-0 [3]

3349-06-2 [1]

15843-02-4 [2]

68134-59-8 [3]

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C 0,1 %: Xi; R43

028-022-00-6

nikkeldi(acetat); [1]

nikkelacetat [2]

E, H

206-761-7 [1]

239-086-1 [2]

373-02-4 [1]

14998-37-9 [2]

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

Xn; R20/22

R42/43

N; R50-53

T; N

R: 49-61-20/22-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-20/22-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N: R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-024-00-7

nikkeldibenzoat

E, H

209-046-8

553-71-9

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-025-00-2

nikkelbis(4-cyclohexylbutyrat)

E, H

223-463-2

3906-55-6

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-026-00-8

nikkel(II)stearat;

nikkel(II)octadecanoat

E, H

218-744-1

2223-95-2

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-027-00-3

nikkeldilactat

E, H

—

16039-61-5

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-028-00-9

nikkel(II)octanoat

E, H

225-656-7

4995-91-9

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat 2; R61

T; R48/23

C; R35

R42/43

N; R50-53

T; C; N

R: 49-61-35-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, C, N; R49-61-35-42/43-48/23-68-50/53

10 % ≤ C < 25 %: T, C, N; R49-61-35-42/43-48/23-68-51/53

5 % ≤ C < 10 %: T, N; R49-61-34-42/43-48/23-68-51/53

2,5 % ≤ C < 5 %: T, N; R49-61-36/38-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-36/38-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-029-00-4

nikkeldifluorid; [1]

nikkeldibromid; [2]

nikkeldiiodid; [3]

nikkelkaliumfluorid [4]

E, H

233-071-3 [1]

236-665-0 [2]

236-666-6 [3]

- [4]

10028-18-9 [1]

13462-88-9 [2]

13462-90-3 [3]

11132-10-8 [4]

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; 49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; 49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-030-00-X

nikkelhexafluorsilicat

E, H

247-430-7

26043-11-8

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-031-00-5

nikkelselenat

E, H

239-125-2

15060-62-5

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-032-00-0

nikkelhydrogenphosphat; [1]

nikkelbis(dihydrogenphosphat); [2]

trinikkelbis(orthophosphat); [3]

dinikkeldiphosphat; [4]

nikkelbis(phosphinat); [5]

nikkelphosphinat; [6]

phosphorsyre, calciumnikkelsalt;[7]

diphosphorsyyre, nikkel(II)salt [8]

E, H

238-278-2 [1]

242-522-3 [2]

233-844-5 [3]

238-426-6 [4]

238-511-8 [5]

252-840-4 [6]

- [7]

- [8]

14332-34-4 [1]

18718-11-1 [2]

10381-36-9 [3]

14448-18-1 [4]

14507-36-9 [5]

36026-88-7 [6]

17169-61-8 [7]

19372-20-4 [8]

Carc. Cat. 1; R49

T; R48/23

R42/43

N; R50-53

T; N

R: 49-42/43-48/23-50/53

S: 53-45-60-61

028-033-00-6

diammoniumnikkelhexacyanoferrat

E, H

—

74195-78-1

Carc. Cat. 1; R49

T; R48/23

R42/43

N; R50-53

T; N

R: 49-42/43-48/23-50/53

S: 53-45-60-61

028-034-00-1

nikkeldicyanid

E, H

209-160-8

557-19-7

Carc. Cat. 1; R49

T; R48/23

R42/43

R32

N; R50-53

T; N

R: 49-32-42/43-48/23-50/53

S: 53-45-60-61

028-035-00-7

nikkelchromat

E, H

238-766-5

14721-18-7

Carc. Cat. 1; R49

T; R48/23

R42/43

N; R50-53

T; N

R: 49-42/43-48/23-50/53

S: 53-45-60-61

028-036-00-2

nikkel(II)silicat; [1]

dinikkelorthosilicat; [2]

nikkelsilicat (3:4); [3]

kiselsyre, nikkelsalt; [4]

trihydrogenhydroxybis[orthosilicato(4-)]trinikkelat(3-) [5]

E, H

244-578-4 [1]

237-411-1 [2]

250-788-7 [3]

253-461-7 [4]

235-688-3 [5]

21784-78-1 [1]

13775-54-7 [2]

31748-25-1 [3]

37321-15-6 [4]

12519-85-6 [5]

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-037-00-8

dinikkelhexacyanoferrat

E, H

238-946-3

14874-78-3

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-038-00-3

trinikkel bis(arsenat);

nikkel(II)arsenat

E, H

236-771-7

13477-70-8

Carc. Cat. 1; R45

T; R48/23

R43

N; R50-53

T; N

R: 45-43-48/23-50/53

S: 53-45-60-61

028-039-00-9

nikkeloxalat; [1]

oxalsyre, nikkelsalt [2]

E, H

208-933-7 [1]

243-867-2 [2]

547-67-1 [1]

20543-06-0 [2]

Carc. Cat. 1; R49

T; R48/23

R43

N: R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-040-00-4

nikkeltellurid

E, H

235-260-6

12142-88-0

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-041-00-X

trinikkeltetrasulfid

E, H

—

12137-12-1

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-042-00-5

trinikkelbis(arsenit)

E, H

—

74646-29-0

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-043-00-0

cobaltnikkelgrå periclas;

C.I. Pigment Black 25;

C.I. 77332; [1]

cobaltnikkeldioxid; [2]

cobaltnikkeloxid [3]

E, H

269-051-6 [1]

261-346-8 [2]

- [3]

68186-89-0 [1]

58591-45-0 [2]

12737-30-3 [3]

Carc. Cat. 1; R49

T; R48/23

R43

T

R: 49-43-48/23

S: 53-45

028-044-00-6

nikkeltintrioxid;

nikkelstannat

E, H

234-824-9

12035-38-0

Carc. Cat. 1; R49

T; R48/23

R43

T

R: 49-43-48/23

S: 53-45

028-045-00-1

nikkeltriurandecaoxid

E, H

239-876-6

15780-33-3

Carc. Cat. 1; R49

T; R48/23

R43

T

R: 49-43-48/23

S: 53-45

028-046-00-7

nikkeldithiocyanat

E, H

237-205-1

13689-92-4

Carc. Cat. 1; R49

Muta. Cat. 3;R68

Repr. Cat. 2; R61

T; R48/23

R42/43

R32

N; R50-53

T; N

R: 49-61-32-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T: R49-61-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-047-00-2

nikkeldichromat

E, H

239-646-5

15586-38-6

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; 49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C 0,1 %: Xi; R43

028-048-00-8

nikkel(II)selenit

E, H

233-263-7

10101-96-9

Carc. Cat. 1; R49

T; R48/23

R42/43

N; R50-53

T; N

R: 49-42/43-48/23-50/53

S: 53-45-60-61

028-049-00-3

nikkelselenid

E, H

215-216-2

1314-05-2

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-050-00-9

kiselsyre, blynikkelsalt

E, H

—

68130-19-8

Carc. Cat. 1: R49

Repr. Cat. 1: R61

Repr. Cat. 3; R62

T; R48/23

R43

N; R50-53

T; N

R: 49-61-43-48/23-62-50/53

S: 53-45-60-61

028-051-00-4

nikkeldiarsenid; [1]

nikkelarsenid [2]

E, H

235-103-1 [1]

248-169-1 [2]

12068-61-0 [1]

27016-75-7 [2]

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-052-00-X

nikkelbariumtitanprimulagul priderit;

C.I. Pigment Yellow 157;

C.I. 77900

E, H

271-853-6

68610-24-2

Carc. Cat. 1: R49

T; R48/23

R43

T

R: 49-43-48/23

S: 53-45

028-053-00-5

nikkeldichlorat; [1]

nikkeldibromat; [2]

ethylhydrogensulfat, nikkel(II)salt [3]

E, H

267-897-0 [1]

238-596-1 [2]

275-897-7 [3]

67952-43-6 [1]

14550-87-9 [2]

71720-48-4 [3]

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N: R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T: R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T: R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-054-00-0

nikkel(II)trifluoracetat; [1]

nikkel(II)propionat; [2]

nikkelbis(benzensulfonat); [3]

nikkel(II)hydrogencitrat; [4]

citronsyre, ammoniumnikkelsalt; [5]

citronsyre, nikkelsalt; [6]

nikkelbis(2-ethylhexanoat); [7]

2-ethylhexansyre, nikkelsalt; [8]

dimethylhexansyre, nikkelsalt; [9]

nikkel(II)isooctanoat; [10]

nikkelisooctanoat; [11]

nikkelbis(isononanoat); [12]

nikkel(II)neononanoat; [13]

nikkel(II)isodecanoat; [14]

nikkel(II)neodecanoat; [15]

neodecansyre, nikkelsalt; [16]

nikkel(II)neoundecanoat; [17]

bis(D-gluconato-O
  1,O
  2)nikkel; [18]

nikkel-3,5-bis(tert-butyl)-4-hydroxybenzoat (1:2); [19]

nikkel(II)palmitat; [20]

(2-ethylhexanoato-O)(isononanoato-O)nikkel; [21]

(isononanoato-O)(isooctanoato-O)nikkel; [22]

(isooctanoato-O)(neodecanoato-O)nikkel; [23]

(2-ethylhexanoato-O)(isodecanoato-O)nikkel; [24]

(2-ethylhexanoato-O)(neodecanoato-O)nikkel; [25]

(isodecanoato-O)(isooctanoato-O)nikkel; [26]

(isodecanoato-O)(isononanoato-O)nikkel; [27]

(isononanoato-O)(neodecanoato-O)nikkel; [28]

fedtsyrer, C6-19-forgrenede, nikkelsalte; [29]

fedtsyrer, C8-18 og C18-umættede, nikkelsalte; [30]

2,7-naphthalendisulfonsyre, nikkel(II)salt; [31]

E, H

240-235-8 [1]

222-102-6 [2]

254-642-3 [3]

242-533-3 [4]

242-161-1 [5]

245-119-0 [6]

224-699-9 [7]

231-480-1 [8]

301-323-2 [9]

249-555-2 [10]

248-585-3 [11]

284-349-6 [12]

300-094-6 [13]

287-468-1 [14]

287-469-7 [15]

257-447-1 [16]

300-093-0 [17]

276-205-6 [18]

258-051-1 [19]

237-138-8 [20]

287-470-2 [21]

287-471-8 [22]

284-347-5 [23]

284-351-7 [24]

285-698-7 [25]

285-909-2 [26]

284-348-0 [27]

287-592-6 [28]

294-302-1 [29]

283-972-0 [30]

- [31]

16083-14-0 [1]

3349-08-4 [2]

39819-65-3 [3]

18721-51-2 [4]

18283-82-4 [5]

22605-92-1 [6]

4454-16-4 [7]

7580-31-6 [8]

93983-68-7 [9]

29317-63-3 [10]

27637-46-3 [11]

84852-37-9 [12]

93920-10-6 [13]

85508-43-6 [14]

85508-44-7 [15]

51818-56-5 [16]

93920-09-3 [17]

71957-07-8 [18]

52625-25-9 [19]

13654-40-5 [20]

85508-45-8 [21]

85508-46-9 [22]

84852-35-7 [23]

84852-39-1 [24]

85135-77-9 [25]

85166-19-4 [26]

84852-36-8 [27]

85551-28-6 [28]

91697-41-5 [29]

84776-45-4 [30]

72319-19-8 [31]

Carc. Cat. 1; R49

Muta. Cat. 3; R68

Repr. Cat. 2; R61

T; R48/23

R42/43

N; R50-53

T; N

R: 49-61-42/43-48/23-68-50/53

S: 53-45-60-61

C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53

2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53

1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53

0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53

0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53

0,1 % ≤ C < 0,25 %: T; R49-43-48/20

0,01 % ≤ C < 0,1 %: Xi; R43

028-055-00-6

nikkel(II)sulfit; [1]

nikkeltellurtrioxid; [2]

nikkeltellurtetraoxid; [3]

molybdennikkelhydroxidoxidphosphat [4]

E, H

231-827-7 [1]

239-967-0 [2]

239-974-9 [3]

268-585-7 [4]

7757-95-1 [1]

15851-52-2 [2]

15852-21-8 [3]

68130-36-9 [4]

Carc. Cat. 1; R49

T; R48/23

R42/43

N; R50-53

T; N

R: 49-42/43-48/23-50/53

S: 53-45-60-61

028-056-00-1

nikkelborid (NiB); [1]

dinikkelborid; [2]

trinikkelborid; [3]

nikkelborid; [4]

dinikkelsilicid; [5]

nikkeldisilicid; [6]

dinikkelphosphid; [7]

nikkelborphosphid [8]

E, H

234-493-0 [1]

234-494-6 [2]

234-495-1 [3]

235-723-2 [4]

235-033-1 [5]

235-379-3 [6]

234-828-0 [7]

- [8]

12007-00-0 [1]

12007-01-1 [2]

12007-02-2 [3]

12619-90-8 [4]

12059-14-2 [5]

12201-89-7 [6]

12035-64-2 [7]

65229-23-4 [8]

Carc. Cat. 1; R49

T; R48/23

R43

N; R50-53

T; N

R: 49-43-48/23-50/53

S: 53-45-60-61

028-057-00-7

dialuminiumnikkeltetraoxid; [1]

nikkeltitantrioxid; [2]

nikkeltitanoxid; [3]

nikkeldivanadiumhexaoxid; [4]

cobaltdimolybdennikkeloctaoxid; [5]

nikkelzirkoniumtrioxid; [6]

molybdennikkeltetraoxid; [7]

nikkelwolframtetraoxid; [8]

olivin, nikkelgrøn; [9]

lithiumnikkeldioxid; [10]

molybdennikkeloxid; [11]

E, H

234-454-8 [1]

234-825-4 [2]

235-752-0 [3]

257-970-5 [4]

268-169-5 [5]

274-755-1 [6]

238-034-5 [7]

238-032-4 [8]

271-112-7 [9]

- [10]

- [11]

12004-35-2 [1]

12035-39-1 [2]

12653-76-8 [3]

52502-12-2 [4]

68016-03-5 [5]

70692-93-2 [6]

14177-55-0 [7]

14177-51-6 [8]

68515-84-4 [9]

12031-65-1 [10]

12673-58-4 [11]

Carc. Cat. 1; R49

T; R48/23

R43

T

R: 49-43-48/23

S: 53-45

028-058-00-2

cobaltlithiumnikkeloxid

E

442-750-5

—

Carc. Cat. 1; R49

T+; R26

T; R48/23

R43

N; R50-53

T+; N

R: 49-26-43-48/23-50/53

S: 53-45-60-61

029-014-00-5

blanding af: 2,2′-[[cis-1,2-cyclohexandiylbis(nitrilomethyliden)]bis[phenolat]](2-)-N,N′,O,O′-kobberkompleks;

2,2′-[[trans-1,2-cyclohexandiylbis(nitrilomethylidyn)]bis[phenolat]](2-)-N,N′,O,O′-kobberkompleks

419-610-7

171866-24-3

Xn; R48/22

N; R51-53

Xn; N

R: 48/22-51/53

S: (2-)22-36-61

030-012-00-1

aluminium-magnesium-zink-carbonat-hydroxid

423-570-6

169314-88-9

R52-53

R: 52/53

S: 61

030-015-00-8

tetrazink(2+)-bis(hexacyanocobalt(3+))diacetat

440-060-9

—

N; R51-53

N

R: 51/53

S: 61

042-005-00-0

blanding af: mono-og di-glyceroler af rapsolie;

rapsoliefedtsyreamid af forgrenet 1,3-propandiamin, N-[3-(tridecyloxy)-propyl]-;

N,N-diorgano-dithiocarbamat molybdenkompleks-diorgano dithiocarbamate molybdenum complex

434-240-6

—

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)24-37-61

050-023-00-5

blanding af: bis[(2-ethyl-1-oxohexyl)oxy]dioctylstannan;

bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxid;

bis(1-phenyl-1,3-decandionyl)dioctylstannan;

((2-ethyl-1-oxohexyl)oxy)-(1-phenyl-1,3-decandionyl)dioctylstannan

422-920-5

—

Xn; R48/22

N; R50-53

Xn; N

R: 48/22-50/53

S: (2-)23-36-60-61

C ≥ 10 %: Xn, N; R48/22-50/53

2,5 % ≤ C < 10 %: N; R50/53

0,25 % ≤ C < 2,5 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

050-024-00-0

blanding af: tri-p-tolyltinhydroxid;

hexa-p-tolyl-distannoxan

432-230-6

—

T; R48/25

Xn; R22

Xi; R38-41

R43

N; R50-53

T; N

R: 22-38-41-43-48/25-50/53

S: (1/2-)22-26-36/37/39-45-60-61

064-001-00-8

gadolinium(III)sulfittrihydrat

456-900-2

51285-81-5

N; R51-53

N

R: 51/53

S: 61

078-011-00-5

hydroxydisulfitoplatin(II)syre

423-310-1

61420-92-6

Xn; R22-48/20/21/22

C; R35

R42/43

R52-53

C

R: 22-35-42/43-48/20/21/22-52/53

S: (1/2-)23-24-26-28-36/37/39-45-61

078-012-00-0

platin(IV)nitrat/salpetersyreopløsning

432-400-1

—

C; R35

N; R50-53

C; N

R: 35-50/53

S: (1/2-)26-36/37/39-45-60-61

082-012-00-6

barium-bly-calcium-caesium-samarium-strontium-bromid-chlorid-fluorid-iodid, europium-doteret

431-780-4

199876-46-5

Xn; R22-48/22

N; R51-53

Xn; N

R: 22-48/22-51/53

S: (2-)22-36-61

601-080-00-5

blanding af: sec-butylphenyl(phenyl)methan, blandede isomerer;

1-(sec-butylphenyl(phenyl)-2-phenylethan, blandede isomerer;

1-(sec-butylphenyl-1-phenylethan, blandede isomerer

431-100-6

—

N; R50-53

N

R: 50/53

S: 60-61

601-081-00-0

cyclohexadeca-1,9-dien

431-730-1

4277-06-9

Xi; R38

R43

R53

Xi

R: 38-43-53

S: (2-)36/37-61

601-082-00-6

blanding af: endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptan;

exo-2-methyl-exo-3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptan

434-420-4

—

Xi; R38-41

N; R50-53

Xi; N

R: 38-41-50/53

S: (2-)23-26-37/39-57-60-61

601-083-00-1

5-endo-hexyl-bicyclo[2.2.1]hept-2-en

435-000-3

22094-83-3

Xn; R65

Xi; R38

R53

Xn

R: 38-65-53

S: (2-)37-62-61

601-084-00-7

blanding af: 5-endo-butyl-bicyclo[2.2.1]hept-2-en;

5-exo-butyl-bicyclo[2.2.1]hept-2-en (80:20)

435-180-3

—

Xn; R65

Xi; R38

N; R50-53

Xn; N

R: 38-65-50/53

S: (2-)37-62-60-61

602-105-00-2

natrium-1,1,2,2,3,3,4,4,4-nonafluor-1-butansulfinat

422-100-7

102061-82-5

Xi; R41

R43

Xi

R: 41-43

S: (2-)24-26-37/39

602-106-00-8

2-brom-4,6-difluoranilin

429-430-0

444-14-4

Xn; R22

N; R51-53

Xn; N

R: 22-51/53

S: (2-)25-61

602-107-00-3

3,3,4,4-tetrafluor-4-iod-1-buten

439-500-2

33831-83-3

Xn; R22

Xi; R38

N; R51-53

Xn; N

R: 22-38-51/53

S: (2-)37-61

602-108-00-9

(2,3,5,6-tetrafluorphenyl)methanol

443-840-7

4084-38-2

Xn; R22

Xi; R36

R43

Xn

R: 22-36-43

S: (2-)26-36/37

603-211-00-1

2,3-epoxypropyltrimethylammoniumchlorid ...%;

glycidyltrimethylammoniumchlorid ...%

B E

221-221-0

3033-77-0

Carc. Cat. 2; R45

Muta. Cat. 3; R68

Repr. Cat. 3; R62

Xn; R21/22-48/22

Xi; R41

R43

R52-53

T

R: 45-21/22-41-43-48/22-62-68-52/53

S: 53-45-61

603-212-00-7

1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyran;

galaxolid;

(HHCB)

214-946-9

1222-05-5

N; R50-53

N

R: 50/53

S: 60-61

603-213-00-2

2-methoxy-2-methylbutan;

tert-amylmethylether

213-611-4

994-05-8

F; R11

Xn; R22

R67

F; Xn

R: 11-22-67

S: (2-)9-16-23-33

603-214-00-8

1,1-diisopropoxycyclohexan

413-740-8

1132-95-2

C; R34

C

R: 34

S: (1/2-)23-26-36/37/39-45

603-215-00-3

1-hydroxy-4-fluor-1,4-diazoniabicyclo[2.2.2]octan-bis(tetrafluorborat)

418-330-2

162241-33-0

E; R2

Xn; R22-48/22

Xi; R41

R43

N; R50-53

E; Xn; N

R: 2-22-41-43-48/22-50/53

S: (2-)22-26-36/37/39-60-61

603-216-00-9

cis-1-amino-2,3-dihydro-1H-inden-2-ol

422-660-2

7480-35-5

Xi; R41

R43

R52-53

Xi

R: 41-43-52/53

S: (2-)24-26-37/39-61

603-217-00-4

2,4,6-tri-tert-butylphenyl-2-butyl-2-ethyl-1,3-propandiolphosphit

423-560-1

161717-32-4

R43

R53

Xi

R: 43-53

S: (2-)24-37/39-61

603-220-00-0

1-{benzyl[2-(2-methoxyphenoxy)ethyl]amino}-3-(9H-carbazol-4-yloxy)propan-2-ol

432-890-5

72955-94-3

R53

R: 53

S: 61

603-221-00-6

1-(2-amino-5-chlorphenyl)-2,2,2-trifluor-1,1-ethandiolhydrochlorid;

[indeholdende < 0,1 % 4-chloranilin (EF-nr. 203-401-0)]

433-580-2

214353-17-0

Xn; R22

C; R34

N; R51-53

C; N

R: 22-34-51/53

S: (1/2-)26-36/37/39-45-61

603-221-01-3

1-(2-amino-5-chlorphenyl)-2,2,2-trifluor-1,1-ethandiolhydrochlorid;

[indeholdende ≥ 0,1 % 4-chloranilin (EF-nr. 203-401-0)]

E

433-580-2

214353-17-0

Carc. Cat. 2; R45

Xn; R22

C; R34

N; R51-53

T; N

R: 45-22-34-51/53

S: 53-45-61

603-222-00-1

(2R,3S,4R,5R,7R,9R,10R,11S,12S,13R)10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-oxo-1-oxacyclotetradecan

433-820-6

118058-74-5

Xi; R36

Xi

R: 36

S: (2-)26

603-223-00-7

2-cyclopentylidencyclopentanol;

1,1′-bi(cyclopentyliden)-2-ol

434-270-1

6261-30-9

Xi; R38-41

R52-53

Xi

R: 38-41-52/53

S: (2-)26-37/39-61

603-224-00-2

3-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluor-2-(trifluormethyl)-hexan

435-790-1

297730-93-9

R53

R: 53

S: 61

603-225-00-8

erythromycin A9-oxim (E);

(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-((2,6,-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-trideoxy-3-dimethylamino-β-D-xylohexapyranosyl)oxy)oxacyclotetradecan-2-on-10-oxim (E)

437-070-0

13127-18-9

N; R51-53

N

R: 51/53

S: 61

603-226-00-3

4,4′(4-(4-methoxyphenyl)-1,3,5-triazin-2,4-diyl)bisbenzen-1,3-diol

444-500-0

1440-00-2

R52-53

R: 52/53

S: 61

603-227-00-9

α-hydro-ω-[[[(1,1-dimethylethyl)dioxy]carbonyl]oxy]-poly[oxy(methyl-1,2-ethanediyl)]ether med 2,2-bis(hydroxymethyl)-1,3-propandiol (4:1);

reaktionsprodukt af α-hydro-ω-((chlorcarbonyl)oxy)-poly(oxy(methyl-1,2-ethandiyl))ether med 2,2-bis(hydroxymethyl)-1,3-propandiol og kalium-1,1-dimethylethylperoxalat

445-060-2

203574-04-3

O; R7

N; R50-53

O; N

R: 7-50/53

S: (2-)3/7-14-36/37/39-60-61

603-228-00-4

(+/-)-(R*,R*)-6-fluor-3,4-dihydro-2-oxiranyl-2H-1-benzopyran;

6-fluor-2-(2-oxiranyl)chroman

419-620-1

—

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)36/37-61

603-229-00-X

natrium-(Z)-3-chlor-3-(4-chlorphenyl)-1-hydroxy-2-propen-1-sulfonat

420-800-7

—

Xi; R38-41

R43

N; R50-53

Xi; N

R: 38-41-43-50/53

S: (2-)24-26-37/39-60-61

603-230-00-5

2,6,6,7,8,8-hexamethyldecahydro-2H-indeno[4,5-b]furan

440-030-5

—

Xi; R38-41

R53

Xi

R: 38-41-53

S: (2-)26-37/39-61

603-231-00-0

(S)-1,1-diphenyl-1,2-propandiol

443-220-6

—

R52-53

R: 52/53

S: 22-61

603-232-00-6

3,3,8,8,10,10-hexamethyl-9-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-1,5-dioxa-9-aza-spiro[5.5]undecan

444-420-6

—

R53

R: 53

S: 61

603-233-00-1

blanding af: 4-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-yliden)-3-methylbutan-2-ol;

4-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-yliden)-3-methylbutan-2-ol;

1-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-yliden)pentan-3-ol;

1-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-yliden)pentan-3-ol;

(E)-4-(3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol;

(E)-4-(3a,4,5,6,7,7a-hexahydro-3H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol

444-430-0

—

N; R51-53

N

R: 51/53

S: 61

603-234-00-7

(1R,4R)-4-methoxy-2,2,7,7-tetramethyltricyclo(6.2.1.0(1,6))undec-5-en

444-480-3

—

Xi; R38

N; R51-53

Xi; N

R: 38-51/53

S: (2-)37-61

604-074-00-0

tetrabrombisphenol-A;

2,2′,6,6′-tetrabrom-4,4′-isopropylidendiphenol

201-236-9

79-94-7

N; R50-53

N

R: 50/53

S: 60-61

604-075-00-6

4-(1,1,3,3-tetramethylbutyl)phenol;

4-tert-octylphenol

205-426-2

140-66-9

Xi; R38-41

N; R50-53

Xi; N

R: 38-41-50/53

S: (2-)26-37/39-60-61

C ≥ 20 %: Xi, N; R38-41-50/53

10 % ≤ C < 20 %: Xi, N; R41-50/53

5 % ≤ C < 10 %: Xi, N; R36-50/53

2,5 % ≤ C < 5 %: N; R50/53

0,25 % ≤ C < 2,5 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

604-076-00-1

phenolphthalein

201-004-7

77-09-8

Carc. Cat. 2; R45

Muta. Cat. 3; R68

Repr. Cat. 3; R62

T

R: 45-62-68

S: 53-45

C ≥ 5 %: T; R45-62-68

1 % ≤ C < 5 %: T; R45-68

604-077-00-7

2-benzotriazol-2-yl-4-methyl-6-(2-methylallyl)phenol

419-750-9

98809-58-6

R53

R: 53

S: 61

604-079-00-8

4,4′-(1,3-phenylen-bis(1-methylethyliden))bis-phenol

428-970-4

13595-25-0

Repr.Cat.3; R62

R43

N; R51-53

Xn; N

R: 43-62-51/53

S: (2-)22-36/37-61

604-080-00-3

4-fluor-3-trifluormethylphenol

432-560-0

61721-07-1

Xn; R20

C; R35

R43

N; R51-53

C; N

R: 20-35-43-51/53

S: (1/2-)26-28-36/37/39-45-61

604-081-00-9

1,1-bis(4-hydroxyphenyl)-1-phenylethan

433-130-5

1571-75-1

N; R50-53

N

R: 50/53

S: 25-60-61

604-082-00-4

2-chlor-6-fluorphenol

E

433-890-8

2040-90-6

Muta.Cat.2; R46

Repr.Cat.3; R62

Xn; R22

C; R34

R43

N; R51-53

T; N

R: 46-22-34-43-62-51/53

S: 53-45-61

604-083-00-X

4,4′-sulfonylbisphenol, polymer med ammoniumchlorid (NH4Cl), pentachlorphosphoran og phenol

439-270-3

260408-02-4

R53

R: 53

S: 61

604-084-00-5

1-ethoxy-2,3-difluorbenzen

441-000-4

121219-07-6

Xn; R22

R52-53

Xn

R: 22-52/53

S: (2-)23-61

604-087-00-1

blanding af: 1,2-naphthoquinondiazid-5-sulfonylchlorid (eller sulfonsyre)monoester og 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethyliden)bisphenol;

1,2-naphthoquinondiazid-5-sulfonylchlorid (eller sulfonsyre)diester og 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethyliden)bisphenol;

1,2-naphthoquinondiazid-5-sulfonylchlorid (eller sulfonsyre)triester og 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethyliden)bisphenol

433-640-8

—

F; R17

R44

R53

F

R: 17-44-53

S: (2-)15-22-61

604-089-00-2

2-methyl-5-tert-butylthiophenol

444-970-7

—

R10

Repr.Cat.3; R63

Xn; R48/20/22-65

Xi; R36/38

R43

R67

N; R50-53

Xn; N

R: 10-36/38-43-48/20/22-63-65-67-50/53

S: (2-)26-36/37-62-60-61

605-037-00-1

trans-3-[2-(7-chlor-2-quinolinyl)vinyl]benzaldehyd;

3-[(E)-2-(7-chlor-2-quinolinyl)vinyl]benzaldehyd

421-800-1

120578-03-2

R53

R: 53

S: 22-61

605-038-00-7

3-methyl-5-phenylpentan-1-al

433-900-0

55066-49-4

Xn; R22

Xi; R38

R43

N; R51-53

Xn; N

R: 22-38-43-51/53

S: (2-)36/37-61

605-039-00-2

3,4-dihydroxy-5-nitrobenzaldehyd

441-810-8

116313-85-0

Xn; R22

Xi; R41

R43

Xn

R: 22-41-43

S: (2-)22-24-26-37/39

606-124-00-7

1-cyclopropyl-3-(2-methylthio-4-trifluormethylphenyl)-1,3-propandion

421-080-7

161462-35-7

Xn; R48/22

N; R50-53

Xn; N

R: 48/22-50/53

S: (2-)36-60-61

606-125-00-2

1-benzylimidazolidin-2,4-dion

421-340-1

6777-05-5

Xn; R22

Xn

R: 22

S: (2-)22

606-126-00-8

1,4-bis(2,3-dihydroxypropylamino)anthraquinon

421-470-7

99788-75-7

N; R51-53

N

R: 51/53

S: 61

606-128-00-9

2,2′-(1,3-phenylen)bis[5-chlor-1H-isoindol]-1,3(2H)-dion

422-650-8

148935-94-8

R53

R: 53

S: 61

606-129-00-4

5-amino-[2S-di(methylphenyl)amino]-1,6-diphenyl-4Z-hexen-3-on;

(2S,4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-on

423-090-7

156732-13-7

R53

R: 53

S: 61

606-130-00-X

4-(1,4-dioxa-spiro[4.5]dec-8-yl)-cyclohexanon

423-860-2

56309-94-5

R43

R52-53

Xi

R: 43-52/53

S: (2-)24-37-61

606-131-00-5

cyclisk 3-(1,2-ethandiylacetal)-estra-5(10),9(11)-dien-3,17-dion

E

427-230-8

5571-36-8

Repr. Cat. 2; R60

Xn; R48/22

N; R51-53

T; N

R: 60-48/22-51/53

S: 53-45-61

606-132-00-0

(6β)-6,19-epoxyandrost-4-en-3,17-dion

433-490-3

6563-83-3

R43

R52-53

Xi

R: 43-52/53

S: (2-)24-37-61

606-134-00-1

androsta-1,4,9(11)-trien-3,17-dion

433-560-3

15375-21-0

Repr. Cat.3; R62

Xn

R: 62

S: (2-)22-36/37

606-135-00-7

cyclohexadecanon

438-930-8

2550-52-9

R53

R: 53

S: 61

606-136-00-2

(3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosan-2,5,8,11,14,17,20,23-octaon

444-350-6

133413-70-4

Xi; R36

R53

Xi

R: 36-53

S: (2-)26-61

606-137-00-8

trans-7,7′-dimethyl-(4H,4H′)-(2,2′)bi[benzo[1,4]thiazinyliden]-3,3′-dion

444-750-0

211387-26-7

R53

R: 53

S: 22-61

606-138-00-3

(2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanon

444-800-1

141645-23-0

R10

Xn; R22-48/22

Xi; R38-41

R43

N; R50-53

Xn; N

R: 10-22-38-41-43-48/22-50/53

S: (2-)23-26-36/37/39-60-61

C ≥ 25 %: Xn, N; R22-38-41-43-48/22-50/53

20 % ≤ C < 25 %: Xn, N; R38-41-43-48/22-50/53

10 % ≤ C < 20 %: Xn, N; R41-43-48/22-50/53

5 % ≤ C < 10 %: Xi, N; R36-43-50/53

2,5 % ≤ C < 5 %: Xi, N; R43-50/53

1 % ≤ C < 2,5 %: Xi, N; R43-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

606-139-00-9

(S)-4-(3,4-dichlorphenyl)-3,4-dihydro-2H-naphthalen-1-on

444-830-5

124379-29-9

R53

R: 53

S: 61

606-140-00-4

2-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-on

444-860-9

474510-57-1

Xn; R48/22

N; R50-53

Xn; N

R: 48/22-50/53

S: (2-)22-36-60-61

606-141-00-X

natrium-3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolat

418-410-7

—

Xi; R36

Xi

R: 36

S: (2-)26

606-142-00-5

blanding af: (1RS,2SR,7SR,8SR,E)-9-og 10-ethyliden-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-on;

(1RS,2SR,7SR,8SR,Z)-10-ethyliden-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-on;

(1RS,2SR,7SR,8SR,Z)-9-ethyliden-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-on

434-290-9

—

Xn; R22

N; R51-53

Xn; N

R: 22-51/53

S: (2-)61

607-580-00-X

ethyl-7-chlor-1-(2,4-difluorphenyl)-6-fluor-1,4-dihydro-4-oxo-1,8-naphthyridin-3-carboxylat

422-360-1

100491-29-0

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)22-24-37-61

607-618-00-5

menadionnatriumbisulfit;

2-naphthalensulfonsyre, 1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, natriumsalt

204-987-0

130-37-0

Xi; R36/38

N; R50-53

Xi; N

R: 36/38-50/53

S: (2-)24/25-60-61

607-619-00-0

menadionnicotinamidbisulfit;

1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalen-2-sulfonsyre, forbindelse med nicotin-3-amid (1:1)

277-543-7

73581-79-0

Xi; R36/38

N; R50-53

Xi; N

R: 36/38-50/53

S: (2-)24/25-60-61

607-620-00-6

trinatriumnitrilotriacetat

225-768-6

5064-31-3

Carc. Cat. 3; R40

Xn; R22

Xi; R36

Xn

R: 22-36-40

S: (2-)26-36/37-46

C ≥ 25 %: Xn; R22-36-40

20 ≤ % C < 25 %: Xn; R36-40

5 ≤ % C < 20 %: Xn; R40

607-621-00-1

milbemectin (ISO);

[blanding af milbemycin A3 (CAS-nr. 51596-10-2) og milbemycin A4 (CAS-nr. 51596-11-3) (30:70)]

—

—

Xn; R20/22

N; R50-53

Xn; N

R: 20/22-50/53

S: (2-)46-60-61

C ≥ 25 %: Xn, N; R20/22-50/53

0,25 % ≤ C < 25 %: N; R50/53

0,025 % ≤ C < 0,25 %: N; R51/53

0,0025 % ≤ C < 0,025 %: R52/53

607-622-00-7

2-ethylhexyl-2-ethylhexanoat

231-057-1

7425-14-1

Repr. Cat. 3; R63

Xn

R: 63

S: (2-)36/37

607-623-00-2

diisobutylphthalat

201-553-2

84-69-5

Repr. Cat. 2; R61

Repr. Cat. 3; R62

T

R: 61-62

S: 53-45

C ≥ 25 %: T; R61-62

5 % ≤ C < 25 %: Xn; R62

607-624-00-8

perfluoroctansulfonsyre;

heptadecafluoroctan-1-sulfonsyre; [1]

kaliumperfluoroctansulfonat;

kaliumheptadecafluoroctan-1-sulfonat; [2]

diethanolaminperfluoroctansulfonat; [3]

ammoniumperfluoroctansulfonat;

ammoniumheptadecafluoroctansulfonat; [4]

lithiumperfluoroctansulfonat;

lithiumheptadecafluoroctansulfonat [5]

E

217-179-8 [1]

220-527-1 [2]

274-460-8 [3]

249-415-0 [4]

249-644-6 [5]

1763-23-1 [1]

2795-39-3 [2]

70225-14-8 [3]

29081-56-9 [4]

29457-72-5 [5]

Carc. Cat. 3; R40

Repr. Cat. 2; R61

T; R48/25

Xn; R20/22

R64

N; R51-53

T; N

R: 61-20/22-40-48/25-64-51/53

S: 53-45-61

607-625-00-3

clodinafop-propargyl (ISO)

—

105512-06-9

Xn; R22-48/22

R43

N; R50-53.

Xn; N

R: 22-43-48/22-50/53

S: (2-)24-36/37-46-60-61

C ≥ 25 %: Xn, N; R22-43-48/22-50/53

10 % ≤ C < 25 %: Xn, N; R43-48/22-51/53

2,5 % ≤ C < 10 %: Xi, N; R43-51/53

0,25 % ≤ C < 2,5 %: Xi; R43-52/53

0,001 % ≤ C < 0,25 %: Xi; R43

607-626-00-9

ethyl-1-(2,4-dichlorphenyl)-5-(trichlormethyl)-1H-1,2,4-triazol-3-carboxylat

401-290-5

103112-35-2

Carc.Cat.2; R45

N; R50-53

T; N

R: 45-50/53

S: 53-45-60-61

607-627-00-4

[(4S,5S)-4-benzyl-2-oxo-5-oxazolidinyl]methyl 4-nitrobenzensulfonat

416-360-0

162221-28-5

R43

Xi

R: 43

S: (2-)22-24-37

607-628-00-X

4-oxo-4-(p-tolyl)smørsyre, addukt med 4-ethylmorpholin

419-240-6

171054-89-0

Xi; R41

Xi

R: 41

S: (2-)26-39

607-629-00-5

[[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl]eddikesyre

419-270-1

123599-82-6

Xi; R36

Xi

R: 36

S: (2-)26

607-630-00-0

acrylsyre, 3-(trimethoxysilyl)propylester

419-560-6

4369-14-6

Xn; R20

C; R34

R43

R52-53

C

R: 20-34-43-52/53

S: (1/2-)26-36/37/39-45-61

607-631-00-6

blanding af: 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl-oxo(phenyl)acetat;

(2-(2-hydroxyethoxy)ethyl)-oxo(phenyl)acetat

442-300-8

—

R43

Xi

R: 43

S: (2-)24-37

607-632-00-1

N-[3-(2,4-di-(1,1-dimethyl-propyl)phenoxy)-propyl]-1-hydroxy-5-(2-methylpropyl-oxycarbonylamino)-naphthamid

420-210-1

111244-14-5

R53

R: 53

S: 61

607-633-00-7

trinatrium-5-{[4-chlor-6-(1-naphthylamino)-1,3,5-triazin-2-yl]amino}-4-hydroxy-3-[(E)-(4-methoxy-2-sulfonatophenyl)diazenyl]-2,7-naphthalendisulfonat

440-480-2

341026-59-3

Xi; R41

R43

Xi

R: 41-43

S: (2-)22-24-26-37/39

607-634-00-2

(S)-(-)-2-acetoxypropionylchlorid;

(1S)-2-chlor-1-methyl-2-oxoethylacetat

420-610-4

36394-75-9

Xn; R22

C; R34

R43

C

R: 22-34-43

S: (1/2-)23-26-36/37/39-45

607-635-00-8

trinatrium-N-(3-propionato)-L-aspartat

422-090-4

172737-80-3

Xi; R41

Xi

R: 41

S: (2-)26-39

607-636-00-3

1-brom-2-methylpropylpropionat

422-900-6

158894-67-8

R10

Carc.Cat.3; R40

C; R34

R43

C

R: 10-34-40-43

S: (1/2-)7/9-8-23-26-36/37/39-45

607-637-00-9

dinatrium-8-amino-5-{4-[2-(sulfonatoethoxy)sulfonyl]phenylazo}naphthalen-2-sulfonat

423-730-5

250688-43-8

Xi; R41

Xi

R: 41

S: (2-)26-39

607-638-00-4

2-hydroxybenzoesyre-2-butyloctylester

431-090-3

190085-41-7

R53

R: 53

S: 61

607-639-00-X

2-(2-oxo-5-(1,1,3,3-tetramethylbutyl)-2,3-dihydro-1-benzofuran-3-yl)-4-(1,1,3,3-tetramethylbutyl)phenylacetat

431-770-1

216698-07-6

R53

R: 53

S: 61

607-641-00-0

2-(formylamino)-3-thiophencarboxylsyre;

2-formamido-3-thiophencarboxylsyre

431-930-9

43028-69-9

Xn; R22

R43

Xn

R: 22-43

S: (2-)22-24-37

607-642-00-6

3,6,9-trithiaundecamethylen-1,11-dimethacrylat

432-210-7

141631-22-3

N; R50-53

N

R: 50/53

S: 60-61

607-643-00-1

dimethyl (2S)-2-hydroxysuccinat

432-310-0

617-55-0

R10

Xi; R41

R43

Xi

R: 10-41-43

S: (2-)24-26-37/39-43

607-644-00-7

methyl-2,2-dimethyl-6-methylencyclohexancarboxylat

432-350-9

81752-87-6

Xi; R38

Xi

R: 38

S: (2-)37

607-645-00-2

tetranatrium-2-(4-fluor-6-(methyl-(2-(sulfatoethylsulfonyl)ethyl)amino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatophenylazo)naphthalen-1,7-disulfonat

432-550-6

243858-01-7

Xi; R41

Xi

R: 41

S: (2-)22-26-39

607-646-00-8

D-erythro-hexansyre-2,4-dideoxy-3,5-O-(1-methylethyliden)-1,1-dimethylethylester;

tert-butyl-2-[(4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetat

432-960-5

124655-09-0

Xn; R22

Xn

R: 22

S: (2-)25

607-647-00-3

5-acetoxy-2-(R,S)butyryloxymethyl-1,3-oxathiolan

433-530-1

143446-73-5

Xn; R22

R43

N; R50

Xn; N

R: 22-43-50

S: (2-)24-37-57-61

607-649-00-4

[3-(chlorcarbonyl)-2-methylphenyl]acetat

433-690-0

167678-46-8

C; R35

R43

C

R: 35-43

S: (1/2-)7/8-26-36/37/39-45

607-650-00-X

2-methyl-1,5-pentandiamin-1,3-benzendicarboxylat

433-910-5

145153-52-2

R43

Xi

R: 43

S: (2-)24-37

607-651-00-5

natrium-2-(nonanoyloxy)benzensulfonat

434-360-9

91125-43-8

Xi; R41

R43

Xi

R: 41-43

S: (2-)24-26-37/39

607-652-00-0

ethyl-N
  2-dodecanoyl-L-argininathydrochlorid

434-630-6

60372-77-2

Xi; R41

N; R50

Xi; N

R: 41-50

S: (2-)26-39-61

607-653-00-6

tetrakis(bis(2-hydroxyethyl)methylammonium)-3-(4-(7-acetylamino-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-5-methoxy-2-sulfonatophenylazo)-7-(4-amino-3-sulfonatophenylamino)-4-hydroxynaphthalen-2-sulfonat

434-840-8

225786-91-4

N; R51-53

N

R: 51/53

S: 61

607-654-00-1

(S)-3-hydroxy-γ-butyrolacton

434-990-4

7331-52-4

R43

Xi

R: 43

S: (2-)23-24-37

607-655-00-7

ethyl-6,8-dichloroctanoat

435-080-1

1070-64-0

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)24-37-61

607-656-00-2

natriumsalt af 4-amino-3,6-bis[[5-[[4-chlor-6-[(2-methyl-4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-2,7-naphthalendisulfonsyre

435-350-7

141250-43-3

Xi; R41

R52-53

Xi

R: 41-52/53

S: (2-)22-26-39-61

607-657-00-8

pentanatrium-7-(4-(4-(3-(2-sulfatoethansulfonyl)phenylamino)-6-(4-(2-sulfatoethansulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalen-1,3,6-trisulfonat

436-920-8

172399-10-9

Xi; R41

Xi

R: 41

S: (2-)22-26-39

607-658-00-3

3,10-diamino-6,13-dichlor-2-((6-(((4-(1,1-dimethylethyl)phenyl)sulfonyl)amino)-2-naphthalenyl)sulfonyl)-4,11-triphenodioxazindisulfonsyre, lithiumkaliumnatriumsalt

440-770-9

371921-63-0

Xi; R41

R52-53

Xi

R: 41-52/53

S: (2-)26-39-61

607-659-00-9

pentanatrium-N-[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-6-chlor-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl] sulfonyl]phenyl]azo]phenyl]-3-aminopropansyre

442-030-0

321912-47-4

Xi; R41

Xi

R: 41

S: (2-)22-26-39

607-660-00-4

2-{4-[4-[4-fluor-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino]phenylazo]phenylazo}naphthalen-4,6,8-trisulfonat, trinatriumsalt

442-230-8

321679-52-1

Xi; R41

Xi

R: 41

S: (2-)22-26-39

607-661-00-X

1,1-dimethylethyl-4′-(brommethyl)biphenyl-2-carboxylat

442-850-9

114772-40-6

R43

R53

Xi

R: 43-53

S: (2-)22-24-37-61

607-662-00-5

methyl-2-(acetylamino)-3-chlorpropionat

442-860-3

87333-22-0

R43

N; R50-53

Xi; N

R: 43-50/53

S: (2-)24-37-60-61

607-663-00-0

bis(2-ethylhexyl)-naphthalen-2,6-dicarboxylat

442-980-6

127474-91-3

R53

R: 53

S: 61

607-664-00-6

methyl-2-chlorsulfonyl-4-(methansulfonylaminomethyl)benzoat

443-120-2

393509-79-0

Xi; R41

N; R51-53

Xi; N

R: 41-51/53

S: (2-)26-39-61

607-665-00-1

trans-methyl-2-ethyl-but-2-enoat

443-150-6

101226-85-1

R10

R: 10

S: 23

607-666-00-7

(2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentansyre

443-560-5

88784-33-2

Xi; R36

Xi

R: 36

S: (2-)26

607-667-00-2

chlor-1-ethylcyclohexylcarbonat

444-950-8

99464-83-2

Muta.Cat.3; R68

R43

Xn

R: 43-68

S: (2-)23-36/37

607-668-00-8

trans-2-isopropyl-5-carboxy-1,3-dioxan

445-770-2

42031-28-7

Xi; R41

R52-53

Xi

R: 41-52/53

S: (2-)22-26-39-61

607-669-00-3

methyl-(9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoat

445-990-9

376588-17-9

R43

R53

Xi

R: 43-53

S: (2-)24-37-61

607-670-00-9

dibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propylammoniumoxalat;

(5-amino-2-butylbenzofuran-3-yl)-[4-(3-dibutylaminopropoxy)phenyl]methanon, dioxalat

448-700-9

500791-70-8

Xn; R48/22

Xi; R41

R43

N; R50-53

Xn; N

R: 41-43-48/22-50/53

S: (2-)22-26-36/37/39-60-61

C ≥ 10 %: Xn, N; R41-43-48/22-50/53

5 % ≤ C < 10 %: Xi, N; R36-43-50/53

2,5 % ≤ C < 5 %: Xi, N; R43-50/53

1 % ≤ C < 2,5 %: Xi, N; R43-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

607-671-00-4

diethyl-1,4-cyclohexandicarboxylat

417-310-0

72903-27-6

N; R51-53

N

R: 51/53

S: 61

607-672-00-X

blanding af: 2-hydroxy-3-(methacryloyloxy)propyl-(2-benzoyl)benzoat;

1-hydroxymethyl-2-(methacryloyloxy)ethyl-(2-benzoyl)benzoat;

x-hydroxy-y-(methacryloyloxy)propyl(eller -ethyl)-(2-benzoyl)benzoat

419-000-0

—

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)24-37-61

607-673-00-5

1-ethyl-5,6,7,8-tetrahydroquinoliniumtosylat

419-570-0

—

Xn; R22

R52-53

Xn

R: 22-52/53

S: (2-)61

607-674-00-0

branched C10-alkyl benzoates

421-090-1

131298-44-7

Xn; R20

Xn

R: 20

S: (2-)23

607-675-00-6

blanding af: cis-9-octadecendisyre;

cis-9-cis-12-octadecadiendisyre;

hexadecandisyre;

octadecandisyre

422-260-8

—

Xi; R41

N; R50-53

Xi; N

R: 41-50/53

S: (2-)26-39-60-61

607-676-00-1

blanding af: 2-methylnonandisyre;

2,4-dimethyl-4-methoxycarbonylundecanedioic acid;

2,4,6-trimethyl-4,6-dimethoxycarbonyltridecandisyre;

8,9-dimethyl-8,9-dimethoxycarbonylhexadecandisyre

423-670-1

—

Xi; R41

R43

Xi

R: 41-43

S: (2-)24-26-37/39

607-677-00-7

2,5-dioxopyrrolidin-1-yl N-{[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl}-L-valinat

424-660-8

—

Xn; R48/22

Xi; R41

R43

Xn

R: 41-43-48/22

S: (2-)22-26-36/37/39

607-678-00-2

blanding af: ethyl-(2R,3R)-3-isopropylbicyclo[2.2.1]hept-5-en-2-carboxylat;

ethyl-(2S,3S)-3-isopropylbicyclo[2.2.1]hept-5-en-2-carboxylat

427-090-8

—

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)23-25-36/37-61

607-679-00-8

blanding af: 3-{5-[3-(4-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(methyl)ammoniumdi(acetat);

3-{5-[4-(3-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido]phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammoniumdi(acetat);

3-{5-[3-(4-{1-[3-(dimethylammonio)propyl]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammoniumdi(acetat)

431-440-5

—

Xi; R41

N; R51-53

Xi; N

R: 41-51/53

S: (2-)22-26-39-61

607-680-00-3

tert-butyl(6-{2-[4-(4-fluorphenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]vinyl}(4S,6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetat

432-810-9

—

R53

R: 53

S: 61

607-681-00-9

blanding af: 9-nonyl-10-octyl-19-carbonyloxyhexadecylnonadecansyre;

9-nonyl-10-octyl-19-carbonyloxyoctadecylnonadecansyre;

dihexadecyl-9-nonyl-10-octylnonadecandioat;

1-octadecyl-19-hexadecyl-9-nonyl-10-octylnonadecandioat;

dioctadecyl-9-nonyl-10-octylnonadecandioat

432-910-2

—

R53

R: 53

S: 61

607-682-00-4

kompleks blanding af kinesisk gummiharpiks, efterfølgende behandlet med acrylsyre

434-230-1

144413-22-9

R53

R: 53

S: 61

607-683-00-X

blanding af: methyl-3-((1E)-2-methylprop-1-enyl)-2,2-dimethylcyclopropancarboxylat;

methyl-3-((1Z)-2-methylprop-1-enyl)-2,2-dimethylcyclopropancarboxylat (20:80)

435-450-0

—

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)24-37-61

607-684-00-5

alkener, C12-14, hydroformyleringsprodukter, destillationsrester, C-(hydrogensulfobutandioater), dinatriumsalte

435-660-2

243662-67-1

Xi; R38

R43

Xi

R: 38-43

S: (2-)24-37

607-685-00-0

ammonium-2-cocoyloxyethansulfonat

441-050-7

—

Xi; R38-41

Xi

R: 38-41

S: (2-)26-37/39

607-686-00-6

6,6′-bis(diazo-5,5′,6,6′-tetrahydro-5,5′-dioxo)[methylen-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonyloxy)-6-methyl-2-phenylen]di(naphthalen-1-sulfonat)

441-550-5

—

E; R2

F; R11

Carc. Cat. 3; R40

E; Xn

R: 2-11-40

S: (2-)7-22-36/37

607-687-00-1

blanding af: 2-{3,6-bis-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (2-10 %);

2-{3,6-bis-[(2,3-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (2-10 %);

2-{3,6-bis-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (2-10 %);

2-{3,6-bis-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (2-10 %);

2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (7-20 %);

2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (7-20 %);

2-{3-[(2,5-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (7-20 %);

2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (7-20 %);

2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (7-20 %);

2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzensulfonat (7-20 %)

442-800-6

—

Xi; R38

N; R51-53

Xi; N

R: 38-51/53

S: (2-)37-61

607-688-00-7

(R)-1-cyclohexa-1,4-dienyl-1-methoxycarbonyl-methylammoniumchlorid

444-320-2

—

Xn; R22

Xn

R: 22

S: (2-)

607-689-00-2

blanding af: methyl-1,4-dimethylcyclohexancarboxylat (»para-isomer« inkl. cis-og trans-isomerer);

methyl-1,3-dimethylcyclohexancarboxylat (»meta-isomer« inkl. cis-og trans-isomerer)

444-920-4

—

R52-53

R: 52/53

S: 61

607-690-00-8

dimethyl-[2S,2S′]-6,6,6′6′-tetramethoxy-2,2′-[N,N′-bis(trifluoracetyl)-S,S′-bi(L-homocysteinyl) diimino]dihexanoat

432-860-1

255387-46-3

R43

Xi

R: 43

S: (2-)24-37

607-691-00-3

magnesiumsalte, fedtsyrer, C16-18-og C18-umættede, forgrenede og lineære

448-690-6

—

R53

R: 53

S: 61

607-692-00-9

zinksalte, fedtsyrer, C16-18-og C18-umættede, forgrenede og lineære

446-470-4

—

R53

R: 53

S: 61

607-693-00-4

hexyl-2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoat

443-860-6

302776-68-7

R53

R: 53

S: 61

607-694-00-X

ethyl-5,5-diphenyl-2-isoxazolin-3-carboxylat

443-870-0

163520-33-0

Xn; R22

R43

N; R50-53

Xn; N

R: 22-43-50/53

S: (2-)22-36/37-60-61

608-042-00-7

(S)-2,2-diphenyl-2-(3-pyrrolidinyl)acetonitrilhydrobromid

421-810-4

194602-27-2

Xn; R22

Xi; R41

R43

N; R51-53

Xn; N

R: 22-41-43-51/53

S: (2-)24-26-37/39-61

608-059-00-X

5-amino-1-(2,6-dichlor-4-(trifluormethyl)phenyl)-1H-pyrazol-3-carbonitril

421-240-6

120068-79-3

N; R51-53

N

R: 51/53

S: 22-61

608-060-00-5

5-methyl-2-[(2-nitrophenyl)amino]-3-thiophencarbonitril

421-300-1

138564-59-7

N; R50-53

N

R: 50/53

S: 22-60-61

608-062-00-6

2-fluor-4-hydroxybenzonitril

422-810-7

82380-18-5

Xn; R22

Xi; R41

N; R51-53

Xn; N

R: 22-41-51/53

S: (2-)22-26-39-61

608-063-00-1

(S)-α-hydroxy-3-phenoxy-benzenacetonitril

441-070-6

61826-76-4

T; R25

Xi; R41

R43

N; R50-53

T; N

R: 25-41-43-50/53

S: (1/2-)9-26-36/37/39-45-60-61

608-064-00-7

cyanmethyltrimethylammoniummethylsulfat

433-720-2

—

R52-53

R: 52/53

S: 61

609-069-00-7

moskusketon;

3,5-dinitro-2,6-dimethyl-4-tert-butylacetophenon;

4′-tert-butyl-2′,6′-dimethyl-3′,5′-dinitroacetophenon

201-328-9

81-14-1

Carc. Cat. 3; R40

N; R50-53

Xn; N

R: 40-50/53

S: (2-)36/37-46-60-61

611-154-00-9

trinatrium-5-benzamido-4-hydroxy-3-(4-methyl-2-sulfonatophenylazo)naphthalen-2,7-disulfonat

403-670-6

92408-46-3

R52-53

R: 52/53

S: 61

611-155-00-4

4,4′-oxybis(benzensulfonylazid)

431-850-4

7456-68-0

E; R3

F; R11

Xn; R48/22

N; R50-53

E; Xn; N

R: 3-11-48/22-50/53

S: (2-)14-22-33-35-36-60-61

611-156-00-X

triammonium-4-[4-[7-(4-carboxylatoanilino)-1-hydroxy-3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoat

432-270-4

221354-37-6

Repr. Cat. 3; R62

Xn; R48/22

N; R51-53

Xn; N

R: 48/22-62-51/53

S: (2-)36/37-61

611-157-00-5

benzensulfonsyre, 3,3′-(methylenbis((dihydroxyphenylen)azo))bis-, kaliumnatriumsalt;

kaliumnatrium-3-[(E)-(6-{3,4-dihydroxy-2-[(Z)-(3-sulfonatophenyl)diazenyl]benzyl}-2,3-dihydroxyphenyl)diazenyl]benzensulfonat

432-590-4

243869-48-9

Xi; R36

R52-53

Xi

R: 36-52/53

S: (2-)26-61

611-158-00-0

reaktionsblanding af: 2,3,4,2′,3′,4′-hexahydroxy-5,5′-diacetyl-diphenylmethan og 6-diazo-5,6-dihydro-5-oxo-1-naphthalensulfonylchlorid og 3-diazo-3,4-dihydro-6-methoxy-4-oxo-1-naphthalensulfonylchlorid

421-520-8

—

F; R11

R53

F

R: 11-53

S: (2-)3-12-16-33-61

611-159-00-6

dinatrium-4-amino-6-((4-((4-(2,4-diaminophenyl)azo)phenylsulfamoyl)phenyl)azo)-5-hydroxy-3-((4-nitrophenyl)azo)naphthalen-2,7-disulfonat

421-880-6

—

Xi; R41

R52-53

Xi

R: 41-52/53

S: (2-)26-39-61

611-160-00-1

blanding af: 1,1,1-tris(phenyl-4′-(3′′-diazo-3′′,4′′-dihydro-4′′-oxo-naphthalen-1′′-sulfonato)ethan;

1,1,1-tris(phenyl-4′-(6′′-diazo-5′′,6′′-dihydro-5′′-oxo-naphthalen-1′′-sulfonato)ethan;

reaktionsprodukt af 1,1,1-tris(p-hydroxyphenyl)ethan med 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchlorid og 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchlorid (2:1);

reaktionsprodukt af 1,1,1-tris(p-hydroxyphenyl)ethan med 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchlorid og 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchlorid (1:2)

422-760-6

—

F; R11

R53

F

R: 11-53

S: (2-)3-12-33-61

611-161-00-7

trinatrium-[1,2′-(2-(8-amino-3,5-disulfonatonaphthalen)azo)-(4′-nitrobenzen)diolato-O,O,N][(Z)-2,2-((phenylcarbamoylprop-1′-enyl)azo)-5-sulfamoylbenzen)diolato-O,O,N]chromat(III)

423-100-1

—

Xi; R41

Xi

R: 41

S: (2-)26-39

611-162-00-2

2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzen-1,3-diolbis(methansulfonat)

429-600-4

—

Xn; R22

Xi; R41

N; R51-53

Xn; N

R: 22-41-51/53

S: (2-)22-26-39-61

611-163-00-8

2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzen-1,3-diolsulfat

429-610-9

—

Xn; R22

Xi; R41

N; R51-53

Xn; N

R: 22-41-51/53

S: (2-)22-26-39-61

611-164-00-3

blanding af: 2,2′-dimethyl-2,2′-azobutannitril;

2-methylpentannitril-2-azo-2′-(2′-methylpropannitril);

2,2′-dimethyl-2,2′-azoheptannitril;

2-methylheptannitril-2-azo-2′-(2′-methylpropannitril);

2-methylheptannitril-2-azo-2′-(2′-methylbutannitril)

429-710-2

—

R10

R32

R44

Xn; R22

N; R51-53

Xn; N

R: 10-22-32-44-51/53

S: (2-)12-15-16-47-51-61

611-165-00-9

blanding af: tetranatrium-4-amino-6-(5-(2,6-difluorpyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(sulfatoethylsulfonyl)phenylazo)naphthalen-2,7-disulfonat;

tetranatrium-4-amino-6-(5-(4,6-difluorpyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethylsulfonyl)phenylazo)naphthalen-2,7-disulfonat

431-830-5

—

R52-53

R: 52/53

S: 61

611-166-00-4

blanding af: pentanatrium-4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalen-2,7-disulfonat;

tetranatrium-4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat;

tetranatrium-4-amino-5-hydroxy-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat

432-100-9

—

Xi; R41

R52-53

Xi

R: 41-52/53

S: (2-)26-39-61

611-167-00-X

natrium-bis[tris(2-hydroxyethyl)ammonium][6-anilino-4′-(4,8-disulfonato-2-naphthylazo)-5′-methyl-3-sulfonatonaphthalen-2-azobenzen-1,2′-diolato]cuprat(II)

435-240-9

—

R52-53

R: 52/53

S: 61

611-168-00-5

blanding af: 3-[[4-chlor-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-5-[[4-chlor-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfophenyl)azo]-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoesyre;

3,5-bis[[4-chlor-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoesyre

435-440-6

—

Xi; R41

Xi

R: 41

S: (2-)22-26-39

611-169-00-0

natrium-5-(2-carboxyphenylazo)-6-hydroxynaphthalen-2-sulfonat

435-800-2

—

R52-53

R: 52/53

S: 61

611-170-00-6

blanding af: trinatrium-2-((1-(2-hydroxy-κ-O-5-(2-sulfonatoethansulfonyl)phenylazo-κ-N
  2)-1-phenylmethyl)azo-κ-N
  1)-4-sulfonatobenzoat(5-)-κ-O)cuprat(II);

dinatrium-2-((1-(5-ethensulfonyl-2-hydroxy-κ-O-phenylazo-κ-N
  2)-1-phenylmethyl)azo-κ-N
  1)-4-sulfonatobenzoat-κ-O-(5-))cuprat(II)

435-880-9

—

R52-53

R: 52/53

S: 22-61

611-171-00-1

blanding af: trinatrium-3-(5-(2,6-difluorpyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-(4-fluor-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalendisulfonat;

trinatrium-3-(5-(4,6-difluorpyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-(4-fluor-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalendisulfonat

436-890-6

—

Xi; R41

R52-53

Xi

R: 41-52/53

S: (2-)22-26-39-61

611-172-00-7

blanding af: triammonium-6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)phenyl)azo-4-hydroxy-2-naphthalensulfonat;

diammonium-3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)azo)-2,5-diethoxyphenyl)azo)benzoat

438-310-7

—

E; R2

Repr. Cat. 3; R62

Xn; R22-48/22

R52-53

E; Xn

R: 2-22-48/22-62-52/53

S: (2-)22-35-36/37-61

611-173-00-2

blanding af: 3-[3-carbamoyl-5-(5-{4-chlor-6-[4-(2-sulfonatooxyethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propansyre, trinatriumsalt;

3-[3-carbamoyl-5-(5-{4-chlor-6-[4-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propansyre, dinatriumsalt

440-510-4

—

Xi; R41

R43

Xi

R: 41-43

S: (2-)22-26-36/37/39

611-174-00-8

blanding af: 3-[5-(4-ethensulfonylbutyrylamino)-2-sulfophenylazo]-5-{4-chlor-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalen-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalen-2,7-disulfonsyre, natriumsalt;

3-[5-(4-(2-chlorethansulfonyl)butyrylamino)-2-sulfophenylazo]-5-{4-chlor-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalen-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalen-2,7-disulfonsyre, natriumsalt

442-290-5

457624-86-1

Xi; R41

Xi

R: 41

S: (2-)22-26-39

611-175-00-3

blanding af: trinatrium-5-{4-chlor-6-[N-ethyl-(3-(2-sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat;

trinatrium-5-{4-chlor-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]naphthalen-2,7-disulfonat;

dinatrium-5-{4-chlor-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[(4-vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat;

tetranatrium-5-{4-chlor-6-[N-ethyl-3-(2-(sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]-4-hydroxynaphthalen-2,7-disulfonat

444-050-5

—

Xi; R41

R52-53

Xi

R: 41-52/53

S: (2-)22-26-39-61

611-176-00-9

2,6-bis(2,3,4-trihydroxybenzyl)-p-cresol, ester med 6-diazo-5,6-dihydro-5-oxo-1-naphthalensulfonat

444-250-2

—

E; R2

F; R11

N; R51-53

E; N

R: 2-11-51/53

S: (2-)22-61

611-177-00-4

blanding af: pentanatrium-bis[6-anilino-3,5′-disulfonatonaphthalen-2-azobenzen-1,2′-diolato]cobaltat(III);

tetranatrium-[6-anilino-3,5′-disulfonatonaphthalen-2-azobenzen-1,2′-diolato][6-anilino-5′-sulfamoyl-3-sulfonatonaphthalen-2-azobenzen-1,2′-diolato]cobaltat(III);

trinatrium-bis[6-anilino-5′-sulfamoyl-3-sulfonatonaphthalen-2-azobenzen-1,2′-diolato]cobaltat(III)

444-290-0

508202-43-5

Xi; R41

R43

R52-53

Xi

R: 41-43-52/53

S: (2-)22-24-26-37/39-61

611-178-00-X

blanding af: pentanatrium-4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalen-2,7-disulfonat;

tetranatrium-4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat;

tetranatrium-4-amino-5-hydroxy-6-[(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat;

trinatrium-4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat;

trinatrium-4-amino-5-hydroxy-3-[(2-hydroxyethylsulfonyl)-phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalen-2,7-disulfonat;

trinatrium-4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[2-sulfonato-4-(2-hydroxyethylsulfonyl)phenylazo]naphthalen-2,7-disulfonat

445-280-9

—

Xi; R41

R43

R52-53

Xi

R: 41-43-52/53

S: (2-)24-26-37/39-61

611-179-00-5

blanding af: pentanatrium-2-[[8-[[4-chlor-6-[[4-(2-sulfonatoethylsulfonyl)]phenyl]amino]-1,3,5-triazin-2-yl]amino-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalen-1,5-disulfonat;

2-[[8-[[4-chlor-6-[[4-[[2-ethenyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalen-1,5-disulfonat

450-010-8

—

Xi; R41

R43

Xi

R: 41-43

S: (2-)22-24-26-37/39

611-180-00-0

jern, komplekser med diazoteret 4-aminobenzensulfonamid, diazoteret 3-aminobenzensulfonsyre, diazoteret 3-amino-4-hydroxybenzensulfonamid,diazoteret 3-amino-4-hydroxy-N-phenylbenzensulfonamid, diazoteret 5-amino-2-(phenylamino)benzensulfonsyre og resorcinol, natriumsalte

417-850-7

—

N; R51-53

N

R: 51/53

S: 22-61

612-238-00-8

(3-chlor-2-hydroxypropyl)trimethylammoniumchlorid ...%

B

222-048-3

3327-22-8

Carc. Cat. 3, R40

R52-53

Xn

R: 40-52/53

S: 36/37-61

612-239-00-3

biphenyl-3,3′,4,4′-tetrayltetraamin;

diaminobenzidin

202-110-6

91-95-2

Carc. Cat. 2; R45

Muta. Cat. 3; R68

T

R: 45-68

S: 53-45

612-240-00-9

pyrimethanil (ISO);

N-(4,6-dimethylpyrimidin-2-yl)anilin

—

53112-28-0

N; R51-53

N

R: 51/53

S: 61

612-241-00-4

piperazinhydrochlorid; [1]

piperazindihydrochlorid; [2]

piperazinphosphat [3]

228-042-7 [1]

205-551-2 [2]

217-775-8 [3]

6094-40-2 [1]

142-64-3 [2]

1951-97-9 [3]

Repr. Cat. 3; R62-63

Xi; R36/38

R42/43

R52-53

Xn

R: 36/38-42/43-62-63-52/53

S: (1/2-)22-36/37-45-63-61

612-242-00-X

cyprodinil (ISO);

4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amin

—

121552-61-2

R43

N; R50-53

Xi; N

R: 43-50/53

S: (2-)24-37-46-60-61

C ≥ 2,5 %: Xi, N; R43-50/53

1 % ≤ C < 2,5 %: Xi, N; R43-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

612-243-00-5

(1S-cis)-4-(3,4-dichlorphenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamin-2-hydroxy-2-phenylacetat

420-560-3

79617-97-3

Xi; R41

N; R50-53

Xi; N

R: 41-50/53

S: (2-)26-39-60-61

C ≥ 10 %: Xi, N; R41-50/53

5 % ≤ C < 10 %: Xi, N; R36-50/53

2,5 % ≤ C < 5 %: N; R50/53

0,25 % ≤ C < 2, 5 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

612-244-00-0

3-(piperazin-1-yl)-benzo[d]isothiazolhydrochlorid

421-310-6

87691-88-1

Repr. Cat. 3; R62

Xn; R22

Xi; R36

R43

N; R50-53

Xn; N

R: 22-36-43-62-50/53

S: (2-)22-26-36/37/39-60-61

612-245-00-6

2-ethylphenylhydrazinhydrochlorid

421-460-2

19398-06-2

Carc. Cat. 3; R40

T; R48/25

Xn; R22

Xi; R41

R43

N; R50-53

T; N

R: 22-40-41-43-48/25-50/53

S: (1/2-)22-26-36/37/39-45-60-61

C ≥ 25 %: T, N; R22-40-41-43-48/25-50/53

10 % ≤ C < 25 %: T, N; R40-41-43-48/25-50/53

5 % ≤ C < 10 %: Xn, N; R36-40-43-48/22-50/53

2,5 % ≤ C < 5 %: Xn, N; R40-43-48/22-50/53

1 % ≤ C < 2,5 %: Xn, N; R40-43-48/22-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

612-246-00-1

(2-chlorethyl)(3-hydroxypropyl)ammoniumchlorid

E

429-740-6

40722-80-3

Carc. Cat. 2; R45

Muta. Cat. 2; R46

Xn; R48/22

R43

R52-53

T

R: 45-46-43-48/22-52/53

S: 53-45-61

612-247-00-7

N-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N′-hydroxy-4-nitrobenzencarboximidamid

423-530-8

152828-23-4

T; R48/25

Xn; R22

R52-53

T

R: 22-48/25-52/53

S: (1/2-)22-36-45-61

612-248-00-2

reaktionsprodukt af diphenylamin, phenothiazin og alkener, forgrenede (C8-10, C9-rige)

439-540-0

—

Xi; R38

R43

R53

Xi

R: 38-43-53

S: (2-)24-37-61

612-249-00-8

4-[(3-chlorphenyl)(1H-imidazol-1-yl)methyl]-1,2-benzendiamindihydrochlorid

425-030-5

159939-85-2

Repr. Cat. 3; R62

Xn; R22

C; R34

R43

N; R51-53

C; N

R: 22-34-43-62-51/53

S: (1/2-)22-26-36/37/39-45-61

612-250-00-3

chlor-N,N-dimethylformiminiumchlorid

E

425-970-6

3724-43-4

R14

Repr. Cat. 2; R61

Xn; R22

C; R35

T; C

R: 61-14-22-35

S: 53-45

612-251-00-9

cis-1-(3-chlorallyl)-3,5,7-triaza-1-azoniaadamantanchlorid

426-020-3

51229-78-8

F; R11

Repr. Cat. 3; R63

Xn; R22

Xi; R38

R43

N; R51-53

F; Xn; N

R: 11-22-38-43-63-51/53

S: (2-)7-22-33-36/37-61

612-252-00-4

imidacloprid (ISO);

1-(6-chlorpyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamin

428-040-8

138261-41-3

Xn; R22

N; R50-53

Xn; N

R: 22-50/53

S: (2-)22-57-60-61

612-253-00-X

7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-on;

[indeholdende < 0,5 % formamid (EF-nr. 200-842-0)]

429-400-7

199327-61-2

R52-53

R: R52/53

S: 61

612-253-01-7

7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-on;

[indeholdende ≥ 0,5 % formamid (EF-nr. 200-842-0) ]

429-400-7

199327-61-2

Repr. Cat. 2; R61

R52-53

T

R: 61-52/53

S: 53-45-61

612-254-00-5

reaktionsprodukter af diisopropanolamin med formaldehyd (1:4)

432-440-8

220444-73-5

Carc. Cat. 3; R40

Xn; R22

C; R34

R43

N; R51-53

C; N

R: 22-34-40-43-51/53

S: (1/2-)13-25-26-36/37/39-45-61

612-255-00-0

1-(3-methoxypropyl)-4-piperidinamin

431-950-8

179474-79-4

Xn; R21/22

C; R34

R52-53

C

R: 21/22-34-52/53

S: (1/2-)26-36/37/39-45-61

612-256-00-6

benzyl(S)-2-[(2′-cyanbiphenyl-4-ylmethyl)pentanoylamino]-3-methylbutyrat

427-470-3

137864-22-3

Xn; R22

R43

Xn

R: 22-43

S: (2-)36/37

612-257-00-1

tripropylammoniumdihydrogenphosphat

433-700-3

35687-90-2

Xn; R22

Xn

R: 22

S: (2-)22

612-259-00-2

N-ethyl-3-trimethoxysilyl-2-methyl-propanamin

437-720-3

227085-51-0

Xi; R41

Xi

R: 41

S: (2-)26-39

612-261-00-3

3,5-dichlor-2-fluor-4-(1,1,2,3,3,3-hexafluorpropoxy)anilin

441-190-9

121451-05-6

Xn; R22

R43

N; R50-53

Xn; N

R: 22-43-50/53

S: (2-)24-37-60-61

C ≥ 25 %: Xn, N; R22-43-50/53

2,5 % ≤ C < 25 %: Xi, N; R43-50/53

1 % ≤ C < 2,5 %: Xi, N; R43-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

612-265-00-5

bis(2-hydroxyethyl)-(2-hydroxypropyl)ammoniumacetat

444-360-0

191617-13-7

R52-53

R: 52/53

S: 61

612-266-00-0

3-chlor-4-(3-fluorbenzyloxy)anilin

445-590-4

202197-26-0

Muta. Cat. 3; R68

Xn; R22-48/22

N; R50-53

Xn; N

R: 22-48/22-68-50/53

S: (2-)22-36/37-60-61

612-267-00-6

bis(hydrogeneret C16-18-talgalkyl)hydroxylamin

418-370-0

—

R43

R53

Xi

R: 43-53

S: (2-)36/37-61

612-269-00-7

blanding af: 1-[di(4-octylphenyl)aminomethyl]-5-methyl-1H-benzotriazol;

1-[di(4-octylphenyl)aminomethyl]-4-methyl-1H-benzotriazol;

blanding af: N-[(5-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)anilin;

N-[(4-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)anilin

420-720-2

—

R53

R: 53

S: 22-61

612-270-00-2

(S)-azetidin-2-carboxylsyre-4-cyanbenzylamidhydrochlorid

433-010-2

—

Xn; R22

R43

R52-53

Xn

R: 22-43-52/53

S: (2-)22-36/37-61

612-271-00-8

blanding af: ethyl-2-((4-(5,6-dichlorbenzothiazol-2-ylazo)phenyl)ethylamino)benzoat;

ethyl-2-((4-(6,7-dichlorbenzothiazol-2-ylazo)phenyl)ethylamino)benzoat

434-970-5

160987-57-5

R53

R: 53

S: 61

612-272-00-3

ammonium-(η-6-2-(2-(1,2-dicarboxylatoethylamino)ethylamino)butan-1,4-dioato(4-))jern(3+)monohydrat

435-210-5

—

N; R51-53

N

R: 51/53

S: 61

612-273-00-9

alkyl(rapsolie), bis(2-hydroxyethyl)ammoniumfluorid

435-650-8

—

Xn; R22

C; R35

N; R50-53

C; N

R: 22-35-50/53

S: (1/2-)26-36/37/39-45-60-61

612-274-00-4

(R,S)-1-[2-amino-1(4-methoxyphenyl)ethyl]cyclohexanolacetat

445-750-3

—

Xn; R22

Xi; R41

R43

R52-53

Xn

R: 22-41-43-52/53

S: (2-)22-24-26-37/39-61

612-275-00-X

fedtsyrer, C18-umættede, dimerer, reaktionsprodukter med 1-piperazinethanamin og tallolie

447-880-6

206565-89-1

Xi; R38-41

R43

N; R50-53

Xi; N

R: 38-41-43-50/53

S: (2-)23-26-36/37/39-60-61

C ≥ 20 %: Xi, N; R38-41-43-50/53

10 % ≤ C < 20 %: Xi, N; R41-43-50/53

5 % ≤ C < 10 %: Xi, N; R36-43-50/53

2,5 % ≤ C < 5 %: Xi, N; R43-50/53

1 % ≤ C < 2,5 %: Xi, N; R43-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

612-276-00-5

1-amino-4-[(4-amino-2-sulfophenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracensulfonsyre, dinatriumsalt, reaktionsprodukter med 2-[[3-[(4,6-dichlor-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethylhydrogensulfat, natriumsalte

451-430-4

500717-36-2

Xi; R41

R43

R52-53

Xi

R: 41-43-52/53

S: (2-)22-24-26-36/37/39-61

612-277-00-0

blanding af: 4-amino-3-(4-ethensulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{4-chlor-6-[4-(2-sulfonatooxyethansulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)naphthalen-2,7-disulfonat kalium/natrium;

4-amino-5-hydroxy-6-(5-{4-chlor-6-[4-(2-sulfonatooxyethansulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethansulfonyl)phenylazo)naphthalen-2,7-disulfonat kalium/natrium

451-440-9

586372-44-3

Xi; R41

Xi

R: 41

S: (2-)22-26-39

612-278-00-6

ethidiumbromid;

3,8-diamino-1-ethyl-6-phenylphenantridiniumbromid

214-984-6

1239-45-8

Muta. Cat. 3; R68

T+; R26

Xn; R22

T+

R: 22-26-68

S: (1/2-)28-36/37-45-63

612-279-00-1

(R,S)-2-amino-3,3-dimethylbutanamid

447-860-7

144177-62-8

Repr. Cat. 3; R62

Xn; R48/22

Xi; R36/38

R43

Xn

R: 36/38-43-48/22-62

S: (2-)22-26-36/37

612-280-00-7

3-amino-9-ethylcarbazol;

9-ethylcarbazol-3-ylamin

H

205-057-7

132-32-1

Carc. Cat. 2; R45

T

R: 45

S: 53-45

613-116-01-4

tolylfluanid (ISO);

dichlor-N-[(dimethylamino)sulfonyl]fluor-N-(p-tolyl)methansulfenamid;

[indeholdende < 0,1 % (w/w) partikler med en aerodynamisk diameter på mindre end 50 μm]

211-986-9

731-27-1

Xi; R36/37/38

R43

N; R50

Xi; N

R: 36/37/38-43-50

S: (2-)25-36/37-46-61

C ≥ 20 %: Xi, N; R36/37/38-43-50

2,5 % ≤ C < 20 %: Xi, N; R43-50

1 % ≤ C < 2,5 %: Xi; R43

613-280-00-X

tetrahydro-1,3-dimethyl-1H-pyrimidin-2-on;

dimethylpropylenurinstof

230-625-6

7226-23-5

Repr. Cat. 3; R62

Xn; R22

Xi; R41

Xn

R: 22-41-62

S: 26-36/37/39

613-281-00-5

quinolin

E

202-051-6

91-22-5

Carc. Cat. 2; R45

Muta. Cat. 3; R68

Xn; R21/22

Xi; R36/38

N; R51-53

T; N

R: 45-21/22-36/38-68-51/53

S: 53-45-61

613-282-00-0

triticonazol (ISO);

(RS)-(E)-5-(4-chlorbenzyliden)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol

—

131983-72-7

N; R51-53

N

R: 51/53

S: 61

613-283-00-6

ketoconazol;

1-[4-[4-[[(2SR,4RS)-2-(2,4-dichlorphenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanon

E

265-667-4

65277-42-1

Repr. Cat. 2; R60

T; R25

Xn; R48/22

N; R50-53

T; N

R: 60-25-48/22-50/53

S: 53-45-60-61

613-284-00-1

metconazol (ISO);

(1RS,5RS;1RS,5SR)-5-(4-chlorbenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol

—

125116-23-6

Repr. Cat. 3; R63

Xn; R22

N; R51-53

Xn; N

R: 22-63-51/53

S: (2-)36/37-46-61

613-285-00-7

1-hydroxybenzotriazol, vandfri; [1]

1-hydroxybenzotriazol, monohydrat [2]

219-989-7 [1]

219-989-7 [2]

2592-95-2 [1]

123333-53-9 [2]

E; R2

E

R: 2

S: 16-35

613-286-00-2

kalium-1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-yliden)-1-propenyl]pyrazol-5-olat;

[indeholdende < 0,5 % N,N-dimethylformamid (EF-nr. 200-679-5)]

418-260-2

183196-57-8

R43

Xi

R: 43

S: (2-)24-37

613-286-01-X

kalium-1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-yliden)-1-propenyl]pyrazol-5-olat;

[indeholdende ≥ 0,5 % N,N -dimethylformamid (EF-nr. 200-679-5)]

418-260-2

183196-57-8

Repr. Cat. 2; R61

R43

T

R: 61-43

S: 53-45

613-287-00-8

1-(3-iod-4-aminobenzyl)-1H-1,2,4-triazol

419-540-7

160194-26-3

Xn; R22

R43

N; R51-53

Xn; N

R: 22-43-51/53

S: (2-)24-37-61

613-288-00-3

1,3-bis(dimethylcarbamoyl)-imidazoliumchlorid

420-930-4

135756-61-5

Xn; R22

Xi; R41

R52-53

Xn

R: 22-41-52/53

S: (2-)22-26-37/39-61

613-289-00-9

3-(4-chlor-2-fluor-5-methylphenyl)-1-methyl-5-(trifluormethyl)-1H-pyrazol

432-020-4

142623-48-1

N; R50-53

N

R: 50/53

S: 60-61

613-290-00-4

4-hydroxy-7-(2-aminoethyl)-1,3-benzothiazol-2(3H)-onhydrochlorid

432-470-1

189012-93-9

Xi; R41

R43

N; R50-53

Xi; N

R: 41-43-50/53

S: (2-)24-26-37/39-60-61

613-291-00-X

2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3H-1,2,4-triazol-3-on

434-820-9

106461-41-0

Xn; R48/22

N; R50-53

Xn; N

R: 48/22-50/53

S: (2-)22-36-60-61

613-292-00-5

N,N′,N′′-tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazin

435-010-8

26157-73-3

Muta. Cat. 3; R68

R52-53

Xn

R: 68-52/53

S: (2-)36/37-61

613-293-00-0

2-(4-tert-butylphenyl)-6-cyan-5-[bis(ethoxycarbonylmethyl)carbamoyloxy]-1H-pyrrolo[1,2-b][1,2,4] triazol-7-carboxylsyre-2,6-di-tert-butyl-4-methylcyclohexylester

448-050-6

444065-11-6

R53

R: 53

S: 61

613-294-00-6

2-hexyldecansyre-[4-(6-tert-butyl-7-chlor-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenylcarbamoyl]methylester

448-260-8

379268-96-9

R53

R: 53

S: 61

613-295-00-1

11-amino-3-chlor-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]thiazepinhydrochlorid

448-720-8

363138-44-7

Xn; R22

Xi; R41

R52-53

Xn

R: 22-41-52/53

S: (2-)22-26-39-61

613-296-00-7

pentakalium-2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-yliden]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1-yl)benzen-1,4-disulfonat

418-270-7

—

R43

R52-53

Xi

R: 43-52/53

S: (2-)24-37-47-61

613-297-00-2

5-(2-bromphenyl)-2-tert-butyl-2H-tetrazol

420-820-6

—

R10

Xn; R22

N; R51-53

Xn; N

R: 10-22-51/53

S: (2-)16-61

613-298-00-8

bis-(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-phenylazo)-1H-pyridin-2-on)ethylendilactat

421-560-6

—

Xn; R48/22

Xi; R41

N; R51-53

Xn; N

R: 41-48/22-51/53

S: (2-)22-26-36/39-61

613-299-00-3

hovedkomponent 1 (isomer 1): 2-{6-fluor-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonapht-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluor-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}propan natriumsalt;

hovedkomponent 1 (isomer 2): 2-{6-fluor-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluor-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}propan natriumsalt;

hovedkomponent 2: 2,3-bis-{6-fluor-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}propan natriumsalt;

hovedkomponent 3: 2,3-bis-{6-fluor-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}propan natriumsalt

422-610-1

—

Xi; R41

Xi

R: 41

S: (2-)22-26-39

613-300-00-7

1-imidazol-1-yl-octadecan-2-ol

434-120-3

—

R43

R53

Xi

R: 43-53

S: (2-)24-37-61

613-301-00-2

dimethyl-1-{[2-methoxy-5-(2-methyl-butoxycarbonyl)phenylcarbamoyl]-[2-octadecyl-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]methyl}imidazol-4,5-dicarboxylat

443-910-7

—

R53

R: 53

S: 61

613-302-00-8

dinatrium-2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydro-pyridin-3-ylazo)-4-(4-fluor-6-(4-(2-sulfonyloxy-ethylsulfonyl)-phenylamino)-1,3,5-triazin-2-ylamino)benzensulfonat

432-980-4

243858-60-8

Xi; R41

Xi

R: 41

S: (2-)22-26-39

613-303-00-3

2-(1-methyl-2-(4-phenoxyphenoxy)ethoxy)pyridin

429-800-1

95737-68-1

N; R50-53

N

R: 50/53

S: 60-61

613-304-00-9

5,6-dihydroxy-2,3-dihydro-1H-indoliumbromid

421-170-6

138937-28-7

Xn; R22

Xi; R41

Xn

R: 22-41

S: (2-)22-26-39

613-305-00-4

2-(2-hydroxy-4-octyloxyphenyl)-2H-benzotriazol

448-630-9

3147-77-1

R53

R: 53

S: 61

613-306-00-X

(2,5-dioxopyrrolidin-1-yl)-9H-fluoren-9-ylmethylcarbonat

433-520-5

82911-69-1

Xn; R22

R43

N; R51-53

Xn; N

R: 22-43-51/53

S: (2-)24-37-61

613-307-00-5

clothianidin (ISO);

3-[(2-chlor-1,3-thiazol-5-yl)methyl]-2-methyl-1-nitroguanidin

—

210880-92-5

Xn; R22

N; R50-53

Xn; N

R: 22-50/53

S: (2-)46-60-61

C ≥ 25 %: Xn, N; R22-50/53

2,5 % ≤ C < 25 %: N; R50/53

0,25 % ≤ C < 2,5 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52/53

613-308-00-0

2-amino-5-methylthiazol

423-800-5

7305-71-7

Xn; R22-48/22

N; R50-53

Xn; N

R: 22-48/22-50/53

S: (2-)22-36-60-61

613-309-00-6

1-methyl-3-phenyl-1-piperazin

431-180-2

5271-27-2

Xn; R21/22

Xi; R38-41

R52-53

Xn

R: 21/22-38-41-52/53

S: (2-)26-36/37/39-61

613-310-00-1

(-)(3S,4R)-4-(4-fluorphenyl)-3-(3,4-methylendioxy-phenoxymethyl)-N-benzylpiperidinhydrochlorid

432-360-3

105813-13-6

Xn; R22

R43

N; R50-53

Xn; N

R: 22-43-50/53

S: (2-)22-24-37-60-61

613-311-00-7

methyl-5-nitrophenyl-guanidin

435-500-1

152460-07-6

Xn; R22

Xi; R36

R43

R52-53

Xn

R: 22-36-43-52/53

S: (2-)22-24-26-37-61

613-312-00-2

2-(4-methyl-2-phenyl-1-piperazinyl)benzenmethanolmonohydrochlorid

420-200-5

—

Xn; R22

Xi; R41

R43

R52-53

Xn

R: 22-41-43-52/53

S: (2-)22-26-36/37/39-61

613-313-00-8

2-(4-(4-(3-pyridinyl)-1H-imidazol-1-yl)butyl)-1H-isoindol-1,3(2H)-dion

442-780-9

173838-67-0

R52-53

R: 52/53

S: 61

613-314-00-3

4-decyloxazolidin-2-on;

4-decyl-1,3-oxazolidin-2-on

443-770-7

7693-82-5

N; R50-53

N

R: 50/53

S: 22-24-60-61

613-315-00-9

tetrakalium-4-[5-[3-carboxylato-4,5-dihydro-5-oxo-1-(4-sulfonatophenyl)pyrazol-4-yliden]-3-(piperidinocarbonyl)penta-1,3-dienyliden]-5-hydroxy-1-(4-sulfonatophenyl)pyrazol-3-carboxylat

430-390-1

—

Xn; R20

R52-53

Xn

R: 20-52/53

S: (2-)25-61

613-316-00-4

trimethylopropan-tri(3-aziridinylpropanoat);

(TAZ)

H

257-765-0

52234-82-9

Muta. Cat. 3; R68

Xi; R41

R43

Xn

R: 41-43-68

S: 26-36/37/39-42

615-044-00-1

4-chlorphenylisocyanat

203-176-9

104-12-1

T+; R26

Xn; R22

Xi; R37/38-41

R42

N; R50-53

T+; N

R: 22-26-37/38-41-42-50/53

S: (1/2-)26-28-36/37/39-45-63-60-61

615-045-00-7

4,4′-methylen-bis(3-chlor-2,6-di-ethylphenylisocyanat)

420-530-1

—

R42/43

R53

Xn

R: 42/43-53

S: (2-)23-24-37-45-61

616-126-00-X

1-methyl-4-nitro-3-propyl-1H-pyrazol-5-carboxamid

423-960-6

139756-01-7

Xn; R22-48/22

R52-53

Xn

R: 22-48/22-52/53

S: (2-)22-36/37-61

616-164-00-7

dimoxystrobin (ISO);

(E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamid

—

149961-52-4

Carc. Cat. 3; R40

Repr. Cat. 3; R63

Xn; R20

N; R50-53

Xn; N

R: 20-40-63-50/53

S: (2-)36/37-46-60-61

C ≥ 25 %: Xn, N; R20-40-63-50/53

5 % ≤ C < 25 %: Xn, N; R40-63-50/53

2,5 % ≤ C < 5 %: Xn, N; R40-50/53

1 % ≤ C < 2,5 %: Xn, N; R40-51/53

0,25 % ≤ C < 1 %: N; R51/53

0,025 % ≤ C < 0,25 %: R52-53

616-165-00-2

beflubutamid (ISO);

(RS)-N-benzyl-2-(α,α,α,4-tetrafluor-m-tolyoxy)butyramid

—

113614-08-7

N; R50-53

N

R: 50/53

S: 60-61

C ≥ 0,25 %: N; R50/53

0,025 % ≤ C < 0,25 %: N; R51/53

0,0025 % ≤ C < 0,025 %: R52/53

616-166-00-8

cyazofamid (ISO);

4-chlor-2-cyan-N,N-dimethyl-5-p-tolylimidazol-1-sulfonamid

—

120116-88-3

N; R50-53

N

R: 50/53

S: 60-61

C ≥ 2,5 %: N; R50/53

0,25 % ≤ C < 2,5 %: N; R51-53

0,025 % ≤ C < 0,25 %: R52/53

616-167-00-3

N,N-dibutyl-(2,5-dihydro-5-thioxo-1H-tetrazol-1-yl)acetamid

418-290-6

168612-06-4

Xi; R36

R43

Xi

R: 36-43

S: (2-)24-26-37

616-168-00-9

1-dimethylcarbamoyl-4-(2-sulfonatoethyl)pyridinium

418-440-0

136997-71-2

R43

Xi

R: 43

S: (2-)22-24-37

616-169-00-4

4-[4-(2,2-dimethyl-propanamido)]phenylazo-3-(2-chlor-5-(2-(3-pentadecylphenoxy)butylamido)anilino)-1-(2,4,6-trichlorphenyl)-2-pyrazolin-5-on

420-220-4

92771-56-7

R43

R53

Xi

R: 43-53

S: (2-)24-37-61

616-170-00-X

(2R)-2-amino-2-phenylacetamid

420-370-0

6485-67-2

Xi; R36

R43

Xi

R: 36-43

S: (2-)22-26-36/37

616-171-00-5

2-(p-chlorphenyl)glycinamid

420-830-0

102333-75-5

Xi; R41

R43

Xi

R: 41-43

S: (2-)24-26-37/39

616-172-00-0

N-(2,2,6,6,-tetramethyl-1-oxylpiperidin-4-yl)acetamid;

(4-acetamido-2,2,6,6-tetramethyl-1-piperidinyl)oxidanyl

423-840-3

14691-89-5

Xn; R22

Xn

R: 22

S: (2-)22

616-174-00-1

2-butyl-1,3-diazaspiro[4.4]non-1-en-4-onhydrochlorid

424-560-4

151257-01-1

Xn; R22

Xi; R36

Xn

R: 22-36

S: (2-)22-26

616-175-00-7

2-(2-hexyldecyloxy)benzamid

431-230-3

202483-62-3

R53

R: 53

S: 61

616-176-00-2

3-N,N-bis(methoxyethyl)aminoacetanilid

432-530-7

24294-01-7

Xn; R22

R52-53

Xn

R: 22-52/53

S: (2-)22-24-61

616-177-00-8

(3-(4-(2-(butyl-(4-methylphenylsulfonyl)-amino)-phenylthio)-5-oxo-1-(2,4,6-trichlorphenyl)-4,5-dihydro-1H-pyrazol-3-ylamino)-4-chlorphenyl)tetradecanamid;

N-[3-({4-[(2-{butyl[(4-methylphenyl)sulfonyl]amino}phenyl)thio]-5-oxo-1-(2,4,6-trichlorphenyl)-4,5-dihydro-1H-pyrazol-3-yl}amino)-4-chlorphenyl]tetradecanamid

432-970-1

217324-98-6

R53

R: 53

S: 61

616-178-00-3

N-(5-(bis(2-methoxyethyl)amino)-2-((2-cyan-4,6-dinitrophenyl)azo)phenyl)acetamid

434-500-9

52583-35-4

R53

R: 53

S: 22-61

616-179-00-9

2-chlor-N-(4-methylphenyl)acetamid

435-170-9

16634-82-5

Xi; R41

R43

N; R50-53

Xi; N

R: 41-43-50/53

S: (2-)22-26-36/37/39-60-61

616-180-00-4

N,N-(dimethylamino)thioacetamidhydrochlorid

435-470-1

27366-72-9

Repr. Cat. 2; R61

N; R50-53

T; N

R: 61-50/53

S: 53-45-60-61

616-181-00-X

4′-methyldodecan-1-sulfonanilid

435-490-9

17417-32-2

N; R50-53

N

R: 50/53

S: 60-61

616-182-00-5

N′-(1,3-dimethylbutyliden)-3-hydroxy-2-naphthohydrazid

435-860-1

214417-91-1

R43

N; R51-53

Xi; N

R: 43-51/53

S: (2-)24-37-61

616-183-00-0

N-dodecyl-4-methoxybenzamid

442-340-6

1854-15-5

R53

R: 53

S: 61

616-184-00-6

3-methyl-N-(5,8,13,14-tetrahydro-5,8,14-trioxonaphth[2,3-c]acridin-6-yl)benzamid

442-560-2

105043-55-8

R53

R: 53

S: 61

616-186-00-7

N,N′-(2-chlor-1,4-phenylen)bis(3-oxobutanamid)

443-010-4

53641-10-4

R52-53

R: 52/53

S: 61

616-188-00-8

2-(5,5-dimethyl-2,4-dioxooxazolidin-3-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-octadecanoylaminophenyl)pentansyreamid

443-980-9

221215-20-9

R43

R53

Xi

R: 43-53

S: (2-)24-37-61

616-189-00-3

N-[5-(bis-(2-methoxy-ethyl)-amino]-2-(6-brom-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-phenyl]acetamid

444-780-4

452962-97-9

R53

R: 53

S: 61

616-190-00-9

N-decyl-4-nitrobenzamid

445-880-0

64026-19-3

R53

R: 53

S: 61

616-191-00-4

2-ethyl-N-methyl-N-(3-methylphenyl)butanamid

446-190-2

406488-30-0

Xn; R22

Xi; R36/38

R43

N; R51-53

Xn; N

R: 22-36/38-43-51/53

S: (2-)24-26-37-61

616-192-00-X

2-[2-(3-butoxypropyl)-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]-5′-tert-butyl-2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-2′-[(2-ethylhexyl)thio]acetanilid

448-060-0

727678-39-9

R53

R: 53

S: 61

616-193-00-5

N-[2-(2-butyl-4,6-dicyan-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-5-diethylamino-phenyl]acetamid

449-940-7

368450-39-9

R53

R: 53

S: 61

616-194-00-0

2,2-diethoxy-N,N-dimethylacetamid

449-950-1

34640-92-1

Xi; R36

Xi

R: 36

S: (2-)26

616-196-00-1

dinatriumsalt af 1-hydroxy-4-(β-(4-(1-hydroxy-3,6-disulfo-8-acetylamino-2-naphthylazo)phenoxy)ethoxy)-N-dodecyl-2-naphthamid

419-990-4

—

N; R50-53

N

R: 50/53

S: 60-61

616-197-00-7

blanding af: kalium-N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoroctansulfonamidat;

N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoroctansulfonamid

422-500-1

—

Xn; R48/22

Xn

R: 48/22

S: (2-)22-36

616-198-00-2

1,3-bis[12-hydroxy-octadecamid-N-methylen]benzen

423-300-7

—

R43

R53

Xi

R: 43-53

S: (2-)24-37-61

616-200-00-1

blanding af: N,N′-ethan-1,2-diylbis(hexanamid);

12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamid;

N,N′-ethan-1,2-diylbis(12-hydroxyoctadecanamid)

432-430-3

—

R43

R53

Xi

R: 43-53

S: (2-)24-37-61

616-201-00-7

12-hydroxyoctadecansyre, reaktionsprodukter med 1,3-benzendimethanamin og hexamethylendiamin

432-840-2

220926-97-6

Xn; R20

R53

Xn

R: 20-53

S: (2-)22-61

616-202-00-2

blanding af: 2,2′-[(3,3′-dichlor[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)]-3-oxo-butanamid;

2-[[3,3′-dichlor-4′-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′-biphenyl]-4-yl]azo]-N-(2-methylphenyl)-3-oxo-butanamid;

2-[[3,3′-dichlor-4′-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′-biphenyl]-4-yl]azo]-N-(2-carboxylphenyl)-3-oxo-butanamid

434-330-5

—

Carc. Cat. 3; R40

R43

R53

Xn

R: 40-43-53

S: (2-)36/37-61

616-203-00-8

blanding af: N-[5-[bis-(2-methoxy-ethyl)-amino]-2-(2-butyl-4,6-dicyan-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl-azo)-phenyl]-acetamid;

N-[2-(2-butyl-4,6-dicyan-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-5-diethylamino-phenyl]-acetamid

442-280-0

—

R53

R: 53

S: 61

616-204-00-3

N,N′′-(methylendi-4,1-phenylen)bis[N′-octylurinstof]

451-060-3

122886-55-9

R53

R: 53

S: 61

617-022-00-7

blanding af: 1,2-dimethylpropylidendihydroperoxid;

dimethyl-1,2-benzendicarboxylat

442-480-8

—

O; R7

Xn; R22

C; R34

R43

N; R51-53

O; C; N

R: 7-22-34-43-51/53

S: (1/2-)3/7-14-26-36/37/39-45-50-61

647-017-00-5

laccase

420-150-4

80498-15-3

R42

Xn

R: 42

S: (2-)23-45

---

BILAG 1C

I bilag I udgår stofferne med følgende numre:

024-004-01-4, 603-037-01-3, 603-155-00-8, and 611-084-00-9.

---

II Retsakter vedtaget i henhold til traktaterne om oprettelse af Det Europæiske Fællesskab/Euratom, hvis offentliggørelse ikke er obligatorisk

AFGØRELSER OG BESLUTNINGER

Europa-Parlamentet og Rådet

| 16.1.2009 | DA | Den Europæiske Unions Tidende | L 11/83 |
| --- | --- | --- | --- |

16.1.2009

DA

Den Europæiske Unions Tidende

L 11/83

---

EUROPA-PARLAMENTETS OG RÅDETS AFGØRELSE

af 14. januar 2009

om udnævnelse af den europæiske tilsynsførende for databeskyttelse og den assisterende tilsynsførende

(2009/30/EF)

EUROPA-PARLAMENTET OG RÅDET FOR DEN EUROPÆISKE UNION HAR —

under henvisning til Europa-Parlamentets og Rådets forordning (EF) nr. 45/2001 af 18. december 2000 om beskyttelse af fysiske personer i forbindelse med behandling af personoplysninger i fællesskabsinstitutionerne og -organerne og om fri udveksling af sådanne oplysninger (1), særlig artikel 42, stk. 1,

under henvisning til den liste over ansøgere, som Kommissionen i overensstemmelse med artikel 42, stk. 1, i forordning (EF) nr. 45/2001 opstillede den 21. oktober 2008 på grundlag af et offentligt stillingsopslag med henblik på udnævnelse af den europæiske tilsynsførende for databeskyttelse og den assisterende tilsynsførende, og

ud fra følgende betragtning:

Europa-Parlamentet og Rådet bør efter fælles aftale udnævne den europæiske tilsynsførende for databeskyttelse og den assisterende tilsynsførende for en periode på fem år fra den 17. januar 2009 —

TRUFFET FØLGENDE AFGØRELSE:

Artikel 1

For perioden fra den 17. januar 2009 til den 16. januar 2014 udnævnes:

| — | Peter HUSTINX til europæisk tilsynsførende for databeskyttelse |
| --- | --- |

—

Peter HUSTINX til europæisk tilsynsførende for databeskyttelse

| — | Giovanni BUTTARELLI til europæisk assisterende tilsynsførende. |
| --- | --- |

—

Giovanni BUTTARELLI til europæisk assisterende tilsynsførende.

Artikel 2

Denne afgørelse har virkning fra dagen for vedtagelsen.

Artikel 3

Denne afgørelse offentliggøres i Den Europæiske Unions Tidende.

Udfærdiget i Bruxelles, den 14. januar 2009.

På Europa-Parlamentets vegne

H.-G. PÖTTERING

Formand

På Rådets vegne

A. VONDRA

Formand

---

(1)  EFT L 8 af 12.1.2001, s. 1.

1

---

Kommissionen

| 16.1.2009 | DA | Den Europæiske Unions Tidende | L 11/84 |
| --- | --- | --- | --- |

16.1.2009

DA

Den Europæiske Unions Tidende

L 11/84

---

KOMMISSIONENS BESLUTNING

af 12. januar 2009

om ændring af beslutning 2007/716/EF for så vidt angår visse virksomheder i sektorerne for kød og mælk i Bulgarien

(meddelt under nummer K(2008) 8988)

(EØS-relevant tekst)

(2009/31/EF)

KOMMISSIONEN FOR DE EUROPÆISKE FÆLLESSKABER HAR —

under henvisning til traktaten om oprettelse af Det Europæiske Fællesskab,

under henvisning til akten om Bulgariens og Rumæniens tiltrædelse, særlig artikel 42,

under henvisning til Rådets direktiv 89/662/EØF af 11. december 1989 om veterinærkontrol i samhandelen i Fællesskabet med henblik på gennemførelse af det indre marked (1), særlig artikel 9, stk. 4, og

ud fra følgende betragtninger:

| (1) | Ved Kommissionens beslutning 2007/716/EF (2) er der fastlagt overgangsforanstaltninger vedrørende de strukturelle krav til visse virksomheder i sektorerne for kød og mælk i Bulgarien i overensstemmelse med Europa-Parlamentets og Rådets forordning (EF) nr. 852/2004 (3) og (EF) nr. 853/2004 (4). Så længe de pågældende virksomheder er i omstillingsfasen, bør produkter med oprindelse i disse virksomheder kun bringes i omsætning på hjemmemarkedet eller anvendes til videre forarbejdning på bulgarske virksomheder, der er omfattet af overgangsordningen. |
| --- | --- |

(1)

Ved Kommissionens beslutning 2007/716/EF (2) er der fastlagt overgangsforanstaltninger vedrørende de strukturelle krav til visse virksomheder i sektorerne for kød og mælk i Bulgarien i overensstemmelse med Europa-Parlamentets og Rådets forordning (EF) nr. 852/2004 (3) og (EF) nr. 853/2004 (4). Så længe de pågældende virksomheder er i omstillingsfasen, bør produkter med oprindelse i disse virksomheder kun bringes i omsætning på hjemmemarkedet eller anvendes til videre forarbejdning på bulgarske virksomheder, der er omfattet af overgangsordningen.

| (2) | Beslutning 2007/716/EF er blevet ændret ved Kommissionens beslutning 2008/290/EF (5), 2008/330/EF (6), 2008/552/EF (7), 2008/678/EF (8) og 2008/828/EF (9). |
| --- | --- |

(2)

Beslutning 2007/716/EF er blevet ændret ved Kommissionens beslutning 2008/290/EF (5), 2008/330/EF (6), 2008/552/EF (7), 2008/678/EF (8) og 2008/828/EF (9).

| (3) | Det fremgår af en officiel erklæring fra den kompetente bulgarske myndighed, at visse virksomheder i sektorerne for kød og mælk er lukket eller har afsluttet forbedringen af deres anlæg og nu er i fuld overensstemmelse med de relevante EF-retsforskrifter. Disse virksomheder bør derfor udgå af listen over virksomheder, der er omfattet af overgangsordningen. |
| --- | --- |

(3)

Det fremgår af en officiel erklæring fra den kompetente bulgarske myndighed, at visse virksomheder i sektorerne for kød og mælk er lukket eller har afsluttet forbedringen af deres anlæg og nu er i fuld overensstemmelse med de relevante EF-retsforskrifter. Disse virksomheder bør derfor udgå af listen over virksomheder, der er omfattet af overgangsordningen.

| (4) | Bilaget til beslutning 2007/716/EF bør derfor ændres i overensstemmelse hermed. |
| --- | --- |

(4)

Bilaget til beslutning 2007/716/EF bør derfor ændres i overensstemmelse hermed.

| (5) | Foranstaltningerne i denne beslutning er i overensstemmelse med udtalelse fra Den Stående Komité for Fødevarekæden og Dyresundhed — |
| --- | --- |

(5)

Foranstaltningerne i denne beslutning er i overensstemmelse med udtalelse fra Den Stående Komité for Fødevarekæden og Dyresundhed —

VEDTAGET FØLGENDE BESLUTNING:

Artikel 1

Bilaget til beslutning 2007/716/EF ændres som angivet i bilaget til nærværende beslutning.

Artikel 2

Denne beslutning er rettet til medlemsstaterne.

Udfærdiget i Bruxelles, den 12. januar 2009.

På Kommissionens vegne

Androulla VASSILIOU

Medlem af Kommissionen

---

(1)  EFT L 395 af 30.12.1989, s. 13.

1

(2)  EUT L 289 af 7.11.2007, s. 14.

2

(3)  EUT L 139 af 30.4.2004, s. 1. Berigtiget i EUT L 226 af 25.6.2004, s. 3.

3

(4)  EUT L 139 af 30.4.2004, s. 55. Berigtiget i EUT L 226 af 25.6.2004, s. 22.

4

(5)  EUT L 96 af 9.4.2008, s. 35.

5

(6)  EUT L 114 af 26.4.2008, s. 94.

6

(7)  EUT L 178 af 5.7.2008, s. 43.

7

(8)  EUT L 221 af 19.8.2008, s. 32.

8

(9)  EUT L 294 af 1.11.2008, s. 11.

9

---

BILAG

I bilaget til beslutning 2007/716/EF foretages følgende ændringer:

| 1) | Følgende linjer i listen over kødforarbejdningsvirksomheder udgår:








  Nr. | Veterinærnr. | Virksomhedens navn | By/vej eller landsby/region |
| --- | --- | --- | --- | --- |
| »1. | BG 0101001 | »Melnichen kombinat Rila STH« AD | gr. Blagoevgrad
  ul. »V. Levski« 56 |
| 19. | BG 0401012 | »Polikomers-SG« EOOD | s. Shemshevo
  obsht. V. Tarnovo |
| 104. | BG 0602004 | »Z i K« OOD | gr. Vratsa
  ul. »Vasil Kanchov« 25 |
| 126. | BG 2202025 | ET »Takt-Asia Milanova« | gr. Sofia
  obsht. Lyulin
  ul. »Obelsko shose« 11 |
| 260. | BG 1204008 | ET »Petar Parvanov — Demetra« | gr. Lom
  ul. »Belogradchishko shose« 1 |
| 283. | BG 1604014 | »Elko« OOD | gr. Plovdiv
  ul. »Brezovsko shose« 170 |
| 355. | BG 2504001 | ET »Stezis« | gr. Omurtag
  Promishlena zona« |

1)

Følgende linjer i listen over kødforarbejdningsvirksomheder udgår:

Nr.

Veterinærnr.

Virksomhedens navn

By/vej eller landsby/region

»1.

BG 0101001

»Melnichen kombinat Rila STH« AD

gr. Blagoevgrad

ul. »V. Levski« 56

19.

BG 0401012

»Polikomers-SG« EOOD

s. Shemshevo

obsht. V. Tarnovo

104.

BG 0602004

»Z i K« OOD

gr. Vratsa

ul. »Vasil Kanchov« 25

126.

BG 2202025

ET »Takt-Asia Milanova«

gr. Sofia

obsht. Lyulin

ul. »Obelsko shose« 11

260.

BG 1204008

ET »Petar Parvanov — Demetra«

gr. Lom

ul. »Belogradchishko shose« 1

283.

BG 1604014

»Elko« OOD

gr. Plovdiv

ul. »Brezovsko shose« 170

355.

BG 2504001

ET »Stezis«

gr. Omurtag

Promishlena zona«

| 2) | Følgende linjer i listen over mælkeforarbejdningsvirksomheder udgår:








  Nr. | Veterinærnr. | Virksomhedens navn | By/vej eller landsby/region |
| --- | --- | --- | --- | --- |
| »16. | BG 1512033 | ET »Voynov-Ventsislav Hristakiev« | s. Milkovitsa
  obsht. Gulyantsi |
| 39. | BG 2312036 | ET »Rosen Deyanski-DEYA« | s. Opitsvet, obsht. Kostinbrod |
| 50. | BG 1612020 | ET »Bor-Chvor« | s. Dalbok izvor
  obsht. Parvomay |
| 60. | BG 2812003 | »Balgarski yogurt« OOD | s. Veselinovo
  obl. Yambolska |
| 110. | 1612013 | »Polidey – 2« OOD | s. Domlyan |
| 171. | 2412019 | »Dekada« OOD | s. Elhovo
  obsht. Stara Zagora |
| 205. | BG 2218045 | »El-Em-Impeks« EOOD | gr. Sofia
  Kv. Gorna bania« |

2)

Følgende linjer i listen over mælkeforarbejdningsvirksomheder udgår:

Nr.

Veterinærnr.

Virksomhedens navn

By/vej eller landsby/region

»16.

BG 1512033

ET »Voynov-Ventsislav Hristakiev«

s. Milkovitsa

obsht. Gulyantsi

39.

BG 2312036

ET »Rosen Deyanski-DEYA«

s. Opitsvet, obsht. Kostinbrod

50.

BG 1612020

ET »Bor-Chvor«

s. Dalbok izvor

obsht. Parvomay

60.

BG 2812003

»Balgarski yogurt« OOD

s. Veselinovo

obl. Yambolska

110.

1612013

»Polidey – 2« OOD

s. Domlyan

171.

2412019

»Dekada« OOD

s. Elhovo

obsht. Stara Zagora

205.

BG 2218045

»El-Em-Impeks« EOOD

gr. Sofia

Kv. Gorna bania«

---

16.1.2009

| 16.1.2009 | DA | Den Europæiske Unions Tidende | L 11/s3 |
| --- | --- | --- | --- |

DA

Den Europæiske Unions Tidende

L 11/s3

---

MEDDELELSE TIL LÆSERNE

Institutionerne har besluttet, at der ikke længere skal henvises til den seneste ændring af en given retsakt.

Medmindre andet er angivet, forstås en henvisning til en retsakt i de tekster, der offentliggøres i Den Europæiske Unions Tidende, derfor som en henvisning til retsakten i dens gældende udgave.

---